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Summary 
 
In the course of evolution life has adapted to the background radiation present 
on Earth. But since the discovery of ionizing radiation in 1890s it became 
widely used in numerous applications and its impact on human health has 
increased. Identification of robust and reliable radiation biomarkers of 
exposure, which can be used as biological dosimeters following a large-scale 
nuclear accident or a terroristic attack are of pivotal importance for 
radiobiological research. On the other hand, specific biomarkers of individual 
radiosensitivity to different types of radiation would be of great value for 
improving radiotherapy treatment (personalized medicine) or for the selection 
of crews for long-term Space missions. 
As the model for our study we chose either human peripheral blood or 
isolated peripheral blood mononuclear cells (PBMCs), depending on the type 
of the experiment. 
As the first step of our study, we aimed at identifying gene expression 
biomarkers of exposure to radiation with increased sensitivity to low-
dose exposures. To this end, PBMCs from healthy volunteers were exposed 
in vitro to two X-ray doses relevant for medical triage: a moderate dose of 1.0 
Gy which might result in acute radiation syndrome and is associated with a 
high probability of long-term stochastic health effects and a low dose of 0.1 
Gy which is not associated with any immediate acute health effects but might 
require medical follow-up as the risk of long-term effects, particularly cancer, 
must be taken into consideration. We performed a whole-genome microarray 
study and identified the biomarkers (genes and exons) most suitable for 
classification of the samples according to the exposure dose. Our analysis 
also showed that several genes, especially those that were differentially 
expressed, are alternatively transcribed and spliced in response to irradiation. 
This suggests that evaluating gene expression at the level of single exons is 
xii 
 
of particular importance for optimal design of primer- or probe-based 
biodosimetric assays. We also confirmed the validity of our approach in a 
biodosimetry interlaboratory comparison study organized by the RENEB 
(Realizing the European Network of Biodosimetry) consortium. 
Based on our previous microarray results we designed a customized qRT-
PCR array for biodosimetry comprising a panel of 25 selected genes. For 
the genes exhibiting alternative splicing, we designed primers interrogating 
the most sensitive exons. This allowed us to validate our approach using a 
system applicable to large-scale radiological accidents. We used 
peripheral blood samples from healthy volunteers exposed to doses from 0 to 
2 Gy at several time points post-irradiation from 8 to 48 hours as reference 
samples and the samples from other individuals were used as “blind 
samples”. We could accurately predict dose, but also time after exposure. In 
this study we also compared different methodologies for RNA extraction 
available on the market and evaluated their applicability to emergency 
situations. We also used these customized qRT-PCR arrays in the second 
biodosimetry interlaboratory comparison organized by the RENEB 
consortium.  
As the last step of this study we aimed to compare the transcriptional 
response and DNA repair kinetics of human PBMCs after exposure to 
different radiation types. Understanding the differences in response of 
normal cells to low- and high-LET radiation is important for several reasons 
and applications. First of all, in order to optimally exploit the benefits of hadron 
therapy, it is essential to adequately predict the treatment outcome in 
comparison to the conventional photon radiotherapy, taking into account not 
only the difference in the response of tumors but also of normal cells. Second 
scenario, although less common, is the exposure of the crew to heavy ions 
during long-term Space missions. In this respect, it is important to study 
whether the response of normal cells to Space radiation and low-LET 
radiation is comparable and that therefore the extrapolations based on 
xiii 
 
predominantly low-LET epidemiological studies used for radiation protection 
purposes are valid in case of high-LET exposures. Transcriptional response 
to high- and low-LET radiation was similar in view of identity of activated 
genes at least at 8 hours post-exposure. However, heavy ions showed higher 
potential of activation of immunity-related gene sets and more persistent 
activation of p53-regulated genes compared to X-rays. With an eye to 
possible long-term Space flights, in the present study we also investigated the 
potential of a core signature of genes responsive to iron ions exposure to 
serve as an indicator of varied DNA repair capacity of healthy astronauts, 
which are expected to be selected for a similar mission.  
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Samenvatting 
 
Doorheen de evolutie hebben levende wezens zich aangepast aan de 
achtergrondstraling op aarde. Het was echter pas sinds de ontdekking van 
straling in de jaren 1890 dat het effectief gebruikt werd door mensen, met 
grote gevolgen op de gezondheid van de bevolking. De identificatie van 
robuste en betrouwbare biomerkers van bestraling zijn cruciaal om te kunnen 
gebruiken als biologische dosimeters (biodosimetrie) na een grootschalige 
nucleaire ramp of terroristische aanval. Bovendien zouden zulke biomerkers 
waardevol kunnen zijn om de individuele stralingsgevoeligheid van patiënten 
aan diverse stralingstypes te bepalen met het oog op gepersonaliseerde 
behandelingen. Verder zou deze bepaling van stralingsgevoeligheid uitermate 
interessant kunnen zijn om de bemanning van langete (interplanetaire) 
ruimtemissies te selecteren. 
Perifeer bloed of geïsoleerde perifere mononucleaire cellen (PBMCs) van 
gezonde vrijwilligers werden gebruikt als studiemiddel, afhankelijk van het 
experimentele ontwerp. 
Als eerste stap van de studie identificeerden we genexpressie biomerkers 
van stralingsblootstelling met verhoogde gevoeligheid na een lage 
dosis straling. Hiervoor werden PBMCs van gezonde vrijwilligers in vitro 
blootgesteld aan twee doses van X-straling die relevant zijn voor medische 
triage: ten eerste een matige dosis van 1.0 Gy, dewelke kan leiden tot acuut 
stralingssyndroom en een gekende rol heeft bij langetermijns stochastische 
effecten. Als tweede dosis werd 0.1 Gy gebruikt, die geen acute 
gezondheidseffecten veroorzaakt, maar waar een langere medische 
opvolging wel noodzakelijk kan zijn om bijvoorbeeld mogelijk gerelateerde 
kanker op te sporen. Op basis van een microarray experiment identificeerden 
we de meest geschikte biomerkers (genen en exonen) om de stalen te 
classificeren afhankelijk van de stralingsdosis. Onze analyse toonde verder 
xv 
 
aan dat verschillende genen, vooral diegenen met een veranderde expressie, 
een alternatieve splicing en transcriptie vertoonden na bestraling. We 
bevestigden onze bevindingen in een onafhankelijke interlaboratorium 
vergelijkende studie voor biodosimetrie, georganiseerd door het RENEB 
(Running the European Network of biological dosimetry and physical 
retrospective dosimetry) consortium.  
Gebaseerd op onze microarray resultaten ontwierpen we een nieuwe qRT-
PCR array voor biodosimetrie, bestaande uit een set van 25 genen. Voor 
de genen met alternatieve splicing ontwierpen we primers voor de meest 
gevoelige exonen. Op deze manier konden we onze strategie uitwerken in 
een systeem dat toepasbaar is voor grootschalige radiologische 
rampen. We gebruikten bloed van gezonde vrijwilligers om kalibratiecurves 
op te stellen met doses van 0 tot 2 Gy op diverse tijdspunten na bestraling, nl. 
8 uur tot 48 uur. Bloedstalen van andere individuen werden gebruikt als 
“blinde stalen”, waarvan nog de bstralingsdosis, noch de tijd na bestraling 
waren gekend. Op basis van onze biomerkers konden we accuraat de dosis 
en de tijd na bestraling achterhalen. In deze studie vergeleken we ook diverse 
commerciële methodes om RNA extractie uit te voeren en trachtten de 
toepasbaarheid ervan in noodsituaties te achterhalen. We gebruikten onze  
qRT-PCR arrays ook in de tweede interlaboratorium vergelijkende studie voor 
biodosimetrie georganiseerd door RENEB. 
Als laatste stap van deze studie wilden we de transcriptionele reactie en 
DNA reparatie-kinetiek bepalen van humane PBMCs na bestraling met 
verschillende types van straling. Een betere kennis van hoe normale cellen 
reageren t.o.v. straling met een lage of hoge lineaire energietransfer (LET) is 
belangrijk voor diverse redenen en toepassingen. Ten eerste, om de 
voordelen van hadrontherapie optimaal te benutten, is het essentieel om 
accuraat de gevolgen van de behandeling (in vergelijking tot conventionele 
foton radiotherapie) te voorspellen. Dit niet enkel voor tumorcellen, maar ook 
voor gezonde cellen. In het tweede scenario, ook al is het minder frequent 
xvi 
 
van toepassing, is er de bestraling van bemanningsleden met zware ionen 
tijdens langdurige ruimtemissies. In deze context is het dan belangrijk om te 
weten of de reactie van cellen op kosmische straling vergelijkbaar is met die 
op lage-LET straling en dat daarom extrapolaties gebaseerd op lage-LET 
epidemiologische studies ook geldig zijn voor hoge-LET blootstellingen. De 
transcriptionele reactie van cellen op hoge- en lage-LET straling was 
grotendeels vergelijkbaar inzake de identiteit van geactiveerde genen op ten 
minste 8 uur na bestraling. Echter, zware ionen vertoonden een hogere 
capaciteit om immuniteit-gerelateerde genen te activeren en een 
langdurigeractivatie van p53-gereguleerde genen in vergelijking tot X-straling. 
Met het oog op mogelijke langetermijns ruimtevluchten bestudeerden we ook 
de mogelijke aanwezigheid van cruciale genen, reactief op bestraling met 
ijzer ionen. Deze zouden als indicator van variabele DNA herstel-
mechanismes kunnen dienen bij het selecteren van gezonde astronauten.  
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1. 
Introduction  
 
1.1 Types of ionizing radiation: electromagnetic and particulate radiation 
Ionizing radiation is the type of radiation which carries enough energy to eject 
electrons from atoms or ionize them, hence the name. The notion of ionizing 
radiation comprises a vast spectrum of physical phenomena. Based on the 
physical nature ionizing radiation can be classified into electromagnetic and 
particulate radiation. The latter is made up of energetic subatomic particles, 
atoms and ions, while the ionizing electromagnetic waves include γ-rays, X-
rays and the higher ultraviolet part of the electromagnetic spectrum [1] (Figure 
1). Absorption of an X-ray or γ-ray photon can cause ionization due to its high 
energy content, which would be in excess of at least 10 eV (considered to be 
the minimum photon energy capable of causing ionization) [2].  
 
Figure 1. The scale of electromagnetic radiation, broken down into categories of ionizing and 
non-ionizing radiation. Available at https://www.mirion.com/introduction-to-radiation-safety/what-
is-radiation/. 
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1.2 Physical origins of different types of ionizing radiation 
Unstable nuclei undergo spontaneous transformation in order to convert to a 
stable state by emitting a part of their energy in the form of α-, β-particles and 
γ-rays. This process is naturally occurring and is called radioactive decay [1]. 
X-rays are in many aspects identical to γ-rays and the difference between the 
two is based on their source: γ-rays are emitted by the atomic nuclei during 
their natural decay, while X-rays are emitted as the result of electronic 
transitions and are produced in X-ray generators [1]. Besides α- and β-
particles, there are other particles such as neutrons, which are produced 
copiously in nuclear fission and fusion and accelerated charged nuclei, which 
are characteristic of cosmic radiation and can be artificially produced in 
particle accelerators [3]. The main characteristics of the above-listed radiation 
types are summarized in Table 1. 
 
1.3 Contributions of different radiation types to possible human 
exposure scenarios 
 
Different radiation types are particularly important in different exposure 
scenarios. For example, X-rays are widely used in medical imaging 
(projectional radiographs, computed tomography, fluoroscopy) and 
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conventional radiotherapy where lower energy X-ray beams are used for skin 
cancer treatment [4], while higher energy beams are used for treating the 
tumors within the body [5]. γ-rays are also used in radiotherapy (e.g., gamma-
knife which is used to treat brain tumors) and nuclear medicine for imaging 
purposes (e.g., Single Photon Emission Computed Tomography and Positron 
Emission Tomography).  
Another type of radiotherapy, hadron therapy, involves the therapeutic use of 
protons and heavier ions, such as carbon ions. Of these, proton therapy is the 
most common [6], though still rarely used compared to other forms of external 
beam radiotherapy. Exposure to protons, alpha-particles and heavier ions up 
to iron also occurs during Space flights [7].  
Radiation exposure as a result of nuclear accidents can happen in three 
ways: total or partial body exposure as a result of close proximity to a 
radiation source, external contamination, and internal contamination [8]. In 
previous reactor accidents, only plant workers and emergency personnel had 
substantial total or partial body external exposure mainly due to β-radiation 
which can be a significant source of dose to skin and high-energy γ-radiation 
which penetrates deeply and results in exposure of internal organs [8]. 
External contamination occurs when the fission products settle on human 
body, thereby exposing skin or internal organs. Internal contamination occurs 
when fission products are ingested, inhaled or enter the body through open 
wounds. The latter is the primary exposure mechanism due to which large 
populations living around a reactor can be exposed to radiation in case of an 
accident [8]. Following a reactor accident a variety of radioisotopes are 
released into the environment. The health threat from each of them depends 
on many factors, such as the half-life, whether they are gaseous and whether 
they are released in substantial quantities [8]. Contamination with most of the 
radioisotopes results in exposure to β- and γ-radiation; some of them are also 
sources of α-particles [8]. Among the different radioisotopes, iodine-131 is an 
important source of exposure because of its prevalence in reactor discharges 
Chapter 1. Introduction 
5 
 
and its tendency to settle on the ground. After entering the body, iodine-131 
rapidly accumulates in the thyroid gland, where it can be a source of 
substantial doses of β- and γ-radiation [8]. 
1.4 Low and high linear energy transfer (LET) radiation 
Linear energy transfer is the average amount of energy that is released per 
unit length of the radiation track. LET depends on the nature of the radiation 
as well as on the material it interacts with and is usually expressed in units of 
keV/µm [3]. Generally speaking, X-, γ-rays and β-particles are considered 
low-LET or sparsely ionizing radiations, while energetic neutrons, protons, α-
particles and heavier charged particles are considered high-LET or densely 
ionizing radiations. The LET of radiation describes its energy deposition 
density, which largely determines the biological consequences of radiation 
exposure [1]. Examples of LET values of main radiation types are given in 
Table 1. The examples of patterns of energy deposition for different types of 
radiation resulting in different distribution of DNA double-strand breaks are 
shown in Figure 2. In contrast to photon radiations, for which the dose 
distribution in matter is characterized by an exponential decline in dose with 
depth, high-energy charged particles deposit relatively little energy as they 
enter the absorbing material but tend to deposit extremely large amounts of 
energy in a very narrow peak, the Bragg peak, as they reach the end of their 
track, which results in a dramatic increase of the LET [9].  
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Figure 2. Simulated patterns of DNA double-strand breaks distribution after photon and ion 
irradiation in a typical cell nucleus (radius of ≈5 μm). Adapted from [10]. 
1.5 Relative biological effectiveness  
Even though LET is widely used to categorize radiation-induced damage, it is 
not a good parameter to describe the full spectrum of biological radiation 
effects. Multiple experiments in irradiated cultured cells and healthy and 
tumor-bearing animals were performed in order to define the biological 
effectiveness of the accelerated particles in comparison to the same physical 
dose of a reference radiation (250kV X-rays or 
60
Co γ-rays) using such 
endpoints, as the cell survival, chromosomal aberrations induction, 
histological changes, median lethal dose, etc. [11]. The obtained value is 
known as the relative biological effectiveness (RBE). An elevated RBE has 
been clearly demonstrated for ions heavier than helium [12]. The RBE rises 
with LET increasing to 100–200 keV/µm and decreases at higher LET values 
- the effect known as the “over-kill” effect, i.e., more dose is deposited in a cell 
than is necessary to kill it [12].  
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1.6 Dose quantities 
The absorbed dose (D) is the energy (Δε) absorbed in specified volume per 
unit mass (Δm):  
D =
Δε
Δm
 
The SI unit used to measure absorbed dose is the gray (Gy). One Gy is 
equivalent to 1 joule per kilogram. The absorbed dose is independent of the 
radiation type and does not describe the biological effect of radiation.  
To enable consideration of stochastic health risk (such as cancer induction) 
based on the different radiation qualities and organ sensitivities, the 
International Commission on Radiological Protection (ICRP) introduced the 
terms equivalent dose and effective dose [13]. The most recent guidelines on 
the calculations for conversion of the absorbed dose into equivalent dose 
which takes into account the radiation type R, and the effective dose which 
takes into account the irradiated tissue (T), are given in the ICRP Publication 
103 [14]. The SI unit of the equivalent and the effective dose is the sievert 
(Sv).  
The equivalent dose absorbed by tissue T (HT) is calculated using the 
following formula: 
 
where, 
WR is the radiation weighting factor  
DT,R is the absorbed dose in tissue T by radiation type R 
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In case there are different types of radiation (R) involved, summation is 
performed. The weighting factors for different radiation types (WR) are given in 
Table 1. 
The effective dose (E) is calculated from the equivalent dose using the 
following formula: 
 
where, 
WT is the tissue weighting factor 
HT is the equivalent dose absorbed by tissue T 
In case there are several organs or tissues (T) being irradiated, summation is 
performed. The weighting factors (WT) for the organs and tissues considered 
for calculation of the effective dose are listed in Table 2. In case of total body 
exposure all the organs and tissues for which specific weighting factors are 
defined are always included in the calculation, while in case of partial body 
exposure only the organs at risk of exposure are taken into account. For the 
gonads, the arithmetic mean of the absorbed doses to ovaries and testes is 
used in conjunction with the weighting factor of 0.20. Absorbed doses to blood 
and blood vessels are not included in the calculation [15]. 
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1.7 Health risks associated with ionizing radiation 
The health effects of ionizing radiation are divided in two main categories: 
deterministic and stochastic effects. The main difference between the two 
types of the effects is the mechanism of their production: stochastic effects 
are caused by non-lethal mutational events in cells, while deterministic effects 
are caused by cell killing. Radiological protection dose limits are generally set 
based on stochastic risks and these fall well below the level at which there is 
any likelihood of deterministic injury [16], while deterministic effects are of 
most relevance in radiotherapy, where normal tissue doses are limited to 
avoid these effects [17]. The approach used by ICRP to take into account the 
induction of stochastic effects by high-LET compared to low-LET radiation is 
to multiply the dose by a radiation weighting factor [14]. However, these 
weighting factors are generally too high to be applied to deterministic effects 
and therefore it is suggested that judgments of RBE should be made from a 
case by case inspection [18]. 
1.7.1 Deterministic effects 
Deterministic effects occur when too many cells are killed by radiation for the 
body to replace within a reasonable time, usually because the stem cell pool 
has also been seriously depleted. Therefore deterministic effects generally 
occur only after high-dose acute exposure with a threshold dose below which 
the effect is not observed. Deterministic effects are generally observed days 
(e.g. prodromal syndrome, gastrointestinal syndrome, central nervous system 
syndrome) or weeks (e.g. haematopoietic syndrome, pulmonary syndrome) 
following radiation exposure; however, certain deterministic effects (e.g. 
cataracts, hypothyroidism) only become evident after a period of years [16].  
1.7.2 Stochastic effects 
Stochastic effects, which include somatic (such as cancer induction) and 
genetic effects, are the main late health effects of radiation exposure, with 
somatic risks being the most detrimental. For both somatic and genetic effects 
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the probability of their occurrence, and not their severity, is dependent on the 
radiation dose [17]. Also, in contrast to the deterministic effects, for stochastic 
effects it is generally accepted that there is no threshold dose for the effect to 
be observed, as there is not enough epidemiological evidence for setting such 
thresholds [19]. The data used to predict stochastic effects, such as radiation-
induced cancers, comes from (a) the Japanese atomic bomb survivors, (b) 
medically exposed populations and (c) occupationally exposed populations 
[20]. BEIR VII Committees, US Environmental Protection Agency, ICRP and 
the United Nations Scientific Committee on the Effects of Atomic Radiation 
(UNSCEAR) developed multiple cancer risk models, taking into account such 
parameters as gender, age at exposure and time since exposure, which result 
in an overall average lifetime excess risk of cancer development of 
approximately 5%/Sv [21]. Development of a malignancy can take 20-30 
years for solid tumors and 5-10 years for leukaemia. For both solid tumors 
and leukaemia, a reduction of excess relative risk with increasing age at 
exposure, and a reduction of excess relative risk with increasing time after 
exposure were shown [17]. The heritable radiation-induced genetic risks 
occur when exposed cells include reproductive ones and are estimated based 
on the data from animal studies combined with the baseline incidence of 
disease in human populations [22]. There is also emerging evidence of 
excess risks of non-cancer late health effects, such as circulatory, digestive 
and respiratory diseases, in the Japanese atomic bomb survivors [23, 24].  
1.8 Sources of ionizing radiation 
Exposure to ionizing radiation from natural sources is an unavoidable feature 
of life on the Earth and for most individuals this exposure exceeds the one 
from man-made sources [25]. The two main natural sources of radiation are 
the high-energy cosmic radiation and the radioactive nuclides originating from 
the Earth’s crust, which are present everywhere, including the human body. 
Since the discovery of X-rays by Wilhelm Konrad Roentgen in 1895 and the 
naturally emitted radiation from uranium by Henri Becquerel in 1896, ionizing 
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radiation has experienced the rise and fall of its popularity. By the 1920s, 
accumulating evidence of the adverse effects of ionizing radiation led to the 
foundation in 1928 of the International X-ray and Radium Protection 
Committee which issued the first radiation protection guidelines, although only 
for professionals in the medical field. In 1950 it was restructured to take 
account of new uses of radiation outside the medical area, and given its 
present name - the International Commission on Radiological Protection.  
Nowadays, man-made sources of ionizing radiation are still widely used for 
multiple industrial, military and medical purposes, but both occupational 
exposures as well as those to the general public are strictly regulated and 
should be limited to 20 mSv/year and 1 mSv/year whole body exposure, 
respectively (excluding any medical and natural background radiation doses) 
[26]. For the purpose of quantifying cancer risk associated with radiation 
exposure the ICRP used as a rule of thumb, effective doses above or equal to 
1 Sv, 100 mSv, 10 mSv, 1 mSv, and 0.1 mSv to signify the terms “moderately 
high”, “moderate”, “low”, “very low”, and “extremely low” doses, respectively 
[27]. 
In 2008 UNSCEAR proposed the classification of radiation exposures given in 
Table 3 [25].  
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Annual average doses and ranges of individual doses of ionizing radiation by 
source are given in Table 4. 
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Table 4. Annual average doses (worldwide) and ranges of individualdosesof ionizing radiation by souree trom [25] 
Souree o r mode 
Natural sourees of exposure 
lnhalation (radon) 
Extern al terrestrial 
lngest ion 
Cosmie radiat ion 
Total natura! 
Artificial sourees of exposure 
Medica! diagnosis (nat therapy) 
Atmospheric nuc lear testing 
Occupational exposure 
Chernobyl accident 
Nuc lear fuel cycle (public 
exposure) 
Total artificial 
Annual 
average 
dose, mSv 
1.26 
0.48 
0.29 
0.39 
2.4 
0.6 
0.005 
0.005 
0.002* 
0.002* 
0.6 
Typical range of individual doses, mSv Comments 
0.2-10 The dose is much higher in some dwellings. 
0.3-1 The dose is higher in some locations. 
0.2-1 
0.3-1 The dose increases with altitude. 
1-13 Sizeable popuiatien groups receive 10-20 mSv. 
0- several tens The averages tor different levels of health care range 
trom 0.03 to 2.0 mSv; averages torsome countries 
are higher than that due to natura! sources; individual 
doses depend on specific examinations . 
Same higher doses around test sites still occur. The average has tallen trom a peak of 0.11 mSv in 
1963. 
-0-20 The average dose to all workers is 0. 7 mSv. Most of 
the average dose and most high exposures are due to 
natura! radialion (specifically radon in mines). 
In 1986, the average dose to more than 300,000 The average in the Narthem hemisphere has 
recovery workers was near1y 150 mSv; and more decreased trom a maximum of 0.04 mSv in 1986 . 
than 350,000 ether individuals received doses Thyroid doses we re much higher. 
greaterthan 10 mSv. 
Doses are up to 0.02 mSv tor critic al groups at 1 
km trom some nuclear reactor sites. 
From essentially zero to several tens lndividual doses depend primarily on medica I 
treatment, occupational exposure and proximity totest 
ar accident sites. 
• Globally dispersed radionuclides. The value for the nuclear fuel cycle represents the maximum per caput annual do se to the public in the future, assuming the practice 
continues tor 100 years, and derives mainly trom globally dispersed, long-lived radionuclides released during reprocessing of nuclear fuel and nuclear power plant operation. 
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As can be seen from the numbers given in Table 4, about 80% of the annual 
dose worldwide is due to the natural sources of radiation. In the developed 
countries, however, as can be seen from Figure 3, the main contribution to 
the average annual exposure dose comes from medical applications. 
Moreover, for example, in the United States of America the dose has 
increased more than 5.5-fold since 1987 (Figure 3). In Belgium, since the 
beginning of use of man-made sources of radiation, the average annual 
exposure dose has doubled [28] (Figure 3). The main contribution to the total 
collective effective dose (47% of it) is made by computed tomography (CT) 
scanning, the average dose per examination in 1997-2007 was 7.4 mSv [29]. 
In Belgium, CT scans contribute to 59% of doses received from diagnostic X-
ray examinations [28].  
 
Figure 3. Upper panel: estimated contributions to public exposure from different sources of 
radiation in the United States in 1987 [30] and 2006 [31]. Lower panel: estimated contributions to 
public exposure from different sources of radiation in Belgium in 1895 and 2006 [28]. 
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In a recent study it was shown, however, that the risks from the medical use 
of ionizing radiation are perceived much lower by the general population 
compared to the experts working with ionizing radiation. Opposite to this, the 
general population had a higher risk perception for nuclear waste, an accident 
in a nuclear installation and natural radiation, and they were more concerned 
about Belgian nuclear installations after the Fukushima accident [32].  
The exposure scenarios most relevant for the present study are discussed 
below. 
1.8.1 Nuclear power plant accidents 
The electricity generation by nuclear power plants grew steadily since 1956. 
Although the doses from nuclear power reactors to which the general public is 
exposed are generally very low and decrease over time because of lower 
discharge levels [25], the possibility of serious accidents raises serious 
concerns among the general public.  
To date there have been two major accidents classified as the highest 
possible Level 7 accidents on the International Nuclear Event Scale [33]: The 
Chernobyl accident on the 26
th
 of April 1986 and the Fukushima Daiichi 
accident on the 11
th
 of March 2011.   
The accident at the Chernobyl nuclear power plant in 1986 is the most severe 
in history. In total 134 plant workers and emergency personnel were exposed 
to high doses of radiation (0.8 – 16 Gy) and suffered acute radiation 
syndrome [34]. Of these, 28 died within the first three months after the 
accident. Besides that, about 530,000 clean-up workers (known as 
“liquidators”) received doses of between 0.02 and 0.5 Gy [34], but for a 
number of reasons, individual doses were monitored inadequately (e.g. only 
one dosimeter was available per group) or were not registered at all (e.g. 
“pre-calculated” doses were used) for many of them [35]. In the longer term, 
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the general population was exposed to low levels of chronic radiation but 
there has been no consistent evidence yet of any other radiation-related 
health effects in the general population, except for more than 6,000 cases of 
thyroid cancer among the people who were children or adolescents in 1986 
[34]. The absence of demonstrated increased risk of developing other cancer 
types, however, is not a proof that no increase has occurred, as such an 
increase is difficult to detect and requires well-designed epidemiological 
studies [36]. According to the predictions based on the models of radiation-
associated risk from epidemiological studies, mainly of Japanese atomic 
bomb survivors, the predicted lifetime excess of cancer and leukaemia deaths 
was assessed to be about 4 000 cases for the three highest exposed groups 
(liquidators, evacuees and residents of the strict control zones) [37]. In 
addition, the fears about the effects of radiation and the uncertainty about the 
exposure doses in the affected population caused them to perceive 
themselves as helpless and lacking control over their future, which may have 
led to further health effects [38-40]. In fact, twenty years after Chernobyl, the 
Chernobyl Forum concluded that the biggest public health problem from 
Chernobyl accident was mental health [41]. 
The recent Fukushima accident was the second largest nuclear disaster ever. 
To date, there have been no fatalities that could be directly ascribed to the 
radiation exposure. In May 2013 UNSCEAR reported that "radiation exposure 
following the nuclear accident at Fukushima Daiichi did not cause any 
immediate health effects. It is unlikely to be able to attribute any health effects 
in the future among the general public and the vast majority of workers". The 
only individuals who received effective radiation doses of over 100 mSv 
predominantly from external exposures were 173 emergency and mitigation 
workers, 12 of which were estimated to have received absorbed doses to the 
thyroid from iodine-131 intake alone of 2 to 12 Gy. The average first-year 
effective doses to evacuees and to the population in the non-evacuated areas 
most affected by the accident were estimated to be in the range from about 1 
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to 10 mSv for adults and about twice as much for 1-year-olds [42]. In the 
World Health Organization (WHO) report the effective doses in the most 
affected areas of Fukushima prefecture were estimated to be within a dose 
range of 10–50 mSv [43]. Methodological options for estimation of the lifetime 
risks for cancer development were consciously chosen to avoid risk 
underestimation, therefore they are likely to represent the upper bound of the 
risk and are not absolute risks for developing such cancers. The additional 
lifetime risk for developing solid cancers (in females) was assessed to be 
around 1% (normally expected risk is 29%), for developing breast cancer (in 
females) – 0.36% (normally expected risk is 5.53%), for developing leukaemia 
(in males) – 0.04% (normally expected risk is 0.60%), for developing thyroid 
cancer (in females) – 0.50% (normally expected risk is 0.75%). The above-
mentioned estimations are valid for individuals exposed as infants [43]. The 
WHO report underlines that, although for the general population inside and 
outside of Japan, the predicted risks are very low, there is need for long-term 
health monitoring of those who are at high risk, along with the provision of 
necessary medical follow-up and support services [43]. Therefore, it can be 
stated that radiation exposure in general was comparatively low and certainly 
below the threshold of acute radiation disease albeit that possible 
measurement inaccuracies must be taken into consideration. For the general 
public the probability of receiving doses higher than 100 mSv after a similar 
nuclear accident is relatively low but the uncertainty about the received dose 
can lead to additional stress causing psychological problems and more 
serious health consequences [40, 44]. Adequate assessment and 
communication of the levels of exposure as well as possible health 
consequences to the general public are therefore of great importance. 
In order to create a sustainable EU network in biodosimetry the Realizing the 
European Network of Biodosimetry (RENEB) project was launched in 2012 
[45]. The goal of RENEB is to support in a coordinated way the response in 
case of major nuclear or radiological emergency in Europe. In order to assess 
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the preparedness of biodosimetric laboratories for emergency situations as 
well as to compare/harmonize the applied methodologies RENEB organized 
several biodosimetry interlaboratory comparison exercises [46-55]. The final 
goal of the project is to use the established network as a part of EU radiation 
emergency management. 
1.8.2 Space radiation 
Humans in Space are subjected to galactic cosmic rays (GCR) and solar 
particle events (SPE) which cause significant but poorly understood risks of 
carcinogenesis [7]. The GCR spectrum is composed primarily of high-energy 
protons and atomic nuclei, namely about 87% high energy protons, 12% 
alpha-particles and 1% heavier ions up to iron  [56] of very high energies 
ranging from hundreds of MeV per nucleon up to 1 GeV per nucleon [57], 
which are very difficult to shield from with currently used materials [58]. SPE 
consist of low to medium energy protons and α-particles, which enables 
efficient shielding inside the spacecraft but not inside a spacesuit during 
extravehicular activities. For the orbital missions a major contribution to the 
exposure dose is made by the geomagnetically trapped protons and electrons 
of the Van Allen radiation belt present at altitudes between 200 and 600 km 
known as the South Atlantic Anomaly (SAA) [59]. According to measurements 
performed during the Euromir ’95 mission on board the Mir Space station, the 
maximum dose due to crossing the SAA was 0.055 mGy and the mean dose 
rate inside the station was calculated to be 0.012-0.014 mGy/h, half of this 
value being due to the SAA [60]. 
According to the published data, chronic exposure to GCR occurs at a dose 
rate of 1.3 mGy/day (4.8 mSv/day equivalent dose) [61] and up to 0.5 Sv/h 
during large SPE [62]. Because of their high LET, a lower physical dose of 
high-charge and energy particles is needed to produce a certain biological 
effect compared to low-LET radiation. According to available calculations, 
during the trip to Mars every cell in the organism would be exposed to a 
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proton every 3 days, to an α-particle every 30 days and at least 3.2x10
12
 cell 
nuclei would be exposed to iron ions [63-65]. Based on the measurements of 
the energetic particle radiation inside the spacecraft containing the Curiosity 
rover on its way to Mars, the dose equivalent for the shortest round-trip there 
of about 500 days with current shielding was found to be 0.66 ± 0.12 Sv [61]. 
Radiation exposures during flight are always monitored using personal 
passive dosimeters (e.g. thermoluminescent dosimeters and solid-state 
nuclear track detectors), in order to detect the different radiation types 
encountered in Space [57]. However, these physical measurements only 
provide absorbed skin doses, which are consequently combined with 
computerized phantoms and radiation transport codes to estimate the dose at 
different regions of the body [66]. Therefore, physical dosimetry is always 
combined with biodosimetry data obtained by means of cytogenetic methods, 
which is more comprehensive in terms of the effects of shielding provided by 
the body itself as well as the effects of all radiation types [67]. Biodosimetry 
can also provide valuable information on individual sensitivity to radiation in 
the presence of additional stress factors such as, for example, microgravity.    
Many of the aspects of health dysregulations associated with long-term Space 
flights are not yet fully characterized and may represent a serious risk to crew 
members during deep Space missions. To date, about 550 persons have 
flown to Space the majority of which remained there for less than 30 days, 
therefore, few effects of return missions to e.g. Mars can be predicted. The 
differences in physical characteristics and biological effects of Space and low-
LET radiation make the usefulness of γ- or X-ray exposure data (from atomic 
bomb survivors and radiotherapy patients) in predicting heavy ion effects 
limited [7]. Cancer development remains the most important health risk factor 
in astronauts [7], but circulatory diseases are likely to be of great importance 
in the newer risk estimates for a mission to Mars [68], especially as recent 
data indicate that the cardiovascular disease mortality rate among Apollo 
astronauts, the only humans having travelled beyond the Earth’s 
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magnetosphere, was 4–5 times higher than in non-flight and low-orbit flight 
astronauts [69]. Experiments in mice performed by the same group suggest 
that the observed sustained vascular endothelial cell dysfunction is caused by 
the exposure to high-LET iron ions, and not the simulated microgravity or the 
combination of both [69]. Numerous studies reported that not only high dose 
exposure during radiotherapy treatment of e.g. lung or breast cancer [70-73], 
but also moderate doses of up to 2 Gy in A-bomb survivors [74] and low-dose 
radiation exposure due to medical procedures or occupational exposures [75-
78] were shown to increase the risk of developing ischemic heart disease and 
cardiovascular disease. In A-bomb survivors, exposed to lower doses, the 
observed cardiovascular effects are mainly ischemic heart disease and 
hypertension, suggesting that the vascular component might be more 
sensitive to lower doses [78, 79]. These observations suggest that the heart 
and blood vessels are not highly-radioresistant and are actually among the 
dose-limiting organs [80, 81].  
Another known health hazard of Space radiation exposure is the higher risk of 
induction of cataracts [82, 83]. Furthermore, several recent studies in animals 
suggest that high-LET radiation exposure may lead to cognitive dysfunction 
[84, 85] or even enhance pathological progression of Alzheimer’s disease 
[86], which could compromise mission critical activities [87]. 
1.8.3 Radiotherapy 
Radiotherapy, along with chemotherapy and surgery, is one of the most 
common cancer treatment options. Radiation  therapy  contributes  to  the  
cure  of  approximately  23%  of  all  cancer patients [88], thus playing an 
important role in cancer management. The majority of patients are treated 
with “conventional” photon beam therapy [88].   
The major improvements in the efficacy of radiation therapy were always 
associated with   significant progress in technology, moving from ortho-
voltage X-rays to 
60
Co and high-energy linear accelerators, combined with 
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more sophisticated diagnostic tools and radiation delivery methods [9]. The 
goal of any kind of radiotherapy is to deliver a high dose of radiation to the 
tumor site, while minimizing the dose to the surrounding healthy tissues and 
organs. Recent advances in external photon beams which can be precisely 
delivered to irregular targets via e.g. three-dimensional conformal, intensity 
modulated and image-guided radiotherapies are considered to be the 
culmination of photon therapy [9]. The search for further improvements is 
therefore directed to alternative radiation modalities such as hadron therapy. 
Hadron therapy is an advanced radiotherapy method, which uses beams of 
charged particles such as protons and carbon ions, which has become a 
promising radiation treatment modality for some types of cancer, such as e.g. 
skull-base tumors, head and neck tumors, prostate cancer, hepatocellular 
adenocarcinoma, bone and soft tissue sarcomas, non-small cell lung cancer 
and recurrent rectal cancer [89-92]. The main advantage of charged particle 
beams is the possibility of more precisely targeting the tumor, while the 
surrounding healthy tissues receive a much lower dose compared to 
conventional photon radiotherapy [93]. This is possible as charged particles 
deposit only a small dose along the way to the target, followed by a sudden 
increase in the dose when the particle is ultimately stopped, known as the 
Bragg peak. The behavior of the particle can be precisely predicted based on 
its physical characteristics and the beam can be directed so that the Bragg 
peak occurs exactly within the tumor site [94]. High-LET carbon ions, in 
addition, also have a higher RBE compared to conventional low-LET photon 
therapy [95], as particles deposit their energy in a more concentrated manner 
resulting in clustered DNA damage which is more lethal to the tumor cells 
[96]. 
About 5–20% patients receiving radiotherapy show abnormal tissue 
responses (e.g., inflammations, infections, ulcerations, fibrosis, necrosis, 
dermatitis and rectitis) during, early or long time after the end of radiotherapy 
[97]. The idea of establishing an assay capable of estimating normal tissue 
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radiosensitivity before the onset of the treatment is highly appealing, as, in 
theory, this would allow exploiting the benefits of radiotherapy dose escalation 
among the non-radiosensitive patients, while subjecting the radiosensitive 
ones to the conventional or even reduced doses [98].  
1.9 Cellular and molecular response to ionizing radiation 
1.9.1 Radiation-induced DNA damage and repair  
“DNA is, in fact, so precious and so fragile that we now know that the cell has 
evolved a whole variety of repair mechanisms to protect its DNA from 
assaults by radiation, chemicals and other hazards” (Sir Francis Crick (1988) 
What Mad Pursuit. Basic Books: New York).  
As Crick expected, cells have evolved elaborate DNA damage repair (DDR) 
mechanisms to respond to DNA damage. It is estimated that each of the 
~10
13
 cells in the human body receives tens of thousands of DNA lesions per 
day as a result of a variety of genotoxic attacks [99].  
The interaction of radiation with cells is extremely complex, as it can occur 
through direct interaction of radiation with cellular components or through 
indirect damage caused by elevated radiation-induced ROS production which 
therefore initiates a complex cellular response. Depending on the type of DNA 
damage, mammalian cells can activate one of the four main repair pathways 
– nucleotide-excision repair (NER), base-excision repair (BER), homologous 
recombination (HR) and non-homologous end joining (NHEJ). A general 
overview of the most common types of DNA damage and their sources, as 
well as the repair mechanisms and consequences is depicted in Figure 4.  
Chapter 1. Introduction 
23 
 
 
Figure 4. a. Common DNA damaging agents (top); examples of DNA lesions induced by these 
agents (middle); and most relevant DNA repair mechanism responsible for the removal of the 
lesions (bottom). b. Acute effects of DNA damage on cell-cycle progression, leading to transient 
arrest in the G1, S, G2 and M phases (top), and on DNA metabolism (middle). Long-term 
consequences of DNA injury (bottom) include permanent changes in the DNA sequence (point 
mutations affecting single genes or chromosome aberrations which may involve multiple genes) 
and their biological effects. cis-Pt – cisplatin, MMC - mitomycin C, (6–4)PP -  6–4 photoproduct 
and CPD – cyclobutane pyrimidine dimer. From [100]. 
The main types of DNA damage caused by ionizing radiation are (a) abnormal 
bases and single-strand breaks (SSBs), which are eliminated by BER, and (b) 
double-strand breaks (DSBs) repaired by recombination repair mechanisms 
(NHEJ or HR). The main components of these DDR mechanisms are listed in 
Table 5 [101]. 
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1.9.1.1 DDR mechanisms relevant for radiation-induced DNA damage 
NER is responsible for repairing a wide class of helix-distorting lesions mostly 
arising from exogenous sources (except for some oxidative lesions), that 
interfere with base pairing and obstruct transcription and replication. BER 
deals with small chemical alterations of bases mainly of endogenous origin 
which may or may not obstruct transcription and replication, although they 
frequently miscode. BER is therefore particularly relevant for preventing 
mutagenesis [100].  
Whereas SSB and base damages can be usually correctly repaired, this is not 
always the case for DSBs. Therefore, DSBs are considered to be the most 
severe as they are more likely to result in chromosome aberrations, genomic 
instability and can ultimately lead to cancer [102, 103]. 
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In NHEJ, DSBs are recognized by the Ku protein, which in its turn binds and 
activates the protein kinase DNA-PKcs, leading to recruitment and activation 
of end-processing enzymes, polymerases and DNA ligase IV [104]. HR is 
always initiated by the generation of single-stranded DNA (ssDNA) promoted 
by the proteins of the MRE11-RAD50-NBS1 (MRN) sensor complex. In 
events catalyzed by RAD51 and the breast-cancer susceptibility proteins 
BRCA1 and BRCA2, the ssDNA then invades the undamaged template. The 
following actions of polymerases, nucleases, helicases and other components 
result in DNA ligation and substrate resolution [105]. The mechanisms of 
NHEJ and HR are depicted in Figure 5. 
Figure 5. Mechanisms of homologous recombination and non-homologous end joining. From 
[106]. 
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The relative contribution of the two DSB repair pathways varies in different 
cell types and in different phases of the cell cycle [107]. To a large extent this 
choice can be explained by the fact that HR requires the presence of an intact 
sister chromatid and, as sister chromatids are only available in G2 and late S-
phase, this repair mechanism is clearly cell-cycle stage specific. In several 
studies on mammalian cells irradiated during different cell cycle phases, 
NHEJ was found to be important in all cell cycle phases and predominant in 
G1 and early S-phase, while HR is particularly important in late S/G2 phase 
[108, 109]. Cell cycle-dependent expression of the key repair proteins may 
also play a role in the DSBs repair mode. Cellular levels of several 
homologous recombination-specific factors such as BRCA1, RAD51 and 
RAD52 increase as cells progress from G1 to S phase [110]. The choice 
between the two DSB repair pathways is also partly determined by whether 
the DNA ends at the DSB require resection - the processing of DNA ends to 
generate 3′ single-strands, which is required for HR but inhibits canonical 
NHEJ in which DNA ends are protected with minimal processing before 
joining [111].  
Protein kinases ATM and ATR, the key DDR-signalling components in 
mammalian cells, also activate protein kinases CHK1 and CHK2 which, 
together with ATM and ATR, reduce cyclin-dependent kinase (CDK) activity. 
Inhibition of CDKs delays or stops the cell cycle at critical stages before or 
during DNA replication (G1/S and intra-S checkpoints) and before cell division 
(G2/M checkpoint), preventing duplication and segregation of damaged DNA 
[112]. If the DNA repair is efficient, the resumption of normal cell functioning 
occurs. Alternatively, if the damage cannot be removed, chronic DDR 
signaling triggers apoptosis or senescence (i.e. permanent cell-cycle 
withdrawal).  
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1.9.1.2 Formation of DDR foci 
In response to DSBs, PI3-K like kinases, including ATM, ATR and DNA-PKcs 
rapidly phosphorylate the conserved C-terminal tail of H2AX at serine-139. 
ATM and DNA-PKcs play an equal role in phosphorylating H2AX following 
ionizing radiation exposure, while ATR is more important for H2AX 
phosphorylation in response to DNA damage that would slow or stall 
replication forks [113]. The phosphorylation of H2AX creates γH2AX, which is 
crucial for modulation of chromatin structure and subsequent accumulation of 
various signalling and repair proteins to DNA breaks [114]. Several essential 
DNA-repair factors implicated either in HR (e.g., BRCA1, RAD51) or in both 
HR and NHEJ (e.g., RAD50, 53BP1) form nuclear foci that co-localize with 
γH2AX [115, 116]. Factors accumulating at DSB sites do not always co-
localize perfectly, with some DDR proteins being present directly at damage 
sites, coating ssDNA resulting from DSB resection, and those associated with 
DSB-flanking chromatin (Figure 6) [117]. DDR proteins initially accumulate at 
DSB sites and then spread at distance via a positive feedback loop involving 
MDC1, which binds γH2AX, the MRN complex, and ATM kinase, which 
phosphorylates additional H2AX molecules further away from the break site 
[117]. Factors involved in NHEJ DSB repair are recruited within seconds upon 
break formation and dissociate within two hours, while HR factors show 
delayed and persistent recruitment to DSBs, reflecting different repair kinetics 
between these two pathways [117].  
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Figure 6. Spatial organization of DDR protein accumulation at DNA DSBs. A. DDR signal 
spreading via a positive feedback loop involving MDC1 and ATM kinase. B. Regional distribution 
of DDR proteins around DSBs. Factors involved in ATR signaling accumulate proximal to the 
break site on ssDNA generated by DNA end resection, while ATM signaling factors localize on 
flanking chromatin regions. From [117]. 
1.9.1.3 LET-dependent differences in DDR 
It was demonstrated that after exposure to high- or low-LET radiation both the 
quality of the DNA repair as well as the kinetics differ [7, 118, 119]. In case of 
high-LET irradiation the high local ionization density of the particle will cause 
more complex DNA damage, also referred to as clustered damage [118, 120, 
121]. Due to the complexity of this damage, the enzymatic activity needed for 
DNA repair will be retarded or might not occur at all, resulting in more cell 
death [118, 122]. The degree of complexity of the damage depends on the 
LET of radiation and reaches a maximum at the LET of 150-200 keV/µm [118, 
Chapter 1. Introduction 
29 
 
123]. Above 200 keV/µm enough energy is deposited to obtain the same 
biological effect and some energy may be wasted, resulting in over-killing 
effect [124]. Studies of DSBs formation and repair after exposure to low- or 
high-LET radiation also showed that the repair kinetics is characterized by a 
fast component and a slow component and that these processes reflect the 
quality as well as the localization of the DNA damage in chromatin of different 
compactness [125-127]. Interestingly, DNA damage induced by the indirect 
effect of both γ-rays and α-particles was shown to be more efficiently repaired 
by NHEJ and BER compared to HR repair [128]. 
1.9.2 Transcriptional response to ionizing radiation: the central role of 
p53 
DNA damage is the major consequence of radiation exposure in cells which 
leads to significant modulation of the transcriptome [129-132]. In response to 
radiation exposure several sensor molecules detect the induced DNA damage 
and rapidly accumulate at the damaged sites. These proteins initiate damage 
processing by transmitting a signal to transducers, which in their turn relay the 
signal to multiple downstream effectors involved in specific pathways, 
resulting in cell death or survival [133]. The activation of these signal 
transduction pathways results in altered expression of target genes.  
One of the key checkpoint proteins in the DNA damage response is the 
transcription factor p53, which transcriptionally controls target genes involved 
in diverse pathways ranging from cell cycle arrest and survival to death by 
apoptosis [134]. In its normal state p53 has a short half-life as a result of 
binding to MDM2, which targets p53 to degradation through a ubiquitin-
dependent pathway on nuclear and cytoplasmic 26S proteasomes [135]. 
Upon exposure to ionizing radiation both p53 and MDM2 are directly 
phosphorylated by ATM at Ser15 and Ser395, respectively [136]. In the 
meantime, ATM also phosphorylates CHK1 and CHK2, which in turn 
phosphorylate p53 at Ser20 [137]. The phosphorylation cascade leads to 
further phosphorylation of T18, weakening the interaction of p53 and MDM2, 
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ultimately resulting in stabilisation of p53 [138]. Other key transcription factors 
in the radiation response are nuclear factor κB (NF-κB), nuclear erythroid-
derived 2-related factor 2 (NRF2), cAMP-responsive element-binding protein 
(CREB), activated protein 1 (AP-1), specificity protein 1 (SP1), and early 
growth response 1 (EGR-1) [139]. Nevertheless, p53 is considered to be the 
central player in the radiation response [131].  
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Figure 7. Mechanisms of p53 activation and regulation of downstream targets. From [140]. 
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The p53 pathway responds to various cellular stress signals, including 
exposure to ionizing radiation, by transcribing a number of genes to 
accomplish several functions (Figure 7). The activation of p53 can have three 
main outcomes: cell-cycle arrest, DNA repair and apoptosis/senescence. 
Apoptosis and senescence are terminal for the cell, whereas cell-cycle arrest 
allows the repair to occur, so that the cell survives [140].  
1.9.2.1 Role of p53 in DDR 
p53 is also involved in DNA repair mechanisms, in both transcription-
dependent and transcription-independent manner. The involvement of p53 as 
a transcription regulator in NER is limited to two known relevant regulatory 
targets - genes encoding the p48 protein (DDB2) and the XPC protein (XPC) 
[141, 142].  
p53 has both transcription-dependent and transcription-independent functions 
in BER, an example being its interaction with endonuclease APE1/Ref-1, 
which functions during the removal of damaged bases and the subsequent 
repair of the resulting apurinic and apyrimidinic sites: APE1/Ref-1 modulates 
the trans-activation and pro-apoptotic functions of p53, while p53 in its turn 
seems to directly regulate transcription of the APE1 gene [143]. In a study by 
Offer et al. p53 was also shown to enhance BER during G0-G1 cell cycle 
stages, while reducing BER and inducing apoptosis in G2-M stages [144].  
Of the two DSB repair pathways, the role of p53 in NHEJ remains poorly 
understood. What is clear is that p53 has several genetic interactions with 
components of the NHEJ pathway that are manifested by downstream effects 
on cellular survival and cell cycle control or effects on DNA repair [143]. For 
example, p53 accumulation leading to cell cycle arrest and apoptosis was 
shown in cells depleted for Artemis endonuclease, which plays a key role in 
NHEJ [145].  
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Several studies demonstrated that p53 can regulate HR DSB repair 
transcriptionally by direct interaction between p53 and the RAD51 promoter 
[146, 147], although its contribution was small compared to other transcription 
factors [148].  
The specific transcriptional response to radiation is dependent on many 
factors, such as genetic background, cell type, radiation quality, time after 
irradiation, dose and dose rate [139]. It is also accepted that the severity of 
DNA damage is critical in directing the signaling cascade to reversible cell 
cycle arrest and DNA damage repair or to apoptosis [134]. Several studies 
also showed tissue specificity with distinct regulation of p53-induced genes in 
different cells and tissue compartments [149-151]. The list of p53 targets 
currently exceeds 100 well-validated genes and is constantly growing with 
dozens potential targets being identified [131, 152, 153]. The p53-regulated 
genes often found as radiation-responsive are, as could be expected, 
involved in cell cycle regulation (e.g. CDKN1A, GADD45A, CCNG1), DNA 
repair (e.g. PCNA, XPC, DDB2, RAD51, POLH) and apoptosis (e.g. BAX, 
FAS, TNFRSF10B, BBC3, FDXR) [154-159].  
1.9.2.2 Role of p53 in cell cycle regulation  
The key transcriptional target of p53, relevant for the G1 and G1/S checkpoint 
responses is the p21
CIP1/WAF1 
(coded by the CDKN1A gene), which inhibits 
cyclin E and cyclin A/CDK2 required for the G1/S phase transition [160]. p21 
also mediates cell cycle progression independently of cyclins and cyclin-
dependent kinases by its direct binding to PCNA, another transcriptional p53 
target, which leads to inhibition of DNA replication [160]. The G2/M 
checkpoint also partly relies on the transcriptional programmes regulated by 
p53, leading to the up-regulation of cell-cycle inhibitors such as p21, 
GADD45a and 14–3–3 sigma proteins [161]. In addition, the p53-activated 
p21 further blocks the phosphorylation of CDC2, thus blocking entry into 
mitosis [162]. 
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1.9.2.3 Role of p53 in induction of apoptosis and senescence  
In case DNA repair is not successful, p53 induces apoptosis through the 
intrinsic mitochondria-mediated pathway, which is predominantly mediated by 
mitochondrial outer membrane permeabilization (MOMP). p53-mediated 
MOMP is regulated by the anti-apoptotic and pro-apoptotic members of the 
BCL2 family proteins [163]. Several pro-apoptotic molecules important for 
MOMP were shown to be transcriptionally regulated by p53, e.g. Bcl-2 
homologous antagonist/killer (BAK1) [164], B-cell CLL/lymphoma 2 (BCL2)- 
associated X-protein (BAX) [165], p53 up-regulated modulator of apoptosis 
(PUMA) [166] and NOXA [167]. Following MOMP, apoptogenic proteins, such 
as cytochrome c, are released to the cytosol. This p53-dependent process 
can be induced by extrinsic or intrinsic activation of effector caspases (e.g. 
caspase 3). The extrinsic pathway involves FAS receptor and tumour necrosis 
factor receptor and results in the activation of effector caspases or the 
initiation of the intrinsic pathway by inducing mitochondrial injury (loss of 
mitochondrial membrane potential or release of cytochrome C), which will 
eventually also lead to the activation of effector caspases [168]. 
Senescent cells are also characterized by enhanced expression of several 
p53-regulated senescence markers, e.g. p21, PML, PAI-1, and DEC1, all of 
which are able to induce senescence themselves [169]. 
1.9.3 Radiation-induced alternative transcription and splicing 
As discussed above, DNA damage caused either by radiation or other factors 
triggers broad changes in the gene expression program of the damaged cells. 
A large body of evidence has shown that the expression of several genes 
involved in the DDR in addition to transcriptional regulation is also controlled 
by mechanisms regulating their splicing profile, the stability of their transcripts 
and/or their utilization by the translational machinery [170]. 
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Alternative transcription and alternative splicing are responsible for the 
production of multiple mature mRNAs from a single gene. The human 
genome comprises less than 20 000 protein-coding genes, coding for almost 
80 000 protein-coding transcripts and the estimated number of proteins 
synthesized from these transcripts is in the range of 250 000 to 1 million 
[171]. Alternative splicing of pre-messenger RNAs (pre-mRNAs), which is the 
alternative selection of exons to be included into mRNAs during splicing, is 
currently regarded as the main process contributing to both transcriptome and 
proteome diversity [172], although alternative transcription was shown to play 
a more important role in some cases, e.g. cerebellar development [173]. 
Alternative transcription initiation by the use of alternative promoters and 
transcription start sites leads to the formation of transcripts differing in their 
first exon or in the length of the 5′ untranslated region (5′-UTR). The use of 
alternative first exons leads to transcripts with different open reading frames 
giving rise to protein isoforms with alternative N termini, while transcripts with 
different 5′-UTR can be subject to differential translational regulation [171].  
Alternative splicing comprises the following major events: exon skipping or 
cassette exon usage, use of alternative acceptor and/or donor sites, intron 
retention, and mutually exclusive exons [171] (Figure 8). Exon skipping 
appears to be the most common (occurs in ∼38% of mouse and human 
genes), while intron retention is the least common (occurs in ∼3% of the 
genes) [174]. 
Another regulatory layer of gene expression is the process of polyadenylation 
[175]. The use of alternative polyadenylation (APA) sites results in the 
formation of transcripts differing in their 3′ ends. Transcripts arising from APA 
may differ in either their coding region (if APA sites are located in a different 
exon or intron) or in the length of their 3′ untranslated region. APA can have 
an effect on transcript localization, stability, translation efficiency and on the 
nature of the encoded protein [171]. 
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Figure 8. Alternative splicing and transcription. (a) Exon skipping, in which exon known as a 
cassette exon is spliced out of the transcript. (b) Alternative 3′ splice site (3′ SS) and (c) 5′ SS 
selection occur when two or more splice sites are recognized at one end of an exon. (d) Intron 
retention occurs when an intron remains in the mature mRNA transcript. (e) Mutually exclusive 
exons. (f) Alternative promoter usage. (g) Alternative polyadenylation. From [176]. 
The physiological activity of proteins encoded by different transcript variants 
from the same gene may, however, differ dramatically. For instance, several 
genes such as BCL2 family members and TID1, have been shown to encode 
both pro- and anti-apoptotic protein isoforms [177, 178]. p53, TRAF2, APAF1, 
caspases 2 and 8, survivin, and PIG3 are other examples of DDR effectors 
regulated at the level of alternative splicing making cell survival/apoptosis 
decisions [179, 180]. Transcription of the TP53 gene also involves positive 
and negative regulation from several promoters, and it is also subject to 
multiple alternative splicing events, such as e.g. intron 2 retention and an in-
frame deletion of 198 bp between exons 7 and 9 [181].  
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In addition to modulating the relative expression of protein isoforms through 
AS, stress can impact on the “productivity” of gene expression, for example 
by inducing “unproductive” splice variants, such as those with premature stop 
codons, which are rapidly degraded by the nonsense-mediated decay 
pathway [170]. Several reports demonstrated a striking regulation of the 
splicing of MDM2, the main p53 negative regulator, by various genotoxic 
agents. The MDM2 alternatively spliced variants lack up to 8 (out of 12) exons 
that include the p53-binding domain and nuclear localization signal, thus 
allowing the increase in p53 protein levels and induction of the p53 pathway 
[182, 183]. 
Stress caused by DNA damaging agents widely modulates the alternative 
splicing of genes involved in the DNA repair, cell-cycle control and apoptosis, 
thus expanding their functional diversity [170]. For example, cisplatin favors 
the production of pro-apoptotic splice variants of c-FLIP, CASP8, CASP9 and 
BCL-X through up-regulation of SC35 splicing factor by E2F1 [184]. UV 
irradiation of human fibroblasts induces ATM-dependent changes in 
alternative splicing of ATRIP gene, which is an essential component of DNA 
damage checkpoint signaling [185]. UV irradiation promotes splicing shifts in 
genes involved in cell cycle control, such as CHEK2, MAP4K2 and ABL1 
[186]. 
In addition to affecting the alternative splicing of specific DDR-related genes, 
DNA damage was shown to play an important role in the regulation of 
alternative splicing in general. UV radiation affects co-transcriptional 
alternative splicing in a p53-independent manner through 
hyperphosphorylation of RNA polymerase II and inhibition of transcription 
elongation thereby affecting the selection of alternative exons [187]. 
Transcription-blocking DNA lesions trigger profound changes in spliceosome 
organization affecting preferentially late-stage spliceosomes [185]. 
Additionally, the same study showed a reciprocal regulation between ATM-
controlled DDR signaling and the core spliceosome, demonstrating ATM 
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contribution to selection of genetic information ultimately included in mature 
transcript [185]. DNA damage also affects transcription, post-translational 
modifications (such as phosphorylation) and localization of splicing factors, 
which interact with exonic and intronic regions of pre-mRNA  and control the 
recruitment and activity of the spliceosome [170]. 
Several recent studies have shown that a large number of genes are 
alternatively spliced or transcribed in response to (UV) radiation [187-190]. 
However, to the best of our knowledge, there have been no studies carried 
out so far to assess the alternative transcription and splicing initiation by high-
LET radiation. In most of the cases the changes observed for other radiation 
types are due to alternative promoter usage by p53 [188, 190]. While the 
exact functional impact of these changes is not known in most of the cases, 
many of the affected genes are involved in DNA repair, cell-cycle control and 
apoptosis. The exact sequence identity of radiation-induced splice variants 
also remains to be identified by means of e.g. next-generation sequencing.  
Functional characterization of radiation-induced transcript variants would also 
increase the understanding of the molecular mechanisms of radiation 
response. 
1.10 Radiation biomarkers 
A biomarker is defined as “any measurement reflecting an interaction 
between a biological system and an environmental agent, which may be 
chemical, physical or biological”[191]. Characteristics of a good biomarker 
include sensitivity, specificity, reproducibility, known variability in the general 
population [191] and the possibility for non-invasive and simple sample 
collection (especially for children) [192]. 
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Pernot et al. suggested to classify radiation biomarkers into four categories, 
based on temporal parameters [192] (Figure 9): 
a) biomarkers of exposure, which are available at some point after 
exposure and can be used to estimate the dose received 
b) biomarkers of susceptibility or individual sensitivity, which are expected 
to remain constant during the lifetime and therefore are available before, 
during or after exposure and can be used to predict an increased risk of 
radiation-induced health effects 
c) biomarkers of late effects, which remain present and become more 
evident with time after exposure and can be used to assess health 
effects before clinical detection of the radiation-induced disease 
d) biomarkers of persistent effects, which allow the assessment of radiation 
effects appearing soon after exposure and present a long time after it 
and at different clinical stages 
 
 
 
 
 
 
 
 
Figure 9.Timing of radiation-induced disease processes and relation with the different types of 
biomarkers.  From [192]. 
Chapter 1. Introduction 
40 
 
In the review by Pernot et al., the following biological classification of radiation 
biomarkers was suggested (Figure 10): 
a) cytogenetic biomarkers (dicentrics, translocations, complex 
chromosomal rearrangements, premature chromosome 
condensation, telomere length and micronuclei) 
b) biomarkers related to nucleotide pool damage (DNA single/double 
strand breaks, extracellular 8-oxo-dG) 
c) biomarkers related to germline inherited mutations/variants (single 
nucleotide polymorphisms and inherited gene mutations, copy 
number variants and alterations) 
d) biomarkers related to induced mutations (glycophorin A in MN blood 
group heterozygotes, hypoxanthine-guanine phosphoribosyl 
transferase gene) 
e) biomarkers related to transcriptional and translational changes 
(changes in RNA levels, changes in protein levels, changes in 
cytokine levels) 
f) biomarkers related to epigenetic modifications (histone modifications, 
DNA methylation, miRNA, phosphoproteome) 
g) other (reactive oxygen species, metabolites and metabolomics, cell 
cycle delay, apoptosis and cell survival, biophysical markers) 
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Figure 10. Biological classification of radiation biomarkers. Vertical double lines represent pairs 
of chromosomes and horizontal double lines represent double strands of DNA. A: acetyl group; 
CCR: complex chromosomal rearrangement; CNV: copy number variant; CRP: C-reactive 
protein; DSB: double strand break; GYPA: glycophorin A; HPRT: hypoxanthine-guanine 
phosphoribosyltransferase; M: methyl group; miRNA: microRNA; P: phosphate group; PCC: 
premature chromosome condensation; ROS: reactive oxygen species; SNP: single nucleotide 
polymorphism; SSB: single strand break; U: ubiquitin; 6-TG: 6-Thioguanine; 8-oxo-DG: 8-Oxo-
deoxyguanosine. From [192].  
The overview of different radiation biomarkers is given in Table 6. 
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Table 6. Overview of radiation biomarkers. Modified trom [192]. 
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Table 6 (continued}. Overview of radiation biomarkers. Modified trom [192]. 
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guanine·phosphoribosyltransferase; IR: ionizing radiation; miRNA: microRNA; PCC: premature chromosomecondensation; SNP: single nucleotide polymorphism; SSB: 
single strand break; ROS: reactive oxygen species. 
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The most recent advances in radiation biomarkers research can be found in 
the review by Hall et al. [193]. The biomarkers relevant for the present study 
will be further discussed in more detail. 
1.10.1 Biomarkers of exposure 
Biomarkers of exposure are probably the best established and validated, 
especially for moderate and high doses of radiation, with multiple biological 
endpoints being used to assess the exposure dose. These biomarkers are 
particularly important for such exposure scenarios, as nuclear power plant 
accidents and smaller-scale accidental radiation exposures, as well as 
terroristic attacks, during which rapid dose assessment for the affected 
population is required [194]. 
1.10.1.1 Dicentric assay 
Cytogenetic measurements, more specifically the dicentric chromosome (i.e. 
chromosome with two centromeres) assay, is considered to be the gold 
standard in biodosimetry, its main advantage being the specificity to radiation 
exposure [195]. In order to produce a dicentric aberration, DNA damage must 
be induced in two unreplicated chromosomes located in close proximity so 
that the damaged chromosomes can undergo exchange as a result of the 
misrepair of DNA strand breaks induced directly by the radiation, or as a 
result of misrepair during the base excision repair [195]. Dicentric 
chromosomes are stable in non-dividing cells such as lymphocytes but as the 
half-life of blood lymphocytes is in the order of weeks to years depending on 
the sub-population [196], this assay is the biomarker of choice for recent 
exposure. This well-validated method can be used to assess doses as low as 
100 mGy if up to 1000 cells are analyzed and also to distinguish between 
partial and whole body exposures [197] and high- and low-LET radiation 
exposures [198]. However, this method also suffers from several drawbacks. 
It is time-consuming, laborious and requires special training and experience, 
which makes it less appropriate for screening of large cohorts of individuals in 
Chapter 1. Introduction 
45 
 
a short time. Several automated systems allowing for faster dicentric scoring 
have been developed so far [199-201]. A simplification of dicentric scoring 
can also be achieved with the application of TC-FISH – the technique which 
allows to simultaneously stain telomeres and centromeres [202].  
1.10.1.2 γH2AX assay 
Another technique often used as biomarker of exposure to radiation is the 
γH2AX assay. Phosphorylation of histone H2AX which occurs within a few 
minutes of DNA damage provides a good marker of induction and repair of 
DSBs caused by radiation [203]. The number of γH2AX foci in the cell nucleus 
is directly proportional to the number of DSBs formed, and their 
dephosphorylation correlates with DSBs repair [204]. γH2AX foci formation is 
not specific to radiation exposure and can arise following multiple cellular 
processes, e.g. replication fork stalling/collapse at regions of single stranded 
DNA, the repair of DNA adducts, crosslinks [205], UV-induced pyrimidine 
dimers [206] and at later stages of apoptosis during DNA fragmentation [207]. 
The main advantage of the γH2AX assay is its high sensitivity. Several recent 
studies on patients undergoing CT-scans showed that γH2AX foci could be 
detected after exposure to low doses of 10 mGy [208] and of ≈3 mGy 
(average dose to the blood) [209] and very low doses of 0.22-1.22 mGy 
(average dose to the blood) [210]. It was also demonstrated that γH2AX 
assay is suitable for estimation of partial body exposures [211] and that it 
outperforms the analysis of dicentrics in this regard [212]. The spatial 
distribution of radiation-induced DNA breaks and the phosphorylation-
dephosphorylation kinetics depends on radiation quality [213-215], therefore 
γH2AX assay is potentially suitable for assessing this parameter. However, 
extensive use of the γH2AX assay as a biomarker of exposure is limited due 
to the fast decline of the signal. There are also other critical features which 
might help increasing the reliability of the assay, such as standardization of 
experimental protocols, used specimens and statistical analysis [216]. 
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1.10.1.3 Gene expression 
The fast development of high-throughput transcriptomic profiling technologies 
since the late 1990s allowed to analyze the expression of a large number of 
genes simultaneously and initiated the search for mRNA biomarkers of 
radiation exposure. One of the earliest microarray studies investigating the 
effect of radiation on gene expression levels in isolated human peripheral 
blood lymphocytes found a dose-dependent induction of a number of genes 
up to three days following exposure [217]. Since then experimental data, 
obtained by means of microarrays [218], quantitative nuclease protection 
assay [219], NanoString technology [154], quantitative PCR (qPCR) [155], or 
chemical ligation-dependent probe amplification assay [158] proved to be 
efficient in providing accurate and rapid prediction of radiation exposure. 
Importantly, most of these studies point to a number of genes showing 
consistent responses in different irradiation set-ups and experimental models 
confirming their high potential as radiation biomarkers [220]. Most of the 
identified genes are known to be regulated by p53 (e.g. MDM2, DDB2 [221], 
FDXR [222], PCNA [223], GADD45A [224], RPS27L [225], SESN1 [226]), and 
involved in classical p53-mediated pathways, such as cell cycle regulation, 
DNA damage repair and apoptosis.  
The specificity of the gene expression response as radiation biomarker is a 
complex issue, as these genes are responsive to DNA damage, which can be 
caused by other DNA-damaging agents. Multiple confounding factors, such as 
age, gender, infections and inflammatory diseases, smoking status and 
lifestyle in general might influence the induction levels of specific genes.  
Recent studies have shown that gene expression analysis is suitable for 
determining exposure to very low doses of radiation, as some of the 
modulated genes are induced by doses as low as 5-25 mGy [155, 227, 228]. 
Nosel et al. showed dose-dependent regulation of genes involved in DNA 
damage repair and p53 signaling starting from 25 mGy, while other genes 
Chapter 1. Introduction 
47 
 
involved in cellular respiration, ATP metabolic processes and chromatin 
organization showed constant modulation from 5 mGy exposure dose [228]. 
Knops et al. could identify nine genes responsible for proteolysis and 
apoptosis regulation which are suitable to predict doses as low as 20 mGy 
with a sensitivity of 86.7% [227].  
Most of these studies, however, used ex vivo irradiated blood samples or 
even isolated PBMCs which might poorly reflect the in vivo response to 
irradiation. Several genome-wide studies have been undertaken to assess the 
in vivo transcriptional response to ionizing radiation using blood samples from 
radiotherapy patients undergoing either total body irradiation [229] or local 
intensity modulated radiotherapy [230]. The results of these investigations 
indicate that in vivo irradiation mainly affects genes involved in pathways that 
are related to the immune system and inflammatory responses, as well as 
p53-mediated pathways. Accordingly, induction of p53-dependent genes was 
observed in patients either undergoing CT scans (up to 43 mGy) or receiving 
(F-18)-fluoro-2-deoxy-d-glucose (6 mGy) [231]. Overall, the examined genes 
were induced in all samples, although differences in the in vivo and in vitro 
response were found, especially for doses below 50 mGy [231]. Other studies 
have identified in vitro gene signatures that could accurately predict the in 
vivo radiation exposure status [55, 158, 232, 233]. Overall, these studies have 
shown that the in vitro transcriptional radiation response is a reliable model for 
the in vivo situation. A recent study in patients undergoing treatment with 
radionuclides (
131
I-labeled metaiodobenzylguanidine) also confirmed the 
validity of biomarkers of external exposure such as CDKN1A, DDB2 and BAX 
as indicators of internal exposure [234]. 
Recent technological advances, such as customized qRT-PCR arrays [235] or 
multiplex qRT-PCR assays [154, 155], which allow rapid PCR amplification of 
a number of genes sufficient for dose estimation, are more appropriate for 
high-throughput screenings in case of a large-scale accident compared to 
genome-wide technologies [55]. The above-mentioned technologies allow fast 
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processing of a large number of samples in virtually any laboratory 
possessing a qPCR instrument, offering gene expression-based biodosimetry 
the advantage of high-throughput, in comparison with classical biodosimetry 
methods, such as dicentric chromosome assay.  
One of the disadvantages of gene expression is that the effect is short-lived 
(up to a few days, depending on the dose), which should nevertheless be 
sufficient for use in case of a radiological accident [236]. Another 
disadvantage of the method is a saturation effect observed for doses higher 
than 2 Gy [51, 55]. In experiments in mice such saturation was observed 
following acute exposure to 6 Gy [237]. Importantly, both effects – the fast 
decline of the signal with time and the effect saturation at higher doses, might 
be significantly affected by in vitro experimental conditions. Therefore further 
validation of the assay in vivo is of pivotal importance. 
1.10.2 Biomarkers of susceptibility 
Defects in DNA repair mechanisms often result in abnormal radiosensitivity of 
cells, for example in such syndromes as ataxia telangiectasia [238], ataxia-
telangiectasia like-disorder [239], radiosensitive severe combined 
immunodeficiency [240], Nijmegen breakage syndrome [241], and LIG4 
deficiency [242]. More specifically, all the above-mentioned syndromes are 
caused by defects of repair of DNA DSBs, which are considered to be the 
most specific and severe damage caused by radiation, likely to result in 
chromosome aberrations and genomic instability [102, 120, 243].  
The research into cellular markers predictive of clinical radiosensitivity was 
first focusing on colony-forming assays [244, 245], followed by reliable 
surrogate endpoints, such as scoring of chromosomal aberrations [246, 247]. 
Other studies aiming at establishing an assay for radiosensitivity prediction 
were focusing on the measurement of DNA DSBs repair efficiency by means 
of the comet assay [248-250] or the γH2AX assay [250, 251]. Nevertheless, 
no single cell-based assay proved to be capable of discriminating the full 
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range of cellular radiosensitivity, independently on the cause of it and there is 
not enough evidence of their utility in clinical practice [98]. It might suggest 
that other mechanisms such as altered cell cycle or defective apoptosis could 
play a critical role toward determining radiosensitivity.  
Alternatively, gene expression profiling might be a promising predictive 
parameter for radiosensitivity [250]. Greve and co-authors identified a set of 
67 genes differentially expressed in non-irradiated peripheral blood 
lymphocytes and those exposed to 5 Gy of γ-rays, which allowed to 
distinguish between the group of severely radiosensitive and non-
radiosensitive breast, head and neck carcinoma patients. Most of the 
identified genes belong to the apoptosis or cell cycle regulation pathways 
[250]. Another study involving 21 prostate cancer patients with severe late 
radiotherapy complications and 17 patients without such symptoms identified 
a classifying gene signature in 2 Gy X-ray irradiated peripheral blood 
lymphocytes predicting radiosensitivity in 63% of the patients [252]. Rieger 
and co-workers used microarray gene expression profiling in lymphoblastoid 
cells derived from a diverse group of cancer patients with acute radiation 
toxicity. A set of 24 genes predicted radiation toxicity in 9 of 14 patients with 
no false positives among 43 controls [253]. A recent study by Forrester and 
co-authors identified an 8-gene signature which could potentially predict 
predisposition to fibrosis in patients prior to radiotherapy treatment [254]. It 
was suggested that radiosensitivity prediction will probably require a multi-
parametric approach, as several, seemingly independent molecular pathways 
are likely to be involved in the development of late adverse tissue reactions 
[98]. In this respect, gene expression measurements are more flexible and 
promising than assays measuring single cellular endpoints. 
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 2.
Scope and outline of research 
 
Every human living on Earth is constantly exposed to very low levels of 
natural ionizing radiation, which are harmless. Occasionally, though, 
individuals are exposed to radiation doses exceeding the natural background 
levels, often as a result of medical diagnostic tests and treatments but 
sometimes through the accidental or deliberate release of radioactivity. 
Identification of radiation biomarkers of exposure, which can be used as 
biological dosimeters following a large-scale nuclear accident or a terroristic 
attack are of pivotal importance. At the same time, specific biomarkers of 
individual radiosensitivity would be of great value for personalized 
radiotherapy treatment or for the selection of crews for long-term Space 
missions.  
As the model for our study we chose peripheral blood or isolated peripheral 
blood mononuclear cells, depending on the type of experiment, for several 
reasons. First, blood is a comparatively easily accessible biological sample, 
which can be collected from a large number of people in case of an accident. 
Second, there are several well-validated products for RNA extraction 
available on the market, which can be adapted for the needs of specific study 
design. Third, blood cells are among the most radiosensitive cell types of the 
body. And last but not least, using blood, which is a liquid tissue composed of 
multiple cell types suspended in plasma containing extracellular matrix, 
cytokines, chemokines and hormones gives a better representation of in vivo 
response to radiation. In our experiments we mainly used 250 kV X-rays 
which is the type of low-LET radiation historically used for biodosimetry 
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purposes in IAEA recommendations. In addition, we used accelerated carbon 
ions and iron ions, which are representative of hadron therapy and Space 
radiation, respectively.  
The recent nuclear accident at Fukushima Daiichi in March 2011 led to 
recognition of the urgent need for effective biodosimetry tools which could 
confirm or quantify exposure to radiation in large cohorts of individuals 
potentially exposed to unknown doses for the purpose of triage and treatment 
[255]. Another important lesson learned from the Fukushima accident was 
that for the general public the probability of receiving doses higher than 100 
mSv in a similar “low-dose scenario” is relatively low. On the other hand, the 
uncertainty about the exposure dose for a large number of individuals highly 
concerned about the possibility of radiation exposure known as “worried 
wells” can lead to additional stress causing psychological problems and more 
serious health consequences [40, 256].  
Besides the development of biodosimetric assays as such, the investigation of 
their suitability for low-cost, fast measurements, which do not require specific 
training or instruments is of pivotal importance.  
Studying the differences in biological response of normal cells to photon and 
particulate radiation is also important for several reasons and applications. 
First of all, adequate prediction of the treatment outcome in comparison to the 
conventional photon radiotherapy would allow optimal exploitation of the 
benefits of hadron therapy. Secondly, in view of the exposure of Space crew 
to heavy ions during long-term Space missions, it is important to study 
whether the response of normal cells to Space radiation and low-LET 
radiation is comparable and that therefore the radiation protection regulations 
based on predominantly low-LET epidemiological studies can be extrapolated 
in case of high-LET exposures. 
In order to address the above-mentioned issues we divided our study in three 
main steps described below: 
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1. As the first step of our study, we aimed at identifying gene 
expression biomarkers of exposure to low-LET radiation with 
increased sensitivity to low-dose exposures. To this end, PBMCs 
from healthy volunteers were exposed in vitro to two X-ray doses 
relevant for medical triage: a moderate dose of 1.0 Gy which might 
result in acute radiation syndrome [257] and is associated with a high 
probability of long-term stochastic health effects and a low dose of 0.1 
Gy which is not associated with any immediate acute health effects 
but might require medical follow-up as the risk of long-term effects, 
particularly cancer, must be taken into consideration [258]. We 
performed a whole-genome microarray study in order to identify the 
biomarkers most suitable for classification of the samples according 
to the exposure dose. We also assessed transcriptional events which 
might have an impact on the identified gene expression biomarkers. 
The results of this study are summarized in the Research article  I 
entitled “Radiation-induced alternative transcription and splicing 
events and their applicability to practical biodosimetry” [259] (Chapter 
3). We also confirmed the validity of our approach in a biodosimetry 
interlaboratory comparison study organized by the RENEB 
consortium, the results of which are published in a research article by 
Abend et al. [55]  
2. Microarrays are an invaluable tool for whole-genome radiation 
response studies but they are not appropriate for use in large-scale 
radiological accidents due to significant costs, time inefficiency and 
the complexity of the analysis. Therefore, as the second step of our 
study, based on our previous microarray results we designed a 
customized qRT-PCR array for biodosimetry comprising a panel of 
25 genes. For the genes exhibiting alternative splicing, we designed 
primers interrogating the most sensitive exons. This allowed us to 
validate our approach using a system applicable to large-scale 
radiological accidents. We used peripheral blood samples from 
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healthy volunteers exposed to doses from 0 to 2 Gy at several time 
points post-irradiation from 8 to 48 h as reference samples and the 
samples from other individuals were used as “blind samples”. In this 
study we also compared different methodologies for RNA extraction 
available on the market and evaluated their applicability to emergency 
situations. The results of this study are summarized in Research 
article II entitled “Gene expression-based biodosimetry using 
customized qPCR arrays: assessment of dose and time after 
exposure” (Chapter 4). We also used these customized qRT-PCR 
arrays in the second biodosimetry interlaboratory comparison 
organized by the RENEB consortium [51, 260].  
3. As the third and final step of this study we aimed to compare the 
transcriptional response and DNA repair kinetics of human 
PBMCs after exposure to different radiation types. To achieve this 
goal, we compared the transcriptional profiles of PBMCs of healthy 
donors after the cells were exposed to 1 Gy of X-rays, iron ions or 
carbon ions. To assess DNA damage induction and repair kinetics, 
we performed γH2AX staining at different time points after exposure. 
With an eye to possible long-term Space flights, we also opted for 
investigating the potential of a core signature of genes responsive to 
iron ions exposure to serve as an indicator of varied DNA repair 
capacity of healthy astronauts, which are expected to be selected for 
a similar mission. The results of this study are summarized in the 
Research article III entitled “Transcriptional profiling of human 
peripheral blood mononuclear cells following the exposure to low- and 
high-LET radiation” (Chapter 5). 
The detailed results obtained in each of the above-mentioned steps of the 
study are described in the following Chapters 3-5. The final Chapter 6 
“General discussion and perspectives” entails the general discussion on the 
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importance of our findings and highlights the future perspectives on radiation 
biomarkers research. 
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3. 
Radiation-induced alternative transcription and 
splicing events and their applicability to practical 
biodosimetry  
This chapter is modified from: 
Macaeva E., Saeys Y., Tabury K., Janssen A., Michaux A., Benotmane M., De Vos W., Baatout 
S., Quintens R. Radiation-induced alternative transcription and splicing events and their 
applicability to practical biodosimetry. Scientific Reports 6, 19251; doi: 10.1038/srep19251 
(2016). 
3.1 Abstract 
Accurate assessment of the individual exposure dose based on easily 
accessible samples (e.g. blood) immediately following a radiological accident 
is crucial. We aimed at developing a robust transcription-based signature for 
biodosimetry from human peripheral blood mononuclear cells irradiated with 
different doses of X-rays (0.1 and 1.0 Gy) at a dose rate of 0.26 Gy/min. 
Genome-wide radiation-induced changes in mRNA expression were 
evaluated at both gene and exon level. Using exon-specific qRT-PCR, we 
confirmed that several biomarker genes are alternatively spliced or 
transcribed after irradiation and that different exons of these genes exhibit 
significantly different levels of induction. Moreover, a significant number of 
radiation-responsive genes were found to be genomic neighbors. Using three 
different classification models we found that gene and exon signatures 
performed equally well on dose prediction, as long as more than 10 features 
are included. Together, our results highlight the necessity of evaluating gene 
expression at the level of single exons for radiation biodosimetry in particular 
and transcriptional biomarker research in general. This approach is especially 
advisable for practical gene expression-based biodosimetry, for which primer- 
or probe-based techniques would be the method of choice. 
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3.2 Introduction 
The recent nuclear accident at Fukushima Daiichi in March 2011 and the 
subsequent growing concerns about large-scale human radiation exposure 
have triggered the widespread recognition that there is an urgent need for 
effective biodosimetry tools that are capable of confirming or quantifying 
exposure to radiation in large cohorts of individuals potentially exposed to 
unknown doses for triage and personalized treatment [255].  
Following the Fukushima accident, the only individuals who received effective 
radiation doses of over 100 mSv, were 173 emergency and mitigation 
workers. Despite this generally low radiation exposure, which was clearly 
below the threshold of acute radiation disease, about 90,000 people were 
evacuated as a preventive safety action. This measure reduced the levels of 
possible exposure but also resulted in a number of evacuation-related deaths 
due to stress and/or lack of medical and social welfare facilities [42]. Hence, a 
rapid and accurate biodosimetry method would reduce the uncertainty about 
received doses and may mitigate psychological and health problems related 
to additional stress among the individuals who may or may have not been 
exposed to radiation (the so-called “worried wells”) [44, 256].   
Cytogenetic measurements, more specifically dicentric assays, are 
considered the gold standard in biodosimetry [195]. While reliable and 
applicable to assess doses as low as 100 mGy, this method is time-
consuming and laborious, and is not amenable to rapid diagnostics. A 
promising alternative technique consists in using gene expression data. 
Indeed, experimental data obtained by means of microarrays [218], 
quantitative nuclease protection assay [219], NanoString technology [154], 
quantitative PCR [155], or chemical ligation-dependent probe amplification 
(CLPA) assay [158] have proven most efficient in accurately and rapidly 
assessing radiation exposure. 
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Several recent studies have shown that transcriptome analysis at the 
individual exon level may significantly add to our understanding of the 
transcriptional response to radiation exposure [188-190]. In particular, 
alternative transcription and alternative pre-mRNA splicing dramatically 
expand the translational repertoire. We hypothesize that alternative 
transcription and splicing analyses applied in the context of radiation 
exposure may generate additional radiation biomarkers with potentially 
increased sensitivity.  
 
To test our hypothesis, we established gene and exon signatures that may 
serve as radiation biomarkers and subsequently compared their reliability and 
effectiveness. We opted for two X-ray doses relevant for triage purposes (0.1 
and 1.0 Gy) and compared these to sham-irradiated control samples. We 
evaluated the predictive performance of gene and exon signatures using 
three different statistical models, which were further used to assess the 
robustness of our gene signature on an independent, publicly available 
dataset (Figure 1). Our results yield new insights into transcriptional  
biomarker identification studies using genome-wide strategies and underline 
the importance of investigation of gene expression at the single exon level. 
3.3 Materials and Methods 
Experimental procedures are schematically summarized in Figure 11. 
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3.3.1 Blood collection and PBMCs isolation 
Peripheral blood samples used for microarrays were collected from 10 
healthy, non-smoking Caucasian donors (5 males/5 females; age range: 23-
50 years; median age: 28 years) in EDTA vacutainer tubes. All procedures 
followed were approved by the local SCK•CEN Ethics Committee and were 
carried out in accordance with the ethical standards of the Helsinki 
Declaration of 1975, as revised in 2000. All donors had signed an informed 
consent form prior to blood donation. Within 30-60 min of blood drawing, 
PBMCs were isolated by centrifugation on Histopaque-1077 (Sigma-Aldrich, 
Bornem, Belgium) density gradient according to the manufacturer’s 
instructions. Isolated cells were suspended at a density of 10
6
 cells/ml in 
LGM-3 culture medium (Lonza, Walkersville, MD, USA) and were allowed to 
equilibrate to culture conditions at 37°C in a humidified 5% CO2 atmosphere. 
Two weeks later, the experiment was repeated using fresh PBMCs from the 
same donors, resulting in a total of 60 samples for microarray hybridization. 
For quantitative RT-PCR (qRT-PCR) validation, blood collected from 5 
different donors (1 male and 4 females), from whom informed consent had 
been obtained, was subjected to identical procedures as the samples used for 
microarray hybridization, unless otherwise indicated. To confirm the results 
obtained for isolated PBMCs in blood samples, blood was collected from 3 
donors (1 male and 2 females), from whom informed consent had been 
obtained, in EDTA vacutainer tubes, which were then directly used for 
irradiation. 
3.3.2 In vitro irradiation 
Cells were irradiated “free-in-air” at 21°C in a horizontal position with single 
doses of 0.1 and 1.0 Gy of X-rays from a Pantak HF420 RX generator at an 
air kerma rate of 0.26 Gy/min or were sham-irradiated. More detailed 
information on the irradiation setup can be found in the Supplementary 
Methods. Following in vitro irradiation, PBMCs were incubated at 37°C in a 
Chapter 3. Radiation-induced alternative transcription and splicing events and their 
applicability to practical biodosimetry 
61 
 
humidified 5% CO2 atmosphere. Blood samples were incubated on a rocking 
platform at 37°C without additional CO2 supply for the indicated time points. 
3.3.3 RNA extraction  
RNA from irradiated and sham-irradiated PBMC samples was extracted 8 h 
after irradiation for microarray hybridization and 8 and 24 h for qRT-PCR 
validation. RNA from blood samples used for qRT-PCR validation was 
extracted 8 and 24 h after irradiation. For RNA isolation from PBMCs, a 
combined approach consisting of the TRIzol® reagent (Invitrogen, Carlsbad, 
CA, USA) extraction method and purification on Qiagen RNeasy columns 
(Qiagen, Venlo, The Netherlands), was used. More detailed information on 
the RNA extraction procedure can be found in the Supplementary Methods. 
The QIAamp RNA Blood Mini Kit (Qiagen, Venlo, The Netherlands) was used 
to extract RNA from blood samples. The starting quantity of blood was 1.5 ml 
per sample.  All procedures were performed following the manufacturer’s 
instructions. RNA concentration was measured on a NanoDrop-2000 
spectrophotometer (Thermo Scientific, Erembodegem, Belgium) and the 
quality of total RNA samples was assessed using Agilent 2100 Bioanalyser 
(Agilent Technologies, Santa Clara, CA, USA). All samples had a RIN >8 and 
were therefore considered as suitable for further processing for microarrays 
and qRT-PCR.  
3.3.4 Microarray hybridization 
Gene expression profiling was performed using the GeneChip® Human Gene 
1.0 ST Array (Affymetrix, Santa Clara, CA, USA), which interrogates 28,536 
well-annotated genes with 253,002 distinct probe sets, allowing expression 
analysis at both gene and exon level. Since each probe corresponds to one 
exon in most of the cases, we will further refer to probe set-level analysis as 
exon-level analysis. More detailed information on the microarray hybridization 
procedure can be found in the Supplementary Methods. All microarray data 
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are available in MIAME compliant format at the ArrayExpress database 
(www.ebi.ac.uk/arrayexpress) under the accession number E-MTAB-3463.  
3.3.5 Microarray data analysis 
3.3.5.1 Gene and exon level ANOVA  
The obtained microarray data were imported into Partek Genomics Suite, 
version 6.6 (Partek Inc., St Louis, MO, USA) as .CEL-files. Probe 
summarization and probe set normalization were done using the Robust 
Multichip Analysis (RMA) algorithm [261], which includes background 
correction, quantile normalization and log2 transformation. Microarray data 
were analyzed both at the level of probe sets and probe sets summarized to 
genes using a three-way ANOVA with dose, gender and batch as factors. 
Inclusion of batch in the model allowed correcting for differences between 
experiments resulting from different scanning days of the microarrays. To 
correct for multiple testing, we used the false discovery rate (FDR) as 
described by Benjamini and Hochberg [262] to adjust p-values (FDR < 0.05). 
We also performed linear contrasts between two specific groups (0.1 Gy vs 
control and 1.0 Gy vs control) within the context of ANOVA. The coefficients 
of the levels in the two compared groups add up to 0. The computations of p-
values are based on Least-squares means, which are the means adjusted by 
other factors. Genes and exons were considered significantly differentially 
expressed between the two groups if adjusted p-values were < 0.05 with no 
fold change cutoff. Pearson’s correlation coefficient was used to assess dose 
dependence of the gene expression levels. We used the Principal 
Components Analysis tool of the Partek software as an exploratory method to 
detect groupings in the dataset as well as to spot possible outliers. This 
technique is used to describe the structure of high dimensional data by 
reducing its dimensionality. It is a linear transformation that converts n original 
variables (genes or exons, in our case) into n new variables, which have three 
important properties: principal components are ordered by the amount of 
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variance explained, they are uncorrelated and they explain all variation in the 
data. PCA was performed at both gene and exon level using normalised 
expression values. The correlation method applied to calculate the dispersion 
matrix adjusted the data to be standardised to a mean of 0 and standard 
deviation of 1.  
3.3.5.2 Alternative splicing analysis 
To predict alternative splicing in irradiated samples compared to controls, we 
used three different methodologies, since it is known that alternative splicing 
analysis from gene arrays is prone to generate false positive results [263]. 
First, we performed Alternative Splicing ANOVA in Partek. A FDR-corrected 
p-value of < 0.05 was considered significant for alternative splicing events. To 
further reduce the number of false positives, we excluded the probe sets with 
log2 value < 3.0 (noise level) in all samples from analysis, except for the 
cases where there was a significant difference in expression of a single exon 
between the groups (p < 0.05). Next, we used two supplementary methods to 
perform a pairwise comparison of the samples (0.1 Gy vs 0.0 Gy and 1.0 Gy 
vs 0.0 Gy) to further increase the reliability of our results. Gene Array 
Analyzer [264] is an on-line tool that uses the Splice Index algorithm [265] and 
allows the user to perform more advanced filtering, i.e., removing probe sets 
that are not expressed in at least one group, removing genes (transcript 
clusters) that are not expressed in both groups, discarding probe sets with 
high potential for cross-hybridization and those with very large gene-level 
normalized intensities. Software parameters were set to default values, 
except for the Splice Index cutoff, which was set to 0.5. AltAnalyze [266] is an 
open-source software utilizing the FIRMA algorithm which is another method 
for detection of alternative splicing [267]. Software parameters were set to 
default values, except for the Minimum alternative exon score and the 
Maximum absolute gene-expression change, which were set to 0.5 and 50, 
respectively. 
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3.3.5.3 Positional Gene Enrichment analysis (PGE) 
The PGE tool [268] is available at 
http://homes.esat.kuleuven.be/~biouser/pge/. We used default parameters to 
detect positional enrichment of radiation-responsive genes. 
3.3.5.4 Prediction analysis 
The following statistical models were evaluated with regard to their predictive 
performance and identification of a minimal list of genes and exons capable of 
discriminating between exposure conditions: generalized linear models, 
Random Forests [269] and Nearest Shrunken Centroids as implemented by 
the PAM (Prediction Analysis for Microarray) method [270]. A more detailed 
description of these models can be found in the Supplementary Methods. 
To compare the predictive performance of genes and exons, two versions of 
the dataset were constructed: (a) a version measuring expression changes at 
the gene level, and (b) a version measuring expression changes at the exon 
level. 
Cross-validation was used to assess whether classification models could be 
constructed to predict the different conditions. The original dataset was split 
into a part for model training (training set) and a part for model evaluation 
(test set), where both sets are disjoint. In our case, the cross-validation had to 
be executed at the level of individuals, since otherwise correlations between 
different conditions of the same biological sample might have led to 
overoptimistic results. This setting best mimics the true setup where new, 
unseen biological samples need to be classified by the model. A higher 
number of possible train-test combinations results in a more robust 
assessment of model performance, since higher numbers of models could be 
averaged. Therefore, we finally used 2-fold cross-validation for the prediction 
analyses (Figure 11). 
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For model hyperparameters that needed to be tuned (such as the lambda 
value for GLM or the threshold for PAM), an internal cross-validation on the 
training partition in each cross-validation loop was used. This optimal value 
was subsequently used to train a final model on the training partition in each 
cross-validation loop, and produce results for the test partition in each cross-
validation loop.  
Performance of the individual models was evaluated by calculating the AUC 
in which a value of 0.5 corresponds to random prediction behavior and a 
value of 1 to optimal prediction performance. This is known to be a robust 
estimator of model performance over different model decision thresholds.  
To validate our results on an independent publicly available dataset, we 
retrieved data from Paul and Amundson [271] (GEO accession number 
GSE23515), describing a set of 95 samples from 24 individuals of different 
age, gender and smoking status exposed to different doses of radiation (0.0, 
0.1, 0.5 and 2.0 Gy). After pre-processing, probe sets that did not map to 
gene symbols and probe sets containing more than 25% empty values were 
filtered out. After this filtering step, 23,031 probe sets were kept for further 
analysis. Subsequently, feature importance rankings were derived from 
classifiers based on RF and PAM as described above. The overlap between 
the top 100 genes from our study and those from Paul and Amundson was 
higher based on the RF ranking; therefore, the cross-validation was 
performed using this model. 
The Venny on-line tool [272] was used to compare gene lists and create Venn 
diagrams: http://bioinfogp.cnb.csic.es/tools/venny/index.html 
3.3.6 Reverse transcription and qRT-PCR 
The following genes were selected for qRT-PCR validation: DDB2, POLH, 
MDM2, TNFRSF10B, FDXR, ASTN2, NDUFAF6, and PCNA (primer 
sequences can be found in Supplementary Table S1). RNA samples from 5 
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donors were used for cDNA synthesis using the GoScript™ Reverse 
Transcription System (Promega, Leiden, The Netherlands) with random 
hexamer primers. For each gene, qRT-PCR reactions were run in duplicate 
using the MESA GREEN® qRT-PCR kit (Eurogentec, Seraing, Belgium) on 
an Applied Biosystems® 7500 Real-Time PCR instrument following the 
manufacturer’s instructions. To determine the efficiency and specificity of the 
designed primers, we ran a standard curve experiment with melt curve for 
every primer pair. Primer sequences and reaction efficiencies are listed in 
Supplementary Table S1. qRT-PCR data were analysed by 7500 Software 
v2.0.6 and Microsoft Excel using the Pfaffl method [273]. The relative amount 
of transcript of the selected genes was normalised to PGK1 and HPRT1 using 
the geometric mean of these reference genes [274]. Relative expression 
levels were tested for statistical significance using the paired t-test; p-values 
of < 0.05 were considered significant. Pearson’s correlation coefficient was 
used to assess dose dependence of the gene expression levels. 
3.4 Results 
3.4.1 Low- and high-dose X-irradiation results in up-regulation of 
common genes 
Whole-genome microarrays were used to analyze genome-wide 
transcriptional changes in human peripheral blood mononuclear cells 
(PBMCs) at 8 h after exposure to X-ray doses of 0.1 and 1.0 Gy compared to 
sham-irradiated control cells. We chose the 8 h post-exposure time point for 
our microarray experiments as in previous studies from our group a significant 
radiation-induced modulation of gene expression was shown at this time point 
[275, 276], while at earlier time points, e.g. 2 h, the transcriptional response 
was significantly less pronounced [155]. Microarray results for several genes 
were validated by qPCR for a later time point of 24 h, as shown below. Three-
way ANOVA revealed 125 significantly differentially expressed genes (FDR < 
0.05) between different doses of X-rays (Supplementary Table S2). Of these, 
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the large majority (90.4%) were dose-dependently induced (Pearson’s 
correlation coefficients in Supplementary Table S2). Gene expression 
changes in response to radiation exposure were not gender-dependent 
(column FDR-corrected p-value (Dose*Gender) in Supplementary Table S2), 
as also previously suggested [271]. Unsupervised hierarchical clustering 
yielded a clear separation of the samples depending on the exposure dose 
(except for 3 out of 20 low dose-irradiated samples, which clustered together 
with the control samples) (Figure 12a). Similar results were obtained using 
principal component analysis (PCA) of the same dataset (Figure 12b). 
Comparison of the controls with each of the different doses yielded 
significantly increased expression levels following exposure to 0.1 Gy in 23 
genes. Of these, 20 genes (87%) were also differentially expressed in cells 
irradiated with 1.0 Gy (Figure 12c). Unsupervised hierarchical clustering using 
this subset of overlapping genes resulted in a perfect separation of the 
samples by exposure dose (Figure 12d).  
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Figure 12. Gene expression changes in PBMCs in response to irradiation at 8 h after exposure. 
In total, 125 genes were identified as differentially expressed by ANOVA (FDR corrected p-
values<0.05) between 0.1 Gy and 1.0 Gy samples and sham-irradiated controls. a. Unsupervised 
hierarchical clustering analysis of these 125 genes (plotted on y-axis) showed good separation of 
samples (x-axis) depending on the dose of exposure. Red: high gene expression, blue: low gene 
expression. b. 2D Principal Components Analysis (PCA) also separated samples depending on 
the dose. Each circle represents the expression profile of the 125 significantly differentially 
expressed genes in one sample. The percentage of the variance explained by the first and the 
second principal components is 44.7% and 6.58%, respectively. Ellipses represent two standard 
deviations. c. Venn diagram showing the overlap of differentially expressed genes after exposure 
to 0.1 and 1.0 Gy of X-rays. d. Unsupervised hierarchical clustering analysis of the 20 
overlapping genes (plotted on x-axis) showed perfect separation of samples (y-axis) depending 
on the dose of exposure. Red: high gene expression, blue: low gene expression. 
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3.4.2 X-irradiation induces alternative transcription and splicing 
Considering the well-documented ability of ionizing radiation to induce 
alternative gene splicing/transcription [187, 188], we first performed an 
Alternative Splicing ANOVA to identify which genes produced alternative 
transcripts following X-ray irradiation (Supplementary Table S3). Our results 
were in accordance with those of Sprung and co-authors [188] for the most 
significant genes, despite differences in experimental models (e.g. PBMCs 
versus lymphoblastoid cell lines) and conditions (doses, time points and gene 
expression platforms). The Splice Index algorithm with additional filtering 
identified much less alternatively spliced genes (3 genes after 0.1 Gy 
exposure and 17 after 1.0 Gy) (Supplementary Table S4). The FIRMA 
algorithm results were in keeping with those obtained by the Splice Index (37 
genes after 0.1 Gy exposure and 39 after 1.0 Gy) (Supplementary Table S5) 
with 15 genes being identified as alternatively spliced in response to 1.0 Gy 
by both algorithms. The same 15 genes were also identified as highly 
significant by the Partek Alternative Splicing ANOVA algorithm, with 13 of 
them among the 30 most significant ones according to their p-values 
(Supplementary Table S3) and, importantly, all 15 genes were differentially 
expressed (Supplementary Table S2). It has been shown before that 
radiation-induced alternative splicing occurs predominantly in genes that are 
differentially expressed at the gene level [188, 190]. 
Although it is not possible to infer the exact sequence identities of specific 
transcript variants from the gene array results, it was clear that different 
alternative splicing and transcription mechanisms had been activated in 
response to radiation exposure. For example, we found evidence of 
transcription from alternative promoters (e.g. ASTN2, NDUFAF6, FDXR and 
PCNA), alternative transcription initiation (e.g. ASTN2), alternative splicing 
(e.g. ASTN2 and FDXR), and use of alternative 3’-UTRs (e.g. ASTN2) (Figure 
13a-d and Supplementary Figure S1). The observed variation in the 
expression levels between different transcripts was validated by qRT-PCR 
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using transcript-specific primers (Figure 13). We found significant differences 
in radiation-induced expression of different variants of ASTN2 (Figure 13a), 
FDXR (Figure 13c) and PCNA (Figure 13d) at 8 h after exposure to 0.1 and 
1.0 Gy, while this difference was not significant for NDUFAF6 after exposure 
to 1.0 Gy, possibly because of large interindividual variations in the 
transcriptional response of this gene (Figure 13b). 
Furthermore, several of the probe sets among the 125 genes that were 
differentially expressed (Supplementary Table S2) have not yet been 
annotated to a gene. Mapping of their sequences to the mouse genome 
showed that most of them hybridize to intronic sequences of the PVT1, EI24, 
REV3L, RNGTT and ITPR2 genes (Supplementary Figure S2). Two other 
probe sets were found to map to a sequence downstream of PCNA and 
upstream of REV3L, respectively. Interestingly, EI24, REV3L, ITPR2 and 
PCNA were among the identified radiation-responsive genes (Supplementary 
Table S2), whereas Pvt1 was recently identified as a radiation-responsive 
gene in the embryonic mouse brain [190]. Our data suggest that these probe 
sets actually identify currently unknown exons of these radiation-responsive 
genes. 
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Figure 13. Radiation-induced alternative splicing. a-d. Upper panels show genomic organization 
of a few transcript variants from the UCSC database of the ASTN2 (a), NDUFAF6 (b), FDXR (c) 
and PCNA (d) genes. Each blue box represents an exon and the interconnecting lines represent 
introns. Lower panels show the log2 normalized intensity signals for each microarray probe, 
located on each specific exon shown above (error bars were left out to increase clarity). Arrows 
indicate the location of the primer pairs (pp) used for qRT-PCR validation. qRT-PCR validation 
results for each primer pair are shown on the right. Graphs represent mean + standard deviation. 
Statistical comparison was performed using the paired t-test (*p-value < 0.05, **p-value < 0.005, 
***p-value < 0.0001, ns: not significant).  
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3.4.3 Radiation exposure induces expression of neighboring genes 
The above results indicate that although radiation exposure leads to exon 
skipping and the use of alternative splice junctions, the mechanism that was 
most often observed to result in transcript variation was the expression of 
transcripts from alternative promoters. Since most of these genes are 
regulated by p53, we hypothesize that the DNA damage response, which is 
activated after irradiation, induces the expression of p53-dependent transcript 
variants, as shown previously in both lymphoblastoid cell lines [188] and the 
embryonic mouse brain [190]. Interestingly, we also observed that a 
significant proportion (23 out of 129 annotated genes; 17.8%) of the genes 
that were differentially expressed after irradiation with 1.0 Gy are genomic 
neighbors, several of which are transcribed from bidirectional promoters 
(Supplementary Figure S3). This finding aligns well with a study in which 
human lung fibroblasts were treated with the p53 activator 5-fluorouracil [277]. 
Chromatin immunoprecipitation with a p53 antibody followed by next-
generation sequencing revealed that about 4% of the high-confidence peaks 
were located at bidirectional promoters [277], including some that are identical 
to those observed by us (e.g. FAS-ACTA2 and ASTN2-TRIM32).  
3.4.4 Differential expression of distinct exons is more pronounced 
compared to entire genes 
For several genes, individual exons responded much stronger to the 
irradiation than others. This suggested that signatures of highly responsive 
exons might be more sensitive and would have greater predictive value as a 
biomarker of radiation exposure compared to genes, whose expression 
signals are averaged over the totality of their exons. This observation led us 
to perform ANOVA at the exon level as well, revealing 706 differentially 
expressed exons (FDR <0.05) between different doses of radiation exposure 
(Supplementary Table S6), with 157 exons being differentially expressed after 
exposure to both 0.1 and 1.0 Gy (Supplementary Table S7). Comparison of 
the distributions of fold changes in expression between genes and exons 
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confirmed that the changes in the exon expression levels were more 
pronounced compared to the genes on a generic basis, especially at the 
higher dose of 1.0 Gy (Figure 14a, 14b). Average fold changes for significant 
genes and exons after exposure to 0.1 Gy were 1.58 and 1.71, respectively 
(Figure 14c), increasing to 1.72 and 2.21 after exposure to 1.0 Gy (Figure 
14d).  
Figure 14. Fold-change induction of exon expression is more pronounced compared to gene 
expression. a-b. Cumulative distributions of fold changes in expression for significantly 
differentially expressed genes and exons after exposure to 0.1 Gy (a) and 1.0 Gy (b) of X-rays. p-
values for the difference between distributions for genes and exons according to the Kolmogorov-
Smirnov test were 0.195 and 0.000 for 0.1 Gy and 1.0 Gy, respectively. c-d. Box plots depicting 
fold changes in expression for the same data as in a, b. (c) Genes and exons upregulated at 0.1 
Gy. (d) Genes and exons upregulated at 1.0 Gy. Centerlines show the median, boxes represent 
the range between the first and third quartiles and whiskers represent the highest and lowest 
values. ***p-value < 0.0001 (Two-tailed Mann-Whitney test).  
Clustering of the samples based on the expression levels of the 706 
differentially expressed exons using unsupervised hierarchical clustering 
(Figure 15a) and PCA (Figure 15b) resulted in perfect separation of the 
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samples according to radiation dose. Together, these results suggest that 
exons might be more sensitive radiation biomarkers. 
 
Figure 15. Probe (exon) expression changes in PBMCs in response to irradiation. In total, 706 
exons were identified as differentially expressed by ANOVA (FDR corrected p-values < 0.05) 
between different irradiation doses. a. Unsupervised hierarchical clustering analysis of the 706 
exons (plotted on y-axis) showed perfect separation of samples (x-axis) depending on the dose of 
exposure. Red: high gene expression, blue: low gene expression. b. 2D Principal Components 
Analysis (PCA) also separated samples depending on the dose. Each circle represents the 
expression profile of the 706 significantly differentially expressed exons in one sample. The 
percentage of the variance explained by the first and the second principal components is 45.9% 
and 7.3%, respectively. Ellipses represent two standard deviations. 
3.4.5 Prediction analysis of transcriptional markers for radiation 
exposure 
To identify signatures of genes and exons that distinguish between different 
irradiation doses, we used three supervised classification models: generalized 
linear models (GLM), Random Forests (RF) and Nearest Shrunken Centroids 
as implemented by the PAM (Prediction Analysis for Microarrays) algorithm. 
Additionally, we assessed the suitability of the above-mentioned models for 
classification of the samples according to exposure dose.  
Table 7 shows the results of all models for gene and exon level analysis in the 
2-fold cross-validation setting. Both PAM and the RF models attained a very 
Chapter 3. Radiation-induced alternative transcription and splicing events and their 
applicability to practical biodosimetry 
75 
 
high performance even with a small number of features, and both models 
outperformed the GLM model. A combined PAM-RF model (features selected 
by PAM combined with classification by RF) achieved perfect classification 
with only two gene features (Table 7).  
 
Similar results were obtained for classification at the exon level (Table 7). 
Here, the PAM and RF models outperformed the GLM model more clearly. 
Comparison between exon and gene level analysis gave slightly inferior 
results for exons, with more features being needed to obtain optimal 
predictive performance. On the other hand, exons performed better than 
genes when 100 or all features were used. The genes/exons that were 
selected as the top 20 most important features for each of the classifiers are 
listed in Table 8. Of these, 12 genes were identified as differentially 
expressed according to ANOVA and suitable for class prediction by both RF 
and PAM (AEN, BAX, DDB2, EDA2R, FDXR, MDM2, POLH, RPS27L, 
SESN1, TNFRSF10B, XPC, ZMAT3).  
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To evaluate the robustness of gene expression signatures for practical 
radiation biodosimetry, we tested the predictive performance of our signature 
on an independent dataset from a study in which whole blood samples from 
male and female smokers and non-smokers were irradiated with similar doses 
to those used in our study, i.e., 0.1 Gy, 0.5 Gy and 2.0 Gy [271]. Using ten of 
our best predictive markers, we were able to classify these independent 
samples with 97% accuracy (Figure 16a), which overall is similar to the 
accuracy obtained in the original publication [271]. Next, we ran the RF model 
on the dataset of Paul and Amundson, and used the ten best predictors for 
cross-validation on our samples. This resulted in 100% accuracy (Figure 16b), 
i.e., identical to what we found using our 10 best gene predictors (Table 7). 
Unfortunately, we were not able to independently validate our exon signatures 
because this dataset did not contain exon-level information. 
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Figure 16. Gene signatures are robust predictive biomarkers of exposure to radiation. a. Five-fold 
cross-validation of our 10 best predictive genes on the dataset of Paul and Amundson [271] 
resulted in 97% accuracy for sample classification. b. Five-fold cross-validation of the 10 best 
predictive genes from the dataset of Paul and Amundson [271] as identified by the Random 
Forests model resulted in 100% accuracy for classification of our samples. c. Overlap between 
differentially expressed genes from this study and gene signatures identified by Paul and 
Amundson  [218], Chauhan and co-authors [235] and Warters and co-authors [278]. Common 
genes between all datasets are DDB2, POLH, MDM2, RPS27L, FDXR, CCNG1, TRIAP1, 
SESN1, FBXO22, PPM1D, ANKRA2, CDKN1A, TRIM22, and BBC3. 
Furthermore, we compared our results with those of three other studies in 
which different subjects, radiation doses (up to 8 Gy), dose rates, radiation 
qualities, time points, cell types and gene expression platforms were used. 
The specific characteristics of these studies are listed in Supplementary Table 
S8. Our comparative analysis revealed a very high degree of overlap in 
radiation-responsive genes between the different experiments, especially 
between those in which peripheral blood or PBMCs were used (Figure 16c). 
Nevertheless, 27 out of 79 genes (34%) that were found to be radiation-
responsive in keratinocytes and fibroblasts [278] were also identified in at 
least two other studies (Figure 16c).  
Together, these results hint at the existence of a core signature of genes that 
may be applicable for radiation biodosimetry for a wide range of doses, dose 
rates, and cell types/specimens after exposure to different radiation qualities. 
3’ 
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3.4.6 Validation of gene and exon expression using qRT-PCR 
qRT-PCR was used to validate the expression changes of several identified 
biomarker genes in PBMCs and peripheral blood. In general, the majority of 
the examined genes showed a dose-dependent up-regulation (Pearson’s 
correlation coefficients ranging between 0.82 and 0.99) after X-irradiation 
(Figure 17), although clear differences in the transcriptional response were 
observed between different genes. For example, most of the tested genes 
(ASTN2, MDM2, NDUFAF6, POLH, TNFRSF10B) showed a 2- to 3-fold 
induction in expression at 8 h after exposure to 1.0 Gy of X-rays, while DDB2, 
PCNA and FDXR expression levels were 4-, 5- and 25-fold induced, 
respectively. Furthermore, most of these genes showed significant differences 
in expression at 8 h after exposure to a dose of 0.1 Gy, demonstrating their 
sensitivity for this radiation dose at this time point. 
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Figure 17. qRT-PCR validation of the microarray results. qRT-PCR results for ASTN2, FDXR, 
POLH and MDM2 genes at 8 and 24 h after irradiation of PBMCs and whole blood. Graphs 
represent mean + standard deviation. Statistical comparison was performed using the paired t-
test (*p-value < 0.05, **p-value < 0.005, ***p-value < 0.0001). 
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Figure 17 (continued). qRT-PCR validation of the microarray results. qRT-PCR results for 
NDUFAF6, PCNA, TNFRSF10B and DDB2 genes at 8 and 24 h after irradiation of PBMCs and 
whole blood. Graphs represent mean + standard deviation. Statistical comparison was performed 
using the paired t-test (*p-value < 0.05, **p-value < 0.005, ***p-value < 0.0001). 
NDUFAF6 (PBMCs) NDUFAF6 (lllhole blood) 
c: 
- 8h 
.Q 
Zl 6 
i!! 
Cl 24h 
a. 
ä\ 4 
., 
5 
.!1!2 
., 
0:: 
0.0 0.1 1.0 O.OGy 0.1 Gy 1.0 Gy 
Dose (Gy) Dose (Gy) 
PCNA (PBMCs) PCNA (lllhole blood) 
c: c: 
- 8h 
.Q 
.Q CJ 24h 
UI ~ 6 UI i!! 
a. a. 
ä\ 4 ä\ 4 
., ., 
.2: .2: 
1§2 122 
., Q) 
0:: 0:: 
0.0 0.1 1.0 O.O Gy 0.1 Gy 1.0 Gy 
Dose (Gy) Dose (Gy) 
TNFRSF108 (PBMCs) TNFRSF108 (lllhole blood) 
c: 
- 8h 
.Q .§ CJ 24h 
UI UI 
UI ~2 i!! 
a. a. 
ä\ 2 x Q) 
., Q) 
.2: 2:1 
12 1 16 
Q) a; 
0:: 0:: 
0.0 0.1 1.0 O.OGy 0.1 Gy 1.0Gy 
Dose (Gy) Dose (Gy) 
DDB2 (PBMCs) DDB2 (lllhole blood) 
c: 8 - 8h 
.Q CJ 24 h Zl 6 *6 i!! 
a. a. 
ä\ 4 ä\ 4 
., Q) 
.2: .2: 
12 2 *2 Q) 
0:: 0:: 
0.0 0.1 1.0 O.OGy 0.1 Gy 1.0 Gy 
Dose (Gy) Dose (Gy) 
Chapter 3. Radiation-induced alternative transcription and splicing events and their 
applicability to practical biodosimetry 
81 
 
To confirm the obtained results, we also assessed the expression levels of 
these genes at a later time point, i.e., 24 h following irradiation, which is more 
applicable to emergency situations. Our results point to differences in the 
kinetics of the transcriptional response of these radiation-induced genes: 
reduced expression levels – but no complete return to basal expression levels 
- for FDXR, similar expression levels for DDB2, MDM2, PCNA, POLH and 
TNFRSF10B, and further increased expression levels for ASTN2 and 
NDUFAF6 after 24 h compared to 8 h (Figure 17). In many cases, however, 
statistical significance of expression changes after exposure to 0.1 Gy was 
lost after 24 h.  
In addition, we performed a similar qRT-PCR validation experiment using 
peripheral blood samples exposed to the same doses. Overall, the obtained 
results were very similar to those observed in PBMCs (Figure 17), 
demonstrating that PBMCs are a suitable model for the transcriptional 
radiation response of blood. 
3.5 Discussion 
Prompted by the rapid development of high-throughput genomic profiling 
technologies, several groups have explored the potential of gene expression 
signatures as biomarkers of (low dose) exposure [154, 218, 227, 235, 279-
281]. Most of the genes identified in these studies are known to be regulated 
by p53 and are involved in cell cycle regulation, DNA damage repair and 
apoptosis and some are already induced after exposure to doses as low as 5-
25 mGy [155, 227, 228, 231]. Furthermore, some of these genes allow to 
discriminate between ionizing radiation response profiles and those induced 
by inflammation [159]. Several genome-wide studies have been undertaken to 
assess the in vivo transcriptional response to ionizing radiation using blood 
samples from radiotherapy patients undergoing either total body irradiation 
[229] or local intensity modulated radiotherapy [230]. The results of these 
investigations indicate that in vivo irradiation mainly affects genes involved in 
pathways that are related to the immune system and inflammatory responses, 
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as well as p53-mediated pathways. Accordingly, induction of p53-dependent 
genes was observed in patients either undergoing CT scans (up to 4.3 cGy) 
or receiving (F-18)-fluoro-2-deoxy-d-glucose (0.6 cGy) [231]. Overall, the 
examined genes were induced in all samples, although differences in the in 
vivo and in vitro response were found, especially for doses below 5 cGy[231]. 
Other studies have identified in vitro gene signatures that could accurately 
predict the in vivo radiation exposure status [158, 232, 233]. Overall, these 
studies have shown that the in vitro transcriptional radiation response is a 
reliable model for the in vivo situation. Another possibility for biodosimetry 
studies is the use of animal models. For instance, it was demonstrated that 
radiation-responsive genes in mice show a response that is similar to that of 
homologous genes from ex vivo human studies [232, 280, 282]. On the other 
hand, gene expression profiles developed through analysis of murine blood 
radiation responses alone were found to be inaccurate in predicting human 
radiation exposures [158]. 
Unlike the moderate to high radiation doses used in most other studies 
dealing with transcriptional radiation biomarkers, the X-ray doses applied in 
this study are low to moderate but nonetheless relevant for medical triage. 
The moderate dose of 1.0 Gy represents the lower limit of doses that result in 
acute radiation syndrome [257] and is associated with a high probability of 
long-term stochastic health effects. The low dose of 0.1 Gy is not associated 
with any acute health effects but might require medical follow-up since the risk 
of long-term effects, particularly cancer, cannot be excluded [258]. To the best 
of our knowledge, only two studies aimed at identifying a predictive gene 
signature based on genome-wide data have used doses of 0.1 Gy or below 
[227, 271]. However, no cross-validation at the individual donor level was 
performed in either of these studies, which may have positively biased the 
results. 
One of the initial steps in our study consisted in a gene-level analysis of the 
microarray data, resulting in a list of genes capable of discriminating between 
Chapter 3. Radiation-induced alternative transcription and splicing events and their 
applicability to practical biodosimetry 
83 
 
the exposure conditions with high accuracy. Furthermore, a substantial 
fraction of the radiation-responsive genes were located in close physical 
proximity on the genome (often as neighbors with bidirectional promoters). 
We propose that these genes are co-regulated, most likely via activation by 
p53, or via chromatin loops which can bring promoters in close proximity, 
thereby exposing them to the same regulatory proteins. This co-regulation 
may be related to the nature of the stress inflicted on the cells by radiation 
exposure (i.e. DNA damage) since the frequency of bidirectional promoters is 
enriched in DNA repair genes compared to other gene classes [283, 284]. 
This observation may also be instrumental in identifying currently 
undiscovered radiation-responsive transcripts. One such new gene we 
identified as a predictive marker is PAPPA-AS1 (Table 7), which is a long 
non-coding RNA transcribed from the opposite strand of PAPPA, presumably 
from a shared bidirectional promoter with ASTN2.  
The specific microarray platform we used, interrogates the vast majority of 
exons from multi-exon genes, allowing to analyze the expression data at the 
exon level as well. Although we could not draw definite conclusions about the 
exact mechanisms underlying these events, our data are suggestive of the 
activation of different alternative splicing mechanisms (exon skipping, 
alternative splice sites, alternative polyadenylation) in response to irradiation. 
However, the most utilized mechanism appeared to be alternative promoter 
usage. Importantly, such events result in significant differences in the 
expression of single exons, while changes in the expression of the gene itself 
are less pronounced. Forrester and Sprung even proposed that dose 
prediction could be improved by the use of radiation-responsive transcript 
variants as biomarkers in combination with unresponsive intragenic controls 
[285]. However, these authors evaluated only three genes, one of which 
turned out unsuitable for dose prediction [285].  
To the best of our knowledge, comparison of gene and exon signatures for 
class prediction is a novel approach in biodosimetry, and has only rarely been 
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applied even in general biomarker research. Tian et al. showed that exons 
outperformed genes as biomarkers of Tourette syndrome [286]. In another 
study gene and exon signatures performed equally well in predicting of overall 
survival in neuroblastoma patients [287]. Likewise, our results are indicative of 
an overall comparable prediction performance of gene and exon signatures.  
From our results, and those from other groups [218, 227, 235, 271, 279, 281], 
it is now clear that there is a core of approximately 20 genes that can be 
regarded as robust biomarkers for radiation exposure to a wide range of 
doses. As such, genome-wide expression studies are undoubtedly highly 
informative to identify accurate dose-prediction signatures. Nevertheless, 
using microarrays for mass casualty screening in a radiological emergency 
situation is not a very realistic approach, due to high costs, limited availability 
of infrastructures equipped for performing these assays, the rather long 
response time and the complexity of the analysis. A more cost- and time-
efficient alternative would be to use primer- or probe-based assays (such as 
qRT-PCR) that measure the expression of a limited number of a priori 
identified biomarkers. However, these methods, in contrast to exon-specific 
microarrays, do not allow to measure the expression of the entire gene but 
only cover a relatively short region of one or a few exons. Therefore, selection 
of the most appropriate exons is imperative prerequisite for using primer- or 
probe-based assays. We validated the expression profiles of some of the 
identified genes that were also alternatively spliced in response to irradiation 
by qRT-PCR using variant- and exon-specific primers for transcripts with 
different radiation responses, and, for many of the tested genes, we only 
found a significant difference in expression in low dose-exposed samples with 
primer pairs amplifying the most sensitive exons. This suggests that these 
exons may be more sensitive markers for prediction of similar low doses and 
possibly also those below 0.1 Gy, i.e., doses at which combined exon signals 
(i.e. gene level) may be no longer predictive. This further highlights the 
importance of always obtaining prior knowledge about expression levels at 
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the exon level when primer- or probe-based assays are used to perform 
“gene-level” expression analysis.  
Our study has a few limitations. First, only two radiation doses and one  time 
point after irradiation were used to identify the predictive signatures. However, 
a comparative analysis with previously published studies, as well as validation 
of the predictive performance of our signatures on an independent dataset 
containing two additional doses, revealed that our signature also applies to 
higher doses and longer time points. Second, the gene expression profiles 
applied in our study stemmed from isolated PBMCs and not from whole blood. 
To address this, we validated gene expression using qRT-PCR on ex vivo 
irradiated peripheral blood samples, revealing highly similar transcriptional 
responses to radiation in PBMCs and blood for the investigated genes.  
In conclusion, we have shown that gene and exon signatures are equally 
performing in predicting exposure to radiation doses within the 0.1-1.0 Gy 
range at 8 h after exposure. We have generated a robust fingerprint for 
predictive biodosimetry and especially triage of individual radiation casualties. 
Implementation of a dedicated assay based on the identified biodosimetric 
panel may lead to improved point-of-care diagnostics for radiological 
accidents. Finally, we have shown the importance of evaluating gene 
expression at the level of single exons for transcriptional biomarker discovery 
in general.  
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3.9 Supplementary material 
 
 
 
Figure S1. Possible alternative splicing events responsible for differences in expression signals 
for different probes of the ASTN2 gene. (A) Radiation-induced expression of a truncated first 
exon of the short ASTN2 variant. (B) Radiation-induced splicing of two cassette exons and 
expression of an alternative 3’ exon. In both panels top tracks indicate fold changes for individual 
probes (green lines) in 1.0 Gy samples compared to 0.0 Gy. The vertical line indicates no 
change. Bottom track shows different transcript variants. Arrows indicate the 5’ to 3’ orientation of 
the gene. 
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Figure S2. Mapping of the probesets currently not annotated to a gene from Table S1. In each 
panel, top tracks indicate Affymetrix probesets while bottom tracks indicate known splice variants. 
Arrows indicate 5’ to 3’ orientation of the gene.  
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Figure S3. Positional gene enrichment analysis shows significant co-localisation of 
radiation-responsive genes. Scale bar indicates percentage of enrichment with 100% 
enrichment corresponding to genomic neighbors. Arrows indicate the 5’ to 3’ 
orientation of the genes. Please note that the separate clusters ACTA2-FAS and 
PANK1-KIF20B are in close proximity (< 1 Mb) on chromosome 10. 
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Supplementary Tables S2-S7 are available in electronic format only 
(as Excel files). 
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Supplementary Methods 
In vitro irradiation 
The beam quality can be approximated to H-250 (ISO4037): 250 kV, 15 mA, 
1.2 mm Al equivalent inherent filtration and 1 mm Cu additional filtration. The 
Kair at the reference position was measured using a NE2571 ionisation 
chamber (SN309) connected to a Farmer 2500 electrometer. The chamber, 
together with the electrometer, was calibrated in terms of Kair and the 
traceability to the international standards was assured. The reference point of 
the ionisation chamber was placed at the same distance with the reference 
position of the samples. The ionisation chamber was always placed in the 
beam, next to the samples, for a precise measurement of the time integrated 
Kair. The stability of the X-ray generator during the irradiation was verified in 
this way. 
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RNA extraction 
For RNA isolation from PBMCs a combination of the TRIzol® reagent 
(Invitrogen, Carlsbad, CA, USA) extraction method and the purification on 
Qiagen RNeasy columns (Qiagen, Venlo, The Netherlands) was used. Briefly, 
5x10
6
 cells were lysed in 1 ml of TRIzol® reagent and further processed 
following the manufacturer’s recommendations. Following the RNA 
precipitation with isopropanol, the obtained pellet was resuspended in 1 ml of 
ethanol and transferred to the RNeasy column. Further purification was done 
according to the manufacturer’s instructions. 
Microarray hybridisation 
Ten µg of cRNA, synthesised and purified from 0.25 µg of total RNA using the 
Ambion® WT Expression kit (Ambion, USA) was used for cDNA synthesis, 
followed by cDNA fragmentation and labeling with the GeneChip® Terminal 
Labeling kit (Affymetrix, Santa Clara, CA, USA). Fragmented and labeled 
cDNA was hybridised to Human Gene 1.0 ST arrays (Affymetrix, Santa Clara, 
CA, USA) using the GeneChip® Hybridization, Wash and Stain kit (Affymetrix, 
Santa Clara, CA, USA) (hybridization module) and hybridization controls 
(Affymetrix, Santa Clara, CA, USA) with rotation at 45°C for 16 hours. After 
hybridization, arrays were washed and stained using GeneChip® 
Hybridization, Wash and Stain kit (stain module) after which the arrays were 
immediately scanned using an Affymetrix GeneChip® Scanner. 
Predictive analysis 
Generalized linear models were trained using the R glmnet package. These 
methods build a regularised linear model which uses the lasso penalty to 
perform feature selection, resulting in only relevant features to receive 
nonzero weights. A multinomial model was used to model the three-class 
classification problem, and an internal five-fold cross-validation was used to 
tune the model's internal parameter lambda. Feature importance measures 
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were then derived from the weights of the linear model. The Random Forest 
based classification model uses an ensemble of randomised decision trees to 
perform classification. We used a collection of 1000 decision trees to build 
these models, and subsequently used the internal feature importance 
mechanism based on entropy reduction to obtain feature importance values. 
The Nearest Shrunken Centroid Classifier gradually shrinks the average gene 
expression centroids of the two groups to the overall centroid. The non-
differentially expressed genes are removed first as the distance between the 
centroids of two groups is small in this case and the group centroids of these 
genes will therefore quickly reach the overall centroid. Differentially expressed 
genes, in contrast, will “survive” the shrinkage much longer and will have a 
higher probability of being used for classification. The optimal level of 
shrinkage is determined with ten-fold cross-validation, which is used to select 
the number of genes for class prediction. Finally, the centroids of these genes 
are used to classify the new samples to the nearest centroid. 
While each of these classifiers has an internal mechanism to select 
informative features based on their internal weight or importance, we also 
experimented with explicitly reducing the number of features describing the 
data. To this end, internal model information was used to weigh features and 
keep only the most important ones. We explored the following number of 
features: 2, 5, 10, 20, 50, 100 most important features, and finally also the 
traditional setting where all features were used. To perform feature selection 
in an unbiased way, we again only selected the most important features from 
the training partition in each cross-validation loop. Subsequently, a model with 
only the selected number of features was retrained on the full training 
partition, and executed on the test partition within each cross-validation loop. 
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4. 
Gene expression-based biodosimetry using customized 
qPCR arrays: assessment of dose and time after exposure 
 
This chapter is modified from: 
Macaeva E., Mysara M., De Vos W., Baatout S., Quintens R. Gene expression-based 
biodosimetry using customized qPCR arrays: assessment of dose and time after exposure. 
Manuscript submitted to International Journal of Radiation Biology. 
4.1 Abstract 
The poor suitability of the currently used biodosimetry methods for mass-
casualty events gives rise to the development of new, time- and cost-efficient 
assays, such as detection of gene expression changes. In the present study, 
we tested the usefulness of gene expression signature integrated in a qRT-
PCR array for the prediction of exposure dose but also the time elapsed since 
irradiation. We used peripheral blood samples from seven healthy volunteers 
as reference samples (doses: 0, 25, 50, 100, 500, 1000, and 2000 mGy; time 
points: 8, 12, 24, 36 and 48 h) and samples from five other individuals as 
“blind samples” (20 in total). Our analysis showed that ΔCt values normalized 
to the reference gene without normalization to the unexposed controls 
contained sufficient information for discrimination of the samples between the 
doses with a correlation coefficient between the true and the predicted doses 
of 0.86. Importantly, we could also classify the samples according to the time 
point with a correlation coefficient between the true and the predicted time 
point of 0.96. In a real accident situation this feature will be of critical 
importance for adequate gene expression-based dose prediction. In this study 
we also compared different methodologies for RNA extraction and chose the 
one most suitable for emergency. Our results represent an important advance 
in the application of gene expression for biodosimetry purposes.  
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4.2 Introduction 
Biodosimetry is the dose estimation after exposure to ionizing radiation by 
means of changes in biological endpoints, or biomarkers. In case of large-
scale radiological accidents, when physical dosimetry is not available for all 
the individuals at risk of exposure, these biomarkers could be used to detect 
individual exposure cases. In such situations triage decisions have to be 
undertaken as soon as possible in order to split the exposed subjects into 
different categories, depending on the exposure dose and radiosensitivity 
[288]. This triage will allow focusing the medical staff and facilities only on the 
subjects in need of urgent medical assistance [288]. 
As yet, the gold standard method in biodosimetry is the detection of dicentric 
chromosomes in peripheral blood lymphocytes (dicentric chromosome assay  
or DCA) [195]. Besides its sensitivity to doses down to 20 mGy [289], this 
method has many other advantages, such as high specificity to ionizing 
radiation, possibility to detect partial body exposure and possibility of 
exposure assessment even months after irradiation [195]. However, DCA is 
low in throughput: it is time-consuming, laborious and requires highly trained 
personnel for scoring. In 2010, the total capacity of European Union 
laboratories specialized in biodosimetry for DCA was estimated to be 1493 
samples in the triage mode and 187 samples in the full mode per week, 
excluding the 48 h time needed for lymphocyte culturing [290]. This would be 
insufficient in case of a large-scale accident with thousands of potentially 
irradiated subjects. 
A promising new approach for biodosimetry that offers superior time-
efficiency, is the analysis of changes in gene expression levels. Several 
genes, which respond to radiation exposure have been studied using different 
methodological approaches, such as whole genome microarray methods 
[218, 227, 259, 280, 281, 291] or quantitative PCR [154, 155, 292-294]. Most 
of the identified genes are known to be regulated by p53 (e.g. MDM2, DDB2 
[221], FDXR [222], PCNA [223], GADD45A [224], RPS27L [225], SESN1 
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[226]), and are involved in cell cycle regulation, DNA damage repair and 
apoptosis. Because some of them are induced after exposure to doses as low 
as 5-25 mGy [155, 227, 228, 231], it can be stated that in terms of sensitivity 
gene expression outperforms DCA, for which the threshold of sensitivity is 
about 20 mGy when scoring a few thousands metaphases [289]. As a result, 
the development of a biodosimetry gene signature and associated assays 
which can be configured as devices suitable for low-cost, “point-of-care” 
measurements make an appealing strategy [219, 294, 295].  
One of the main difficulties in using changes in gene expression as a 
biomarker of exposure is the highly dynamic nature of the signal. The 
expression of every single gene following radiation exposure is affected not 
only by the dose, but also by the time, and the kinetics of expression is 
specific for every gene [155].  This means that knowledge of the time span 
between exposure and measurement is pivotal for correct dose prediction, or 
methods have to be devised that turn static snapshots into temporal 
information. Using a signature of genes rather than one single gene may 
allow assessing the time after exposure based on the combination of their 
expression profiles. In addition, finding the right methodological approach to 
monitor gene expression as early as possible following exposure is also 
important. Possible solutions to this include immediate snap freezing of blood 
in liquid nitrogen or dry ice, which might be challenging in field conditions, or 
addition of special whole blood preservation buffers [296], which would also 
solve the problem of effective preservation of easily-degradable RNA. Another 
challenge of using blood for gene expression studies is the heterogeneity of 
blood cells. About 99% of blood cells are red blood cells, including immature 
reticulocytes, which contain high levels of globin mRNA (accounting for ∼ 
70% of all mRNA in blood), which can compromise the detection of other 
specific mRNAs from white blood cells [297]. Although qPCR is less affected 
by globin mRNA contamination, this parameter is highly important for such 
techniques as microarrays [298] and next generation sequencing [296].  
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Recently, we used microarrays to analyze the expression response of human 
peripheral blood mononuclear cells (PBMCs) exposed ex vivo to radiation 
doses of 0.0, 0.1, and 1.0 Gy and we observed that many differentially 
expressed genes were also alternatively transcribed/spliced in response to 
radiation [259]. We thereby identified a signature of genes and exons that 
showed high performance in dose prediction [259]. We now used the most 
radiation-sensitive exons to design a qPCR array for biodosimetry. Notably, 
the genes used for these qPCR arrays are also responsive to high-LET 
radiation, such as carbon and iron ions (see Chapter 5). In addition, we also 
included three genes (PF4, GNG11 and CCR4) which were shown to be up-
regulated in response to low-dose exposure (0.05 Gy) and down-regulated by 
higher dose (1 Gy) at 6 h post-irradiation [276]. 
In the present study we investigated the potential of this assay to predict both 
dose and time after exposure. In addition, we compared different RNA 
extraction protocols and assessed their applicability to an emergency 
situation. 
4.3 Materials and methods 
4.3.1 Comparison of RNA extraction methods 
As the first step of the present study, the performance of two RNA extraction 
kits specifically designed for RNA extraction from blood samples - QIAamp 
RNA Blood Mini Kit (Qiagen, Hilden, Germany) and PAXgene Blood RNA Kit 
(PreAnalytiX, Hombrechtikon, Switzerland) - was tested under different 
conditions (Figure 18).  
Peripheral blood samples were collected from five healthy donors with 
informed consent and ethical approval from the local SCK•CEN Ethics 
Committee. The procedure was carried out in accordance with the ethical 
standards of the Helsinki Declaration of 1975, revised in 2000.  
Chapter 4. Gene expression-based biodosimetry using customized qPCR arrays: 
assessment of dose and time after exposure 
98 
 
RNA extractions were performed following the manufacturer’s instructions, 
unless mentioned otherwise (see Figure 18 for details). RNA concentration 
was measured on a Trinean Xpose instrument (Trinean, Gent-Brugge, 
Belgium) and the quality of total RNA samples was assessed using Agilent 
2100 Bioanalyser (Agilent Technologies, Santa Clara, CA, USA).  
Globin mRNA contamination was assessed using qRT-PCR with primers 
specific to HBA1 and HBB genes using isolated PBMCs as a reference. 
PBMCs isolation was performed as described in [259]. RNA extraction from 
isolated PBMCs was performed using the RNeasy Mini Kit (Qiagen, Venlo, 
The Netherlands) following the manufacturer’s instructions.  
 
Figure 18. Schematic representation of the experimental procedures. 
cDNA synthesis was performed using the GoScript™ Reverse Transcription 
System (Promega, Leiden, The Netherlands) with random hexamer primers. 
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For each gene, qRT-PCR reactions were run in duplicate using the MESA 
GREEN® qRT-PCR kit (Eurogentec, Seraing, Belgium) on an Applied 
Biosystems® 7500 Real-Time PCR instrument following the manufacturer’s 
instructions. qRT-PCR data were analyzed by 7500 Software v2.0.6 and 
Microsoft Excel using the Pfaffl method [273]. The relative amount of 
transcript of the selected genes was normalized to PGK1 and HPRT1 
reference genes (RGs) using the geometric mean of these reference genes 
[274]. 
4.3.2 Blood collection and in vitro irradiation 
Peripheral blood samples were collected in EDTA coated tubes from healthy 
donors with informed consent and ethical approval from the local SCK•CEN 
Ethics Committee. All procedures were carried out in accordance with the 
ethical standards of the Helsinki Declaration of 1975, as revised in 2000. Half 
of the samples were used as reference samples, the other half was used as 
blind samples. Donor information can be found in Table 9. 
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Each blood sample was collected in an EDTA-coated tube and aliquoted in 
either 5 ml (reference samples) or 2 ml (blind samples) tubes for irradiation. 
Reference samples were irradiated with 0, 25, 50, 100, 500, 1000, and 2000 
mGy, after which the tubes were placed on a rocking platform in an incubator 
at 37°C without CO2 supply. The irradiations were performed at room 
temperature with an Xstrahl machine (250 kV, 1.4 mm Cu + 3.8 mm Al 
filtration) at a dose rate of 0.14 Gy/min. At 8, 12, 24, 36 and 48 h after 
irradiation an 1 ml aliquot was taken from each sample and used for RNA 
extraction. The doses and fixation time points for blind samples were 
assigned randomly and are given in Table 10.  
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4.3.3 RNA extraction, quantification and quality control  
The QIAamp RNA Blood Mini Kit was used to extract RNA from the blood 
samples used in the biodosimetry part of the present study. All procedures 
were performed following the manufacturer’s instructions, unless stated 
otherwise. RNA concentration was measured on a Trinean Xpose instrument  
and the quality of total RNA samples was assessed using Agilent 2100 
Bioanalyser (Agilent Technologies, Santa Clara, CA, USA). All samples had a 
RIN >8 and were therefore considered as suitable for further processing. 
4.3.4 Reverse transcription and qRT-PCR 
cDNA synthesis on the samples used for biodosimetry part of this study was 
performed using RT
2
 First Strand Kit (Qiagen, Germantown, MD, USA) 
following the manufacturer’s instructions. qRT-PCR was run using custom 
RT
2
 Profiler PCR Arrays (Qiagen, Germantown, MD, USA). In the present 
study a standard 96-well plate-format arrays were used, including 25 genes of 
interest, four RGs (HPRT1, PGK1, GAPDH and B2M), positive PCR control, 
human genomic DNA contamination control and reverse transcription control. 
Each 96-well array could therefore be used to run three samples. The list of 
genes present on the arrays is given in Supplementary Table S9. Based on 
our previous results [259], for the genes alternatively transcribed/spliced in 
response to irradiation primers were designed to target the most responsive 
regions (Supplementary Table S9). qRT-PCR was run using RT² SYBR 
Green Mastermix (Qiagen, Germantown, MD, USA) following the 
manufacturer’s instructions on an Applied Biosystems® 7500 Real-Time PCR 
instrument. qRT-PCR arrays data were analyzed using the dedicated 
software available at: 
http://www.qiagen.com/be/shop/genes-and-pathways/data-analysis-center-
overview-page/custom-rt2-pcr-arrays-data-analysis-center/ 
After comparing the variability of expression (standard deviations and 
variances of Ct values in 245 reference samples) of the four RGs, it was 
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decided to use only B2M to normalize the relative amounts of transcript of the 
genes of interest. The obtained ΔCt values to RG were used to train the 
prediction models. Relative expression levels were tested for statistical 
significance using 2-way ANOVA with Bonferroni post-hoc test. 
4.3.5 Classification 
Two models were built to predict both the radiation dose and time point of 
each blind sample based on the gene expression profiles. Two separate 
datasets were used for training and testing. For training the models, the data 
acquired from seven donors (reference samples, Table 8) were used, while 
for testing we used the data of seven different donors (blind samples, Table 
8). Training both models consists of five consecutive steps, 1) identify the 
genes most likely responsible for the prediction of the radiation doses and 
time points (i.e. feature identification), 2) selecting the most informative 
features (i.e. feature selection), 3) building both models using the classifiers 
available (i.e. model training), 4) testing the models with a database 
unexposed to the training step (i.e. model testing), 5) selecting the best 
performing model for both problems (i.e. model nomination). 
Feature (gene) identification was performed in our previous study [259] (see 
Chapter 3). Both dose and time point were treated as a regression variable 
ranging from 0 mGy to 2000 mGy and 0 h to 48 h, respectively. Importantly, 
the testing dataset was not only constructed from new subjects but also new 
intermediate doses such as 30, 60, 400, 700, 900, 1200 and 1600 mGy not 
used for training the model were included. This is particularly important to 
illustrate the independency of the model from the set of training instances. 
Secondly, we attempted to perform a feature selection step, important to 
reduce the complexity and increase the accuracy of the model. To investigate 
if all features were necessary for the predictive model, we used the WEKA 
software implementation to get an idea of the importance of all attributes. 
Interestingly, however, performing the principle component analysis for 
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feature pre-selection illustrated the necessity for all features to describe 95% 
of the variance within the training dataset (data not shown). Consequently all 
features were included for training both models using a wide range of 
classifiers available in WEKA [299]. 
Different classification and regression models were considered including 
Support Vector Machines (SVM), linear regression, Multi-Layer Perceptron (a 
neural network), nearest neighbour, and three decision tree models: M5Base 
(implementing base routines for generating M5 Model trees and rules), 
decision stump and Fast decision tree learner as implemented in WEKA 
[299]. Next, each of the trained classifiers was tested using the test dataset, 
during the fourth step (model testing). To select the optimal classifier, we 
trained and tested various models. We reported for each classifier Pearson 
correlation coefficient and the relative absolute error (RAE) calculated for 
dose prediction as following: 
 
𝑹𝑨𝑬𝑫𝒐𝒔𝒆 = ∑ |𝒙𝒊 − 𝒚𝒊|
𝒏
𝒊=𝟏 / ∑ |𝒛 − 𝒚𝒊|
𝒏
𝒊=𝟏   
 
where 𝒙𝒊 is the predicted dose, 𝒚𝒊 is the true dose, 𝒛 is the average of x 
values, for every n cases.  
 
For time point prediction RAE was calculated as following: 
 
𝑹𝑨𝑬𝑻𝒊𝒎𝒆 = ∑ |𝒙𝒊 − 𝒚𝒊|
𝒏
𝒊=𝟏 / ∑ |𝒛 − 𝒚𝒊|
𝒏
𝒊=𝟏   
 
where 𝒙𝒊 is the predicted time point, 𝒚𝒊 is the true time point, 𝒛 is the average 
of x values, for every n cases.  
Finally, we nominated the best performing model for each case (predicting the 
radiation doses and time points) achieving the lowest mean absolute error 
while having the highest correlation coefficient.   
Chapter 4. Gene expression-based biodosimetry using customized qPCR arrays: 
assessment of dose and time after exposure 
104 
 
4.4 Results 
4.4.1 Optimization of RNA extraction protocols for emergency situations 
To optimize RNA extraction for emergency situations, different protocols were 
compared and the total RNA content, integrity and contamination was 
quantified. 
In this part of the study a few modifications of the standard protocols of two 
commercially available kits, which might be useful for a mass-casualty event, 
were tested: PAXgene tubes, which are specifically designed for direct 
collection of blood and preservation of RNA for up to 3 days at room 
temperature and up to 50 months at -20°C and QIAmp kit intended for 
molecular biology applications. PAXgene system showed consistently high 
yields (3.11-3.78 µg of RNA per ml of blood on average) of high-quality RNA 
(average RIN 8.22-9.42), in case blood was directly collected in PAXgene 
tubes (Figure 18, Standard PAXgene protocol, Modified protocols 1 and 2). 
Alternatively, the option of collecting the blood in standard EDTA-coated 
tubes followed by transfer into PAXgene tubes was also explored (Figure 18, 
Modified protocol 3). This approach resulted in extraction of high-quality RNA 
(average RIN 9.2), however RNA yields were lower compared to the standard 
PAXgene procedure (2.47 µg of RNA per ml of blood on average). 
Importantly, sufficient RNA (1.16 µg of RNA per ml of blood on average) of 
acceptable quality (average RIN 6.84) could also be extracted from the blood 
samples which were frozen at -20°C and transferred into PAXgene tubes after 
thawing (Figure 18, Modified protocol 4). QIAmp protocol does not allow 
processing of frozen blood, therefore the options of protocol modifications 
were limited (Modified protocol 5), but both tested protocols involving this kit 
resulted in high yields of RNA (3.29-3.59 µg of RNA per ml of blood on 
average) of high quality (average RIN 9.7-9.9) (Figure 18, Modified protocol 5 
and QIAmp standard protocol). Another parameter which was tested is the 
contamination of RNA samples with excessive globin mRNA. In this respect, 
QIAmp kit clearly outperformed PAXgene, showing low globin mRNA 
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contamination results comparable to those obtained for isolated PBMCs, used 
as a reference.  
4.4.2 Robust dose- and time-dependent response of the biodosimetric 
gene panel 
In order to identify the best endogenous controls consistently expressed 
across the sample population, we compared the variability of expression of 
PGK1, HPRT1, GAPDH and B2M. The standard deviations of Ct values for 
B2M were lower than for PGK1, HPRT1, and GAPDH (Table 11). Also the 
differences between the minimal and maximal registered Ct values for B2M 
were the lowest (~5-fold compared to ~10-fold for the other genes). 
Therefore, in the subsequent analyses, the Ct values of target genes were 
normalized to the Ct values of B2M. 
 
Blood samples from seven healthy volunteers exposed to X-ray doses 
ranging from 25 to 2000 mGy were used as reference samples at five 
different time points following exposure: 8, 12, 24, 36 and 48 hours. In total, 
25 genes were assessed (Figure 19). Overall, it was clear that for many 
genes in a similar in vitro experiment 36 h time point is the limit as at 48 h a 
significant up-regulation was observed also in non-exposed samples. At 48 h 
post-irradiation, some genes, e.g. AEN, did no longer demonstrate differential 
expression with respect to non-exposed samples. This fading effect could be 
observed to some extent for the majority of radiation-responsive genes, albeit 
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with different kinetics. An exception was CDKN1A, the expression of which in 
control samples increased with a peak at 24 h and gradually decreased up to 
48 h (Figure 20). 
This effect was more pronounced (i.e. the effect of radiation was totally 
masked at 48 h) and sometimes observed at earlier time points for the genes 
involved in apoptosis (e.g. TNFRSF10B, Figure 20). Other genes, such as 
FDXR, showed stable dose-dependent up-regulation at all the time points 
(Figure 20). A few genes, e.g. SESN1, did not show a consistent dose-
dependent response in contrast to what was expected (Figure 20). Three 
genes (PF4, GNG11 and CCR4) which were previously shown to differentially 
respond to low- and high-dose exposures [276], in our set up did not show 
significant differences in response with respect to dose, however, the 
expression of GNG11 and CCR4 was clearly affected by the time after 
exposure. 
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Figure 19. Heatmaps showing expression levels (relative to control samples at 8 h, log2 
transformed) for all the 25 genes (shown in rows) included in the qPCR arrays in response to 
exposure to different doses (shown in columns) at five time points.  
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Figure 20. Changes in expression of several genes (TNFRSF10B, CDKN1A, FDXR) present on 
qPCR arrays. Data are shown for blood samples of seven healthy donors irradiated in vitro with 
doses from 0 to 2000 mGy and fixed at 5 time points after exposure. Error bars represent 
standard deviations. Statistical comparison was performed using repeated measures 2-way 
ANOVA with Bonferroni post-hoc test (*p < 0.05, **p < 0.005, ***p< 0.0001). 
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Figure 20 (continued). Changes in expression of several genes (SESN1, PF4, GNG11) present 
on qPCR arrays. Data are shown for blood samples of seven healthy donors irradiated in vitro 
with doses from 0 to 2000 mGy and fixed at 5 time points after exposure. Error bars represent 
standard deviations. Statistical comparison was performed using repeated measures 2-way 
ANOVA with Bonferroni post-hoc test (*p < 0.05, **p < 0.005, ***p< 0.0001). 
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4.4.3 Dose and time after exposure can be predicted from changes in 
gene expression  
The ΔCt values of all the reference samples were used as the training dataset 
for building the dose and time point prediction models. Following this, the 
selected model was used to predict the dose and the time after exposure of 
the blind samples. The obtained results are shown in Table 12 and Figure 23.  
 
For the dose prediction, the fast decision tree learner (implemented as 
REPTree in WEKA) was found capable of achieving the highest Pearson 
correlation coefficient between the true and the predicted doses of 0.86 with 
the lowest RAE of 42%. The merit of this classifier is that it builds the decision 
based on the information gained and prunes the tree branches using reduced-
error pruning (with backfitting) (Figure 21).  
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Figure 21. The decision tree for the REPTree model built for dose prediction, ending with 11 
“leaves” (for each the dose prediction is calculated).      
Dose prediction was more accurate for doses below 0.5 Gy (Pearson 
correlation 0.85) compared to higher doses (Pearson correlation 0.55), 
probably resulting from the well-known plateau effect of the gene expression 
response at high doses. Although most of the genes were required to explain 
the variability within the data, set of four genes including MDM2, FDXR, 
ASCC3 and CDKN1A was considered particularly important for dose 
prediction. For the time point prediction, the M5Base decision tree classifier 
(implemented in WEKA as M5P) was able to achieve a correlation coefficient 
between the true and the predicted time points of 0.96 (with lowest RAE of 
28%). M5Base implements base routines for the generation of the M5 model 
[300, 301]. It functions as a decision tree by splitting the data into branches 
and leaves based on few parameters, but instead of assigning the "time 
points" for each leave, a linear regression function is calculated for each leave 
(enabling a continuous numeric prediction) (Figure 22). 
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The latest time point, 48 h, seemed to be the most difficult to predict with the 
highest number of predictions out of the ±4 h interval (Table 12). The most 
discriminative genes were AEN, ASCC3, CDKN1A, GNG11 and CCR4, 
although all genes were found necessary to describe the dissimilarity within 
the data. In case of both dose and time point prediction using only the most 
important genes did not result in significantly better model performance (data 
not shown). All three samples misclassified according to the true dose were 
also misclassified according to the true time point. Among the individuals who 
donated blood for blind samples, one was a smoker, one recently stopped 
smoking and one individual reported a recent infection. Prediction of the 
doses or time points for these individuals was not particularly more 
problematic, however, a trend for dose overestimation could be observed 
(Figure 23).  Also, the median age of donors whose blood was used for 
reference samples (27 years) was lower, than that of the blind sample donors 
(54 years), nevertheless dose prediction was still efficient. 
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Figure 23. Dose (A) and time point (B) prediction results for the blind samples. CC – correlation 
coefficient. 
4.5 Discussion 
Gene expression is emerging as a highly powerful readout for biodosimetry. 
Several studies demonstrated the usefulness of microarray technology for 
analyzing large sets of transcripts for dose prediction [218, 232, 259, 280]. 
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However, as was demonstrated in a recent biodosimetry exercise, the 
analysis of a short list of genes, or even one gene by means of qPCR 
technology, is far more straightforward and cheaper than the microarray 
analysis, while the accuracy of dose prediction is essentially similar [55]. 
Many of the genes included in our biodosimetry panel were also previously 
tested by other groups [155, 231, 292, 293], suggesting their robustness as 
radiation biomarkers. Nevertheless our panel composition is unique because  
we could select the most radiation-sensitive exons of the respective genes for 
qRT-PCR analysis based on our previous results [259].  
Gene expression changes are a highly dynamic process, therefore knowing 
the point in time at which sample is taken following the radiation exposure is 
highly important for correct dose estimation. The classification method used in 
our study allowed to classify the samples according to the time elapsed since 
exposure with high precision (errors ≤ 4 h). The importance of time factor is 
also highlighted by the fact that all three samples misclassified according to 
the true dose were also misclassified according to the true time point. It is 
important to note, however, that the gene expression kinetics might be 
different following in vivo exposure, as a result adaptation of the methodology 
for in vivo exposure situation might be required. 
Another difficulty of any biodosimetric analysis is the correct choice of the 
unexposed controls to be used for comparison with the exposed samples. It is 
particularly critical because confounding factors, such as age, gender, 
infections and inflammatory diseases, smoking status and lifestyle in general 
might influence the expression levels of specific genes. In this regard, using a 
signature of genes rather than one gene, in our opinion, could already help 
solving the problem and allow for effect compensation. Experiments 
performed by Tucker et al. in mice and by Budworth et al. in ex vivo irradiated 
human blood samples showed that although the expression of some 
biodosimetry-relevant genes (e.g. CDKN1A, FDXR, BBC3) is affected by the 
bacterial endotoxin lipopolysaccharide, they could still be used for dose 
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prediction even in the presence of inflammatory stress [159, 302]. The 
performance of a dose prediction gene signature was also found to be 
unaffected by gender or smoking status of blood donors [271]. In our case, 
dose prediction for samples of smokers or a donor with a recent infection was 
also efficient, however, these results need further validation on a larger cohort 
of donors. Importantly, our approach allowed efficient identification of 
unexposed blind samples even in the absence of pre-exposure samples from 
the same individuals. 
Also, in many studies published so far fold change in expression between 
irradiated and control samples were used [154, 155, 231]. However, this 
approach will not be applicable to a real large-scale accident as the data for 
control samples from each potentially exposed individual will not be available. 
Therefore, in the present study, we opted to use ΔCt values compared to the 
RGs. This approach was previously used by Tucker et al. [292] and Brzoska 
and Kruszewski [293], as well as in two biodosimetry exercises organized by 
the RENEB consortium [51, 55].  
The dose prediction was not confounded by the time that elapsed after 
exposure and vice versa. This indicates that even at later time points after 
irradiation, dose prediction based on a signature of genes is still possible. The 
transcriptional biodosimeters used in the present study were chosen based on 
our previous microarray results. However, not all of the tested genes 
responded to ionizing radiation as was expected. This highlights the 
importance of accurate validation of transcriptional biomarkers identified in 
microarray studies. A few genes from our panel were statistically most 
important parameters for dose (MDM2, FDXR, ASCC3 and CDKN1A) and 
time point (AEN, ASCC3, CDKN1A, GNG11 and CCR4) prediction, however, 
they do not capture all variability within the data, therefore relying only on 
these few genes would reduce the accuracy of the prediction. Out of the three 
genes (PF4, GNG11 and CCR4) which were previously shown to differentially 
respond to low- and high-dose exposures [276], in our set up only PF4 
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followed a similar expression profile. Importantly, these chemokine-related 
genes showed time-dependent changes in expression profile, most probably 
induced by in vitro culture conditions, contributing to time point prediction in 
blind samples. 
For most of the studied genes we consistently found a plateau in expression 
for high doses (1000 and 2000 mGy), which probably contributed to less 
precise dose prediction in blind samples. This saturation effect at doses 
higher than 2 Gy was also previously observed during RENEB biodosimetry 
exercise [55] and in our preliminary experiments (data not shown). This 
feature may reflect a saturation of the response, but it might also be the result 
of in vitro culture conditions. In radiotherapy patients undergoing total body 
irradiation several genes included in our panel (e.g. CDKN1A, FDXR, and 
PHPT1) showed further up-regulation after 3.75 Gy compared to 1.25 Gy 
[233]. Nevertheless, our approach has good potential to allow correct 
identification of the “worried wells” from the individuals with relatively low-level 
radiation exposure (below 100 mGy) and those who might manifest the acute 
radiation syndrome symptoms, which occur after whole-body or significant 
partial-body irradiation of greater than 1000 mGy delivered at a high-dose rate 
[303]. In experiments in mice this saturation effect was observed at acute 
exposure to 6 Gy [237].  
Although a more common approach for similar studies is diluting the blood 
samples either 1:1 or 1:3 with appropriate culture medium supplemented with 
fetal bovine serum, which still results in about 47% of unstimulated 
lymphocytes undergoing apoptosis after 48 h in culture [304],we opted for 
using undiluted blood samples for our experiments. We realize that this 
protocol might not be optimal, especially for longer incubation time points, 
such as 36 and 48 h, but our goal was to interfere as little as possible with the 
samples, as gene expression changes might be affected by culture 
conditions, and more specifically by addition of fetal bovine serum [305, 306]. 
A similar approach was used by Manning and co-authors, and cell viability of 
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approximately 99% was found in blood samples incubated for 24 h at 37°C. In 
our study the genes, most affected by incubation time were those involved in 
apoptosis (e.g. AEN and TNFRSF10B), suggesting the increase in number of 
dying cells with time. Our results allow us to set a threshold of feasibility of 24 
or 36 h, depending on the gene, for similar in vitro experiments. In vivo 
irradiation experiments performed by Tucker and co-authors in mice 
confirmed the possibility of dose prediction based on gene expression for at 
least 7 days after exposure, which is very promising, but whether the same is 
true in humans remains to be investigated [237]. Studies involving 
radiotherapy patients showed that prediction of in vivo radiation dose using 
gene signatures was possible for at least 24 h following the first fraction of 2 
Gy local exposure to the pelvis [55] and after one and three 1.25-Gy fractions 
of total body exposure [233].  
A highly important step in biodosimetric triage of casualties of a nuclear 
accident is collecting and preserving the blood samples in an appropriate way 
for further analysis.  For gene expression measurement the time elapsed from 
exposure to blood collection and sample fixation is critical for correct dose 
estimation, as gene expression in non-frozen and non-stabilized blood would 
still be subjected to change. Several approaches to solve this issue were 
previously tested. Brzoska and Kruszewski extracted RNA for gene 
expression analysis from blood which was frozen and stored at -75°C, 
therefore allowing for preservation of gene expression signature at the 
moment of blood collection [293]. However, this approach might still not be 
practical in field conditions due to the lack of very low temperature freezers. 
An alternative approach, tested during the recent RENEB biodosimetry 
exercise, includes the addition of RNA stabilization reagents which protect 
RNA from degradation allowing for sample storage and transportation at room 
temperature for several hours or even days [51]. However, this methodology 
still requires the availability of significant quantities of such reagents at the 
accident site. In addition, the further processing of the samples might be 
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affected by transport conditions [51]. Therefore, in our study we tested 
another approach, consisting in blood freezing at -20°C, which would allow 
blood preservation without any specific equipment or reagents. Upon delivery 
to the biodosimetric laboratory, blood samples would be thawed and 
transferred to PAXgene tubes, allowing for recovery of sufficient RNA of 
acceptable quality.  
Taken together, in the present study, we proved the usefulness of a 
biodosimetric panel of genes in predicting both dose and time after in vitro 
exposure. Our results confirm that the analysis of expression of these genes, 
which can be carried out in virtually any laboratory possessing a qPCR 
instrument, can certainly provide sufficient information for triage purposes in 
comparatively short amount of time. The validity of our customized 
biodosimetric qPCR arrays was recently confirmed in interlaboratory 
comparison exercise organized by the RENEB consortium [51]. Although in 
this exercise different experimental procedures, including different dose 
assessment approach were used, we could still achieve good dose prediction 
[51], confirming the flexibility and versatility of our method. We also suggest a 
blood preservation method allowing for further RNA extraction feasible for 
field conditions. Further research is needed to confirm the time- and dose-
wise validity and applicability of our signature for in vivo situation, as well as 
to reveal the potential impact of confounding factors on the reliability of the 
gene expression-based biodosimetry. 
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5. 
Transcriptional profiling of human peripheral blood 
mononuclear cells after exposure to equivalent doses of 
photons and heavy ions 
 
This chapter is modified from: 
Macaeva E., Tabury K., Van Walleghem M., Michaux A., Janssen A., Averbeck N., Moreels M., 
De Vos W., Baatout S., Quintens R. Transcriptional profiling of human peripheral blood 
mononuclear cells after exposure to equivalent doses of photons and heavy ions. Manuscript 
under revision for resubmission to Oncotarget journal. 
5.1 Abstract 
Understanding the differences in the cellular response to low- and high-LET 
radiation is important in order to optimally exploit the benefits of particle 
therapy, as well as to adequately apply radiation protection measures to 
astronauts during Space missions.  To address this need, we compared the 
transcriptional profiles of freshly isolated peripheral blood mononuclear cells 
after exposure to 1 Gy of X-rays, iron ions or carbon ions. While all radiation 
types induced a p53-dependent gene expression response at 8 h after 
exposure, heavy ions exposure triggered a prolonged activation of p53-
mediated genes after 24 h as compared to X-rays. This coincided with a 
stronger induction of DNA damage repair and larger residual DNA damage as 
evidenced by γH2AX immunostaining. Despite a common p53 signature 
between low-LET and high-LET irradiation, specific gene sets related to 
immune response and epithelial-mesenchymal transition were significantly 
enriched in cells irradiated with heavy ions. In addition, irradiation, and in 
particular exposure to carbon ions, promoted radiation-induced alternative 
splicing. Classification of DNA repair-related gene signature revealed a strong 
correlation with radiation type, timing and especially the donor, suggesting 
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that it may serve as a sensitive indicator of individual DNA damage repair 
capacity.  
In conclusion, we have shown that both low- and high-LET irradiation induce 
similar transcriptional pathways, albeit with variable amplitude and timing, but 
also elicit radiation-type specific events that may have implications for cancer 
progression and treatment.  
5.2 Introduction 
The use of charged particles is a promising modality of cancer therapy. At the 
same time, exposure to charged particles represents a significant risk factor 
for chronic and late effects in astronauts. Particle therapy, which uses focused 
beams of charged particles such as protons and carbon ions, has become the 
treatment of choice for targeting specific solid tumors [9]. The main advantage 
of charged particle beams is the possibility of more precise tumor targeting, 
while the surrounding healthy tissues receive a much lower dose compared to 
conventional photon radiotherapy [9]. High-LET carbon ion radiation also has 
a higher relative biological effectiveness (RBE) compared to conventional low-
LET photon therapy [95], as particles deposit their energy in a more 
concentrated manner and therefore result in more complex and clustered 
DNA damage which is more lethal to the tumor cells [96]. However, other 
endpoints but cell death, such as chromosome aberrations, genetic 
alterations and normal tissue damage, also show an increased RBE for high-
LET radiation [122]. Normal tissue injury is a complex process, which is not 
solely caused by cell death. Radiation-caused DNA damage triggers changes 
in the microenvironment through chemokines and cytokines, altered cell-cell 
interactions, influx of inflammatory cells and the induction of restorative 
processes [307]. Genes involved in DNA damage repair, apoptosis, 
proliferation and inflammatory processes may play a role in the normal tissue 
response to irradiation [308].  
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Astronauts are at increased risk for high-LET radiation exposure in space. 
The more feasible and realistic long-term and interplanetary space missions 
and commercial space flights become, the more concern they raise about 
possible health risks due to exposure to cosmic radiation. Humans in Deep 
space would be subjected to galactic cosmic rays (GCR) and solar particle 
events (SPE), which result in levels of radiation hundreds of times higher than 
on Earth. The GCR spectrum is composed of about 87% high energy protons, 
12% alpha-particles and 1% of heavier ions up to iron [56] which are 
extremely penetrating and difficult to shield [309]. SPE consist of low to 
medium energy protons and alpha-particles. Up to now, the assessment of 
radiation risk for astronauts is almost completely based on extrapolation from 
epidemiological data on low-LET exposures. Therefore, comprehensive 
models and radiobiological studies comparing the biological response to 
different radiation types are needed to validate this approach [310].  
The particles and energies which are most often used for particle therapy 
partially overlap with the lower range of charge and energies of the ions 
commonly related to space applications (Z=1-26 and approximately 100-1000 
MeV/nucleon). Understanding the cellular radiation response and the 
processes governing individual sensitivity to high-LET radiation is of pivotal 
importance in rational choice of radiotherapy treatment schemes. The same 
holds true for the risk assessment of astronauts and the development of 
effective protection measures. 
Radiobiological transcriptional studies can bring valuable results in this 
regard, revealing the biological basis of the cellular response to different 
radiation types [311]. However, there have been only a limited number of 
studies comparing gene expression profiles following exposure to low- and 
high-LET radiation in isolated human peripheral blood mononuclear cells 
(PBMC) exposed in vitro to α-particles and X-rays [235] and human peripheral 
blood exposed in vitro to neutrons and X-rays [312] or mouse blood cells 
exposed in vivo to neutrons and X-rays [313].  
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To gain more insight into the cellular response to low- and high-LET radiation, 
we compared the transcriptional profiles of PBMCs of healthy donors after the 
cells had been exposed to X-rays, carbon ions and iron ions. We identified 
biological processes over-represented as a response to heavy ions exposure 
or X-ray exposure, as well as processes shared by both types of radiation. 
Our results provide an important basis for further detailed investigations of 
differential normal tissue responses to high- and low-LET radiation.  
5.3 Materials and methods 
5.3.1 Blood collection and PBMCs isolation 
Peripheral blood samples were collected from healthy donors in 9 ml EDTA 
vacutainer tubes (10 individuals were involved in the X-ray, 12 individuals in 
the carbon ions and 6 in the iron ions experiment). Blood collection was 
approved by the local SCK•CEN Ethics Committee and were carried out in 
accordance with the ethical standards of the Helsinki Declaration of 1975, as 
revised in 2000. Prior to blood donation all the donors involved in the present 
study signed an informed consent form. Within 30-60 min of blood drawing, 
PBMCs were isolated by centrifugation on Histopaque-1077 density gradient 
(Sigma-Aldrich, Bornem, Belgium) according to the manufacturer’s 
instructions. Isolated cells were suspended at a density of 10
6
 cells/ml in 
LGM-3 culture medium (Lonza, Walkersville, MD, USA) and allowed to 
equilibrate to culture conditions at 37°C in a humidified 5% CO2 atmosphere.  
5.3.2 In vitro irradiation 
X-ray, carbon and iron ion irradiations were performed independently, on 
different days. X-ray irradiation experiments were performed at the irradiation 
facility at the Belgian Nuclear Research Centre, Mol, Belgium (for 
microarrays) and at GSI, Darmstadt, Germany (for qRT-PCR validation and 
γH2AX staining). At SCK•CEN, PBMCs were exposed to 1.00 Gy of X-rays, 
using a Pantak HF420RX machine (250 kV, 15 mA, dose rate of 0.26 Gy/min) 
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as described in [259]. For samples that were irradiated at GSI, freshly isolated 
PBMCs were transported for 4 h by car to GSI using a transportable 
incubator. Irradiation with heavy ions was done at GSI’s heavy-ion 
synchrotron SIS. Carbon ion exposure (0.25 and 1.00 Gy) was performed in 
the middle of a 25 mm spread-out Bragg peak (center depth 42.5 mm, 
realized with a PMMK bolus), obtained by active energy variation of the beam 
in the range of 114.6 – 158.4 MeV/u. Accordingly, the dose averaged LET at 
the proximal and distal part of the samples (5-ml plastic tube, inside diameter 
10 mm) was 60-80 keV/µm. Irradiation with iron ions (0.25 and 1.00 Gy) was 
performed with a monoenergetic beam (1 GeV/u; LET 155 keV/µm). X-ray 
exposures were performed using an IV320-13 X-ray tube (250 keV, 16 mA, 
dose rate of 0.5 Gy/min; Seifert, Germany) at 0.25 and 1.00 Gy. Sham-
irradiated samples were always subjected to exactly the same procedures as 
the irradiated ones, except for the radiation exposure itself. After in vitro 
irradiation, cells were incubated at 37°C in a humidified 5% CO2 atmosphere 
for the indicated time until further processing. 
5.3.3 RNA extraction  
RNA from irradiated and sham-irradiated PBMCs samples was extracted 8 
and 24 hours after irradiation with X-rays and carbon ions and after 8, 12 and 
24 hours after exposure to iron ions. For RNA isolation, a combination of the 
TRIzol® reagent (Invitrogen, Carlsbad, CA, USA) extraction method and the 
clean-up on Qiagen RNeasy columns (Qiagen, Venlo, The Netherlands) was 
used. Briefly, 5 x 10
6 
cells were lysed in 1 ml of TRIzol® reagent and further 
processed following the manufacturer’s recommendations. Following the RNA 
precipitation with isopropanol, the obtained pellet was re-suspended in 1 ml of 
ethanol and transferred to the RNeasy column. Further purification was done 
according to the manufacturer’s instructions. RNA concentration was 
measured on a NanoDrop-2000 spectrophotometer (Thermo Scientific, 
Erembodegem, Belgium) and the quality of total RNA samples was assessed 
using Agilent 2100 Bioanalyser (Agilent Technologies, Santa Clara, CA, 
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USA). Only samples with an RNA integrity number >7 were considered as 
suitable for further analysis. For the X-ray experiment the samples from 10 
donors were used for further microarray hybridization, in case of carbon and 
iron ions samples from 4 donors were used. 
5.3.4 Microarray hybridization 
Gene expression profiling was performed using the GeneChip® Human Gene 
1.0 ST Array (Affymetrix, Santa Clara, CA, USA) which interrogates 28,536 
well-annotated genes with 253,002 distinct probe sets, allowing expression 
analysis at both gene and exon level. Ten µg of cRNA, synthesized and 
purified from 0.25 µg of total RNA using the Ambion® WT Expression kit 
(Ambion, USA) was used for cDNA synthesis, followed by cDNA 
fragmentation and labeling with the GeneChip® Terminal Labeling kit [263]. 
Fragmented and labeled cDNA was hybridized to Human Gene 1.0 ST arrays 
[263] using the GeneChip® Hybridization, Wash and Stain kit [263] 
(hybridization module) and hybridization controls [263] with rotation at 45°C 
for 16 hours. After hybridization, arrays were washed and stained using the 
GeneChip® Hybridization, Wash and Stain kit (stain module) after which the 
arrays were immediately scanned using an Affymetrix GeneChip® Scanner.  
5.3.5 Microarray data analysis 
The obtained microarray data were imported into Partek Genomics Suite, 
version 6.6 (Partek Inc., St Louis, MO, USA) as .CEL-files. The probe 
summarization and probe set normalization were done using the Robust 
Multichip Analysis (RMA) algorithm (Wu and Irizarry 2004)[261] which 
includes background correction, quantile normalization and log2 
transformation. Microarray data were analyzed using ANOVA with dose, 
donor and time point (whenever applicable) as factors. To correct for multiple 
testing, we used the false discovery rate (FDR) as described by Benjamini 
and Hochberg [262] to adjust p-values (FDR < 0.05). Genes were considered 
significantly differentially expressed between the two groups if adjusted p-
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values were < 0.05. In some cases, a more stringent additional cut-off of fold-
change ≥|2| was used, as explained in the text.  
We also performed Alternative Splicing ANOVA in Partek to detect genes 
which were alternatively spliced in response to different radiation types. A 
FDR-corrected p-value of < 0.05 was considered significant for alternative 
splicing events. To further reduce the number of false positives, the probe 
sets with log2 values below the noise level in all samples were excluded from 
analysis, except for the cases where there was a significant difference in 
expression of a single exon between the groups (p < 0.05). 
The Venny on-line tool [272] was used to compare gene lists and create Venn 
diagrams: http://bioinfogp.cnb.csic.es/tools/venny/index.html 
The Gene Ontology Biological Processes enrichment analysis was performed 
using the on-line tool DAVID [314]:  
https://david.ncifcrf.gov/home.jsp  
5.3.6 Reverse transcription and qRT-PCR 
The following genes were selected for qRT-PCR validation: PCNA, 
GADD45A, RPS27L, ASTN2, NDUFAF6, FDXR, MAMDC4. The same RNA 
samples as those used for microarray hybridization (n=6), whenever possible, 
were used for cDNA synthesis with the GoScript™ Reverse Transcription 
System (Promega, Leiden, The Netherlands) with random hexamer primers. 
For each gene, qRT-PCR reactions were run in duplicate using the MESA 
GREEN® qRT-PCR kit (Eurogentec, Seraing, Belgium) on an Applied 
Biosystems® 7500 Real-Time PCR instrument following the manufacturer’s 
instructions. To determine the efficiency and specificity of the designed 
primers, a standard curve experiment with melt curve was run for every 
primer pair. qRT-PCR data were analysed by 7500 Software v2.0.6 and 
Microsoft Excel using the Pfaffl method [273]. The relative amount of 
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transcript of the selected genes was normalized to PGK1 and HPRT1 using 
the geometric mean of these reference genes [274].  
5.3.7 Rank-Rank Hypergeometric Overlap (RRHO) analysis 
The RRHO algorithm allows for the comparison of two microarray datasets. 
Each dataset is processed as a ranked list based on expression differences 
between two classes of samples (0 Gy and 1 Gy, in our case). RRHO 
analysis [315] was performed using the on-line tool 
(http://systems.crump.ucla.edu/rankrank/index.php).  
As this algorithm only allows the comparison of two gene lists at a time, the 
following comparisons were performed: X-rays vs carbon ions, X-rays vs iron 
ions and carbon ions vs iron ions using a step size of 100. 
5.3.8 Transcription factor and Gene Ontology terms enrichment analysis 
Transcription factor and Gene Ontology terms enrichment analysis was 
performed using the Enrichr on-line tool 
(http://amp.pharm.mssm.edu/Enrichr/) [316, 317] which uses input gene lists 
to calculate enrichment of genes based on different databases of chromatin 
immunoprecipitation experiments and Ontologies. We used the “ENCODE 
and ChEA Consensus TFs from ChIP-X” and “GO Biological Process 2015” 
databases to calculate enrichment of transcription factor binding and 
biological processes, respectively. 
5.3.9 Gene Set Enrichment Analysis (GSEA) 
Gene set enrichment analysis [318] was performed using default settings: the 
significance of the normalized enrichment score for each gene set was 
assessed through 1000 gene set permutations. Gene sets with a FDR q-value 
< 0.25 were considered significant, as suggested by the GSEA tutorial. For 
each radiation type, 1-Gy and sham-irradiated samples analyzed at 8 h after 
exposure were used for comparison. To have a general view of response to 
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each radiation type, Hallmark Gene Sets collection of the Molecular 
Signatures Database was used. This collection consists of 50 gene sets 
representing specific well-defined biological states and processes, which 
helps to reduce noise and redundancy in different available databases and 
provides a better delineated biological space for GSEA.  
5.3.10 γH2AX foci detection using fluorescent microscopy 
PBMCs from four donors were fixed in 4% paraformaldehyde (Merck KGaA, 
Darmstadt, Germany) at 0.5, 2, 6 and 24 h following irradiation with X-rays 
and carbon ions. For iron ions an additional time point of 12 h was used. 
Following the fixation step, cells were cytospun on glass slides using 
Shandon
TM
 EZ Double Cytofunnels
TM
 (Thermo Fisher Scientific) and 
permeabilized with 0.25% Triton X (Sigma Aldrich, Belgium) for 5 min, 
blocked with 3% bovine serum albumin (Sigma Aldrich, Belgium) for 30 min 
and incubated overnight at room temperature with monoclonal mouse anti-
γH2AX (phospho S139) antibody [3F2] (ab22551, Abcam, Cambridge, MA, 
USA) at 4°C. Cells were then incubated for 1 h with polyclonal goat anti-
mouse secondary antibody coupled to FITC (F2012, Sigma Aldrich, Belgium) 
at 37°C and then mounted in Vectashield mounting medium containing DAPI 
(Vector Laboratories, Burlingame, CA, USA). Between each of the previous 
steps, the slides were washed with phosphate-buffered saline. 
An automated inverted fluorescence microscope (Eclipse Ti, Nikon, Tokyo, 
Japan), equipped with a motorized XYZ stage was used for the image 
acquisition of the immunostained slides. Images were acquired with a 40X 
Plan Fluor oil objective (Numerical aperture 1.3) and an Andor iXon3 camera 
(Andor Technology, South Windsor, CT, USA), providing images with a lateral 
resolution of 0.2 µm/pixel. For each sample, 25 fields were acquired on 7 Z-
planes (separated by 1 μm). The obtained images were analyzed with the 
CellBlocks.ijm script [319], written for FIJI image analysis freeware [320], 
essentially as described before [321]. In brief the image analysis workflow 
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starts by segmenting each nucleus in the DAPI channel, using an automatic 
thresholding algorithm, after noise reduction and flat field correction. 
Subsequently, γH2AX foci are selectively enhanced by means of a multiscale 
Laplacian and segmented by means of automatic thresholding. Within each 
nucleus, the intensity of the γH2AX channel is measured along with the 
number of γH2AX foci and the foci occupancy, i.e., the total projected area of 
the nucleus that is occupied by spots (total spot area divided by the nucleus 
area). On average, 500 nuclei were analyzed per sample.  
5.4 Results  
5.4.1 Gene level analysis shows a high degree of overlap between genes 
affected by low- and high-LET irradiation 
To compare the effects of high- and low-LET radiation exposure on gene 
expression in human PBMCs, microarray analysis was performed at 8 h after 
exposure to 1 Gy of X-rays, carbon ions or iron ions. This time point was 
chosen because we observed a prominent gene expression response after 8 
h in our previous studies [259, 276]. Sixty-nine, 95 and 78 differentially 
expressed genes (FDR-corrected p < 0.05) were detected after exposure to 
X-rays, carbon ions or iron ions, respectively, compared to control samples 
(Figure 24A-E; Supplementary Tables S10-12). The majority of these genes 
was induced after irradiation (Figure 24A-E), including 30 genes that were 
differentially expressed in response to all radiation types. Of these, 14 genes 
were up-regulated more than 2-fold (Figure 24E). Based on this analysis, the 
overlap between X-rays and carbon ions (p = 3.1e-96) and X-rays and iron 
ions (p = 5.2e-95) was more significant compared to the overlap between the 
two types of heavy ions (p = 9.1e-79).  
When comparing two independent high-throughput gene expression 
experiments with different sample numbers, threshold-free methods 
outperform threshold-based ones in providing reliable results [315]. Thus, to 
obtain a better impression of the overall similarity in gene expression after 
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exposure to different radiation types, the Rank-rank Hypergeometric Overlap 
algorithm was used. This revealed a very significant degree of overlap among 
the top up-regulated genes for the comparisons between X-rays and carbon 
ions (Figure 24F) as well as X-rays and iron ions (Figure 24G). For the 
comparison between the two high-LET ions (Figure 24H) the degree of 
overlap was not only more significant, but also more vast, comprising the  
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Figure 24. Changes in gene expression in PBMCs after exposure to X-rays, carbon ions and iron ions. (A-C) Volcano plots and heatmaps of gene expression 
changes between controls and cells irradiated with X-rays (A), carbon ions (B) and iron ions (C) at 8 h after exposure. Red points on volcano plots indicate 
genes with FDR <0.05, orange points indicate genes with |FC| >2 and green points indicate genes with FDR <0.05 and |FC| >2. Heatmaps show expression 
profiles of differentially expressed genes with a FDR <0.05 
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Figure 24 (continued). Changes in gene expression in PBMCs after exposure to X-rays, carbon ions and iron ions. (D, E) Venn diagrams showing overlap in 
differentially expressed genes with FDR <0.05 (D) or FDR <0.05 and |FC| >2 (E) between the different radiation types. (F-H) Rank-rank hypergeometric 
overlap heatmaps indicating overlap in gene expression changes between X-rays and carbon ions (F), between X-rays and iron ions (G), and between 
carbon ions and iron ions (H). Color scale bars indicate the log10-transformed hypergeometric p-values. 
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majority of up-regulated genes in both conditions. Together, our data show 
that irrespective of the radiation type, the large majority of the affected genes 
are up-regulated after exposure, and that the identity of these genes is highly 
similar, although some radiation type-specific genes do seem to exist.   
According to the transcription factor enrichment analysis, for all radiation 
types, the affected genes were most likely transcriptionally regulated by p53 
(Figure 25, left panel), and they were enriched in functions related to 
canonical p53-dependent pathways such as response to (UV) radiation, 
negative regulation of the cell cycle, DNA repair and apoptosis (Figure 25, 
right panel), as shown by the Gene Ontology (GO) terms enrichment analysis. 
Figure 25. Transcription factor enrichment and GO term enrichment. Left panel: transcription 
factor enrichment results following exposure to X-rays, carbon ions and iron ions. Right panel: 
Biological processes that are mostly affected following exposure to X-rays, carbon ions and iron 
ions, based on gene level analysis. 
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5.4.2 GSEA reveals stronger enrichment of inflammation and epithelial-
mesenchymal transition [322] gene sets by high-LET radiation 
In contrast to gene set analysis methods, such as GO, which search for 
enriched terms in a priori defined lists of differentially expressed genes, GSEA 
is a threshold-free method using all the analyzed genes, ranked by their 
expression ratio, to get a list of terms enriched in all genes weighting their 
ranks. GSEA is more powerful in detecting modest but coordinated changes 
[323]. 
Gene set enrichment analysis for all the samples exposed to 1 Gy of all 
radiation types showed a classical DNA damage response, with p53-pathway, 
apoptosis and DNA damage repair-related gene sets being very significantly 
enriched (Table 13, Figure 26A). Interestingly, especially after exposure to 
heavy ions, also several immune response-related gene sets were identified 
as significantly enriched in irradiated samples (Table 13, Figure 26). For 
instance, genes related to the inflammatory response showed no preferential 
enrichment in either sham- or X-irradiated PBMCs. In contrast, exposure to 
heavy ions, especially iron ions, resulted in a significant up-regulation of these 
genes (Figure 26B). Similarly, the radiation effect on genes involved in TNFα 
signaling was more pronounced after heavy ion irradiation compared to X-
irradiation (Figure 26C). Another gene set common for all radiation types was 
the EMT (Table 13, Figure 26D). Together, these results corroborate the 
observation that exposure of PBMCs to heavy ion irradiation induces 
generally more pronounced changes in gene expression compared to X-rays, 
while certain pathways, especially those related to inflammation are 
particularly affected by heavy ions.  
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Table 13. GSEA basedon Hallmark Gene Sets 
X-rays Carbon ions 
I 
Gene Set FDR NES Gene Set q-value 
p53 pathway 0.00 2.96 p53 pathway 
DNA repair 0.00 2.14 IL2-STAT5 signaling 
!Apoptosis 0.00 2.00 Cholesterol homeostas is 
Oxidative phosphorylation 0.04 1.61 TNFa signaling via NF-kB 
!Adipogenesis 0.05 1.58 IL6..JAK·STAT3 signaling 
TNFa signaling via NF-kB 0.15 1.42 !Apoptosis 
Epithelial-mesenchymal transition 0.18 1.37 DNA repair 
mTORC1 signaling 0.24 1.31 Myc targets V2 
lnflammatory response 
Epithelial-mesenchymal transition 
1Wnttj3-catenin signaling 
Estregen response early 
Interferon gamma response 
Notch signaling 
!AIIograft rejection 
Estregen response late 
Hypoxia 
Bold: gene sets related to the 1mmune system and mflammat1on. 
NES - normaliz.ed enrichment score 
Iron ions 
FDR NES Gene Set FDR NES q-value q-value 
0.00 2.60 p53 pathway 0.00 2.64 
0.00 1.88 TNFa signaling v ia NF-kB 0.00 2.30 
0.00 1.82 IL6..JAK-STA T3 signaling 0.00 2.00 
0.00 1.81 DNA repair 0.00 1.99 
0.01 1.66 Apoplosis 0.00 1.94 
0.01 1.66 lnflammatory response 0.00 1.85 
0.01 1.65 Coagulation 0.00 1.83 
0.03 1.55 Epithelial-mesenchymal transition 0.01 1.70 
0.05 1.48 Interferon gamma response 0.04 1.51 
0.07 1.42 Interferon alpha response 0.08 1.43 
0.09 1.39 Allograft rejection 0.22 1.30 
0.09 1.37 
0.17 1.29 
0.23 1.25 
0.23 1.24 
0.23 1.23 
0.23 1.22 
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Figure 26.  GSEA analysis. GSEA enrichment plots for four gene sets following exposure to X-
rays, carbon and iron ions. Gene sets with a distinct peak at the beginning or the end of the 
ranked list are generally the most relevant, indicating that this specific gene set is enriched in up- 
or down-regulated genes, respectively.  
5.4.3 qRT-PCR analysis shows radiation type- and time-dependent gene 
expression response  
Seven genes (PCNA, GADD45A, RPS27L, ASTN2, NDUFAF6, FDXR, 
MAMDC4) that were significantly up-regulated in response to all radiation 
types were selected for qRT-PCR validation. To obtain better insight in the 
dose- and time-dependence of these genes, a lower dose (0.25 Gy) as well 
as an additional time point (24 h) were included (Figure 27). For the selected 
genes, the expression patterns at 8 h after exposure were in general 
comparable for all radiation types, confirming the microarray results. 
However, while all of these genes, except MAMDC4, reduced in expression 
with time in X-irradiated cells, their up-regulation was in general retained, or 
often even further induced in cells exposed to heavy ions, especially in the 
case of carbon ions.  
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Figure 27.  qRT-PCR validation of the microarray results. qRT-PCR results for NDUFAF6, PCNA, 
FDXR, MAMDC4 genes (shown in rows) at 8 and 24 h after irradiation with 0.25 and 1.00 Gy of 
X-rays, carbon or iron ions (shown in columns). Graphs represent mean of six biological 
replicates + standard deviation. Statistical comparison was performed using 2-way ANOVA with 
Bonferroni post-hoc test (*p < 0.05, **p < 0.005, ***p< 0.0001).  
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Figure 27 (continued).  qRT-PCR validation of the microarray results. qRT-PCR results 
forGADD45A, RPS27L, and ASTN2 genes (shown in rows) at 8 and 24 h after irradiation with 
0.25 and 1.00 Gy of X-rays, carbon or iron ions (shown in columns). Graphs represent mean of 
six biological replicates + standard deviation. Statistical comparison was performed using 2-way 
ANOVA with Bonferroni post-hoc test (*p < 0.05, **p < 0.005, ***p< 0.0001).  
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5.4.4 Low- and high-LET radiation both induce production of alternative 
transcripts  
Exposure to low-LET radiation not only changes gene expression as such but 
also triggers the production of alternative transcripts (due to alternative 
splicing or transcription) [188, 189, 259]. Here, a core signature of the genes 
alternatively spliced in response to all radiation types was identified (Figure 
29A), the majority of which were also significantly differentially expressed at 
the gene level (36 out of 46), aligning with our previous results [259]. More 
overlap was observed between iron and carbon ions – 47.6% of the genes 
were in common, while between the X-rays and each of the heavy ions types 
the overlap was only about 15%. We also compared the number of 
differentially expressed exons between different radiation types in order to 
assess the levels of induction of transcript variants. Exposure to 1 Gy of X-
rays resulted in significant (FDR < 0.05) up-regulation of 724 exons, to 1 Gy 
of carbon ions – of 511 exons and to 1 Gy of iron ions – of 708 exons (Figure 
29B, Supplementary Table S13). In this case, more overlap was observed 
between iron ions and X-rays – 39.7% of exons were in common (Figure 
29B). When comparing the fold-changes in expression of the overlapping 246 
exons (Supplementary table 13), the highest induction levels were shown by 
carbon ions (Figure 29C). In addition, changes in expression of the 20-exon 
signature identified in [259] as particularly responsive to X-rays and important 
for classification of the samples depending on the exposure dose were 
compared between different radiation types (Supplementary Table S13). This 
comparison revealed that most of the above-mentioned 20 exons are in 
general less responsive to heavy ions compared to X-irradiation (Figure 29D). 
The detailed results for four genes overlapping for all radiation types (PCNA, 
VWCE, FDXR and MAMDC4) are shown in Figure 29E-H). In this case, the 
most pronounced alternative splicing response was observed after carbon 
ions exposure, especially this was the case for MAMDC4 and VWCE. The 
Gene Ontology Biological Processes terms enriched in alternatively spliced 
genes common for all radiation types were predominantly related to apoptosis 
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and DNA damage repair (Supplementary Table S14). The detailed results of 
the Gene Ontology Biological Processes terms enrichment for genes 
identified as alternatively spliced specifically after exposure to X-rays, carbon 
ions and iron ions can be found in Supplementary Table S14. 
Figure 28.  Radiation-induced alternative splicing. A. Venn diagram showing the number of 
alternatively spliced genes with FDR-corrected p-value < 0.05 at 8 h after exposure to 1 Gy of X-
rays, carbon or iron ions. B. Venn diagram showing the number of differentially expressed exons 
with FDR-corrected p-value < 0.05 at 8 h after exposure to 1 Gy of X-rays, carbon or iron ions. C. 
Changes in exon expression induced at 8 hours after exposure to 1 Gy of different radiation 
types. Centerlines show the median, boxes represent the range between the first and third 
quartiles and whiskers represent the highest and lowest values. Statistical comparison was 
performed using Wilcoxon matched-pairs signed rank test (****p-value < 0.0001). D. Heatmap 
showing fold-changes in expression of the 20 exon signature (probe set numbers are shown in 
brackets) identified as particularly responsive to X-ray exposure in [259] 8 hours after exposure to 
1 Gy of different radiation types. 
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Figure 28 (continued).  Radiation-induced alternative splicing. E-H. Alternative 
transcription/splicing of VWCE, FDXR, MAMDC4 and PCNA genes at 8 h after exposure to 1 Gy 
of X-rays, carbon or iron ions. Genomic organization of each gene is shown below the graph in 
purple; every box represents an exon of the gene, schematic representation of the exons does 
not correspond to their actual size. Fold-changes to control values are shown for every probe set 
specific to each exon of the gene. Median fold-change to control value for each radiation type is 
shown with the dotted line. Error bars represent SEM (n = 10 for X-rays, n = 4 for carbon and iron 
ions). Statistical comparison was performed using repeated measures 2-way ANOVA with Sidak’s 
post-hoc test (*p < 0.05, **p < 0.005, ***p<0.001, ****p< 0.0001). 
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5.4.5 Heavy ions exposure results in clustered DNA damage and slower 
DNA damage repair compared to X-rays 
Quantification of DNA damage is commonly performed by counting the 
number of nuclear γH2AX foci. For diffuse radiation such as X-rays, this has 
been shown to be a robust readout [324, 325]. However, high-LET radiation 
induces strongly clustered breaks along the track of the beam that may result 
in few microscopic foci, but with large relative size when a cell is visualized 
perpendicular to the orientation of the beam track (Figure 30A). Thus, γH2AX 
spot occupancy (Figure 30C) better reflects the severity of the damage 
caused by heavy ions compared to X-rays [321]. Indeed, when calculated as 
the number of foci per nucleus, the absolute number of unrepaired breaks 
after 24 h was similar for all radiation types (Figure 30B). However, when 
considering spot occupancy, the amount of unrepaired DNA DSBs was 23% 
for X-rays, 42% for carbon ions and 31% for iron ions. When considering the 
spot occupancy per nucleus, the amount of damage still present 24 h after 
exposure to iron ions was comparable to the amount of damage observed in 
X-irradiated cells at 0.5 h (Figure 30C). The severity of DNA damage as 
assessed by the spot occupancy of γH2AX foci was therefore clearly LET-
dependent. For X-rays and iron ions the maximal foci occupancy was 
detected at 0.5 h post-irradiation, while for carbon ions this peak was 
observed at 2 h post-irradiation.  
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Figure 29. DNA repair kinetics after exposure to different types of radiation. A. Representative 
examples of immunostained γH2AX foci in PBMCs 6 h following (from left to right) sham-
irradiation, exposure to 1 Gy of X-rays, iron ions and carbon ions. B. The number of γH2AX foci 
per nucleus after exposure to 1 Gy of X-rays, carbon and iron ions at different time points 
(median of three biological replicates for X-rays and carbon ions and four biological replicates for 
iron ions, error bars represent standard deviations). C. The occupancy of γH2AX foci per nucleus 
(average of three biological replicates for X-rays and carbon ions and four biological replicates for 
iron ions, error bars represent standard deviations) after exposure to 1 Gy of X-rays, carbon and 
iron ions at different time points. Statistical comparison was performed using unpaired t-test (*p < 
0.05, **p < 0.005, ***p<0.001, ****p< 0.0001). 
5.4.6 Gene expression may serve as a proxy for DNA damage repair 
efficiency 
To compare the changes in gene expression with DNA repair kinetics at the 
level of individual donors, samples from four individuals that were irradiated 
with iron ions were used. All four individuals showed a clear time-dependent 
kinetic of DNA repair (Figure 31E). The percentages of DNA DSBs repaired 
after 24 h was calculated for every donor. For Donor 1 it was about 65%, 
Donor 2 – 72%, Donor 3 – 76%, Donor 4 – 70%, thus the DNA repair rate of 
Donor 1 was the lowest. 
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Figure 30.  Individual differences in DNA damage repair kinetics and gene expression induced by 
exposure to iron ions. A. Hierarchical clustering of DNA repair genes shows time- and subject-
dependent expression. B-D. Dose-dependent expression of selected DNA repair genes shows 
higher induction in Donor 1 compared to other donors. Bars show the mean of three time points, 
error bars - SD. Statistical comparison performed using repeated measures 2-way ANOVA with 
Tukey’s post-hoc test (*p < 0.05, **p < 0.005, ***p < 0.001, ****p < 0.0001). E. Individual DNA 
repair kinetics of four donors as percentage of γH2AX foci occupancy compared to 1 Gy-sample 
at 0.5 h . Error bars - SEM of 2 technical replicates. F-I. Expression levels of DNA repair genes 
show overall higher expression in Donor 1 compared to other donors. Box plots show the mean of 
all samples (all doses and time points), whiskers show minimal and maximal values. Statistical 
comparison was performed using unpaired t-test (***p< 0.001).   
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Hierarchical clustering of the gene expression profiles of DNA repair-related 
genes showed time- and subject-dependent expression. This resulted in two 
major clusters of samples depending on the time point, with 24-h samples 
segregating from 8-h and 12-h samples (Figure 31A). Within each time 
cluster, expression profiles of Donor 1 clustered separately from those of the 
other three subjects (Figure 31A). Some DNA repair genes (e.g. PCNA, 
DDB2, RBM14) showed an enhanced radiation response in Donor 1 
compared to other donors, especially after a high dose (Figure 31B-D). This 
donor also showed overall elevated levels of expression of several DNA 
damage response-related genes, (e.g. ATM, ATR, RAD51D, MRE11A) 
independent of the irradiation dose and time point (Figure 31F-I). This 
indicates that individual differences in the overall and radiation-induced 
expression levels of DNA repair genes exist, which may explain individual 
differences in DNA repair kinetics.  
5.5 Discussion 
In the present study we investigated and compared genome-wide 
transcriptional response of human PBMCs after acute exposure to three 
radiation types with different LET characteristics: X-rays, carbon and iron 
ions. An equal dose of 1 Gy was used, as our main goal was to identify the 
differences in response caused by high- and low-LET radiation rather than 
comparing RBE-weighted doses. It was also previously suggested to compare 
equal rather than equitoxic doses of high- and low-LET radiation in the 
context of gene expression analysis [326]. In addition, we analyzed the DNA 
repair kinetics after exposure to the above-mentioned radiation types. It 
should also be noted, that PBMCs include multiple cell sub-populations, the 
vast majority of which are in G0 phase of the cell cycle. This fact is particularly 
important for the genes involved in cell cycle regulation, but also for those 
involved in the DNA damage repair, as these cells can only use non-
homologous end-joining and not homologous recombination to repair the 
DSBs [327]. In addition, differences in DNA damage response in G0 cells 
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seem to be strictly cell type-specific and depend on the physiological context 
[328, 329].  
 
X-rays and heavy ions induce a similar p53-dependent gene expression 
response, albeit with different amplitude and dynamics  
 
In our study, we found an overall very similar primary p53-dependent 
response to all radiation types at 8 h after exposure. A similar observation 
was made in normal human fibroblasts following γ-radiation and decays of 
high-LET-like (125)I [330]. A study by Kurpinski and co-authors showed that 
most of the differentially expressed genes which were in common after 
exposure to 1 Gy of X-rays and iron ions in human mesenchymal stem cells 
were involved in cell cycle and DNA damage response and repair, which is in 
accordance with our observations [331]. Although we also found several 
genes “unique” to a specific radiation type, it is likely that many of them would 
also respond to the other radiation types in a different experimental set-up 
(i.e. time-dose combination). Some of the observed differences, however, 
may also be explained by the different nature of X-rays (photons) and heavy 
ions (particles). The DNA damage caused by particles is more complex and 
difficult to repair compared to X-rays, as confirmed by slower DNA repair 
kinetics shown in our study as well as in endothelial cells exposed to nickel 
ions [332]. qPCR validation of gene expression changes at later time points 
also showed differences in kinetics of expression of several genes in 
response to exposure to high- and low-LET radiation.  
Heavy ions exposure results in more significant enrichment of immune 
response-related gene sets as compared to X-rays. 
Interestingly, GSEA identified several immune response-related gene sets as 
significantly enriched specifically in samples irradiated with particles. Among 
these, NF-kB plays a central role in regulation of the expression of pro-
inflammatory cytokines and chemokines such as TNF-α, IL-1, IL-2, IL-6 and 
Chapter 5. Transcriptional profiling of human peripheral blood mononuclear cells after 
exposure to equivalent doses of photons and heavy ions 
149 
 
MCP-1 [333, 334]. It is clear that different radiation types have the potential to 
induce different immune alterations [334].  In a study by Baumstark-Khan 
high-LET argon ions (272 keV/µm) induced a stronger NF-kB-dependent 
reporter gene expression compared to X-rays [335]. A later study from the 
same group showed that carbon ions (33 and 73 keV/µm) and X-rays activate 
NF-kB-dependent gene expression in HEK293 cells 4 h after exposure. 
However, activation by carbon ions was induced by 1.3 Gy while activation by 
X-rays required a higher dose of 16 Gy [336]. These results indicate that a 
lower dose of high-LET radiation than of low-LET radiation is required to 
activate NF-kB. This observation suggesting overall increase of carcinogenic 
potential related to NF-kB activation [337, 338] might have implications for 
both radiotherapy patients and astronauts on long-term Space missions. 
However, there are two sides of the coin. Carbon ions were also shown to 
induce anti-tumor immunity in a murine model [339]. Another study examining 
five human cancer cell lines showed that comparable levels of high mobility 
group box 1, which plays an important role in activating anti-tumor immunity 
were detected after irradiation with equitoxic doses of X-rays and carbon ions, 
meaning that a lower dose of carbon ions was needed to achieve the same 
effect [340]. These results suggest that carbon ion therapy might activate the 
immune system to a greater extent than conventional radiotherapy, even 
when equivalent doses are used. 
 
Irradiation, and in particular exposure to carbon ions, promotes 
alternative transcription and splicing. 
Another important aspect of the transcriptional response to ionizing radiation 
[188, 190, 259] and other genotoxic agents [185-187, 341, 342] is alternative 
splicing and transcription. Exposure to low and moderate doses of low-LET 
ionizing radiation initiates alternative splicing and transcription of a large 
number of genes [188, 190, 259]. In the present study, we observed a more 
pronounced response after exposure to heavy ions, especially carbon ions. 
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The exons most extensively regulated in response to X-ray exposure were not 
the most regulated after particle exposure, suggesting specificity in response. 
The most significant alternative transcription/splicing induction observed after 
exposure to carbon ions might be, at least in part, explained by the higher 
fluence used for the carbon irradiation compared to iron ions resulting in cells 
being hit by more ions.  
Although it is not possible to draw any definite conclusions on the biological 
relevance of this observation from the microarray data, it is tempting to further 
study the role of alternatively transcribed/spliced genes in the response to 
different radiation types. In a very recent study exposure to UV was shown to 
trigger a shift from protein-coding mRNA of the ASCC3 gene, which was 
alternatively spliced in response to heavy ions exposure in our set up, to a 
shorter non-coding isoform [343]. The non-coding ASCC3 isoform, in fact, 
counteracts the function of the protein-coding isoform and has an opposite 
effect on transcription recovery after UV-induced DNA damage [343]. 
Gene expression may serve as a sensitive indicator of individual DNA 
damage repair capacity. 
Defects in DNA repair mechanisms often result in abnormal radiosensitivity of 
cells [238-242]. Studies aiming at establishing an assay for predicting 
radiosensitivity focused on colony-forming assays [244, 245] or the 
measurement of DNA DSBs repair efficiency by means of the comet assay 
[248, 249, 344] or the γH2AX assay [344, 345]. However, no single DNA 
damage-based assay proved to be capable of discriminating the full range of 
cellular radiosensitivity [98]. A possible explanation is that radiosensitivity can 
also be associated with differences in cell cycle and apoptosis pathways 
regulation [346, 347]. In this regard, transcriptional changes, which allow not 
focusing on one single cellular aspect, were suggested to be a promising 
predictive parameter for radiosensitivity [252, 344]. Greve and co-authors 
identified a set of 67 differentially expressed genes in peripheral blood 
lymphocytes exposed to 5 Gy of γ-rays, which allowed distinguishing between 
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the group of severely radiosensitive and non-radiosensitive breast, head and 
neck carcinoma patients [344]. Rieger and co-workers used microarray gene 
expression profiling in lymphoblastoid cells derived from a diverse group of 
cancer patients with acute radiation toxicity. A set of 24 genes predicted 
radiation toxicity in 9 of 14 patients with no false positives among 43 controls 
[253].  
In our study, we integrated the two approaches mentioned above based on 
the data of four donors after exposure of PBMCs to iron ions. It is important to 
mention that all the subjects involved in this study were apparently healthy, 
without any known abnormal variations in radiosensitivity. Our main goal was 
not to assess the radiosensitivity of these individuals as such, but rather to 
explore the potential of gene expression signatures in reflecting the efficiency 
and kinetics of DNA repair as measured by γH2AX assay. As could be 
expected, we did not find any significant differences in DNA repair efficiency 
of the four studied donors. However, we could make an interesting 
observation. Donor 1, who showed the lowest rate of DNA DSBs repair, also 
had a distinct gene expression profile observed for some genes as highest 
levels of up-regulation compared to control and for the others as higher 
overall expression in all samples. Interestingly, a recent study comparing 
transcriptional response of radiosensitive and radioresistant immortalized B-
lymphocytes also showed a greater and prolonged response in radiosensitive 
cells [348]. Genes regulated by p53 and involved in DNA damage response 
and apoptosis were still up-regulated in the radiosensitive cells and not in the 
radioresistant ones 24 h post-exposure to 2 Gy of γ-rays [348].  
Although at this stage we performed a small-scale pilot study, our results 
could be of interest for assessing the DNA repair efficiency and overall 
response to radiation in Mars mission crew members and, potentially, 
radiotherapy patients. Moreover, gene expression measurements are more 
straight-forward and are technically less affected by such factors as radiation 
type compared to the γH2AX assay. At the same time, measuring gene 
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expression for radiosensitivity assessment has another advantage of allowing 
to have a broader look at it rather than focusing on DNA damage repair as 
such, as virtually any gene can be included in the assay.  
In conclusion, we have shown that both low- and high-LET irradiation induce 
similar transcriptional pathways, albeit with variable amplitude and timing, but 
that high-LET also elicits specific and more persistent transcriptional events 
that may exacerbate the carcinogenic potential or, on the other hand, induce 
immune response against tumour cells. Our results imply that more detailed 
investigations of transcriptional response could bring new insight into 
differential normal tissue responses to high- and low-LET radiation and might 
have implications for the development of particle therapy treatment and 
radiation protection. 
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6. 
General discussion and perspectives  
 
The importance of radiation biomarker research 
Every human living on Earth is constantly exposed to very low levels of 
natural ionizing radiation, which are harmless. Occasionally, though, 
individuals are exposed to radiation doses exceeding the natural background 
levels, often as a result of medical diagnostic tests and treatments but 
sometimes through the accidental or deliberate release of radioactivity. The 
fact that exposure to radiation doses higher than 100 mGy increases the risk 
of cancer development and, at higher doses, can even cause cardiovascular 
diseases and cataracts is already well-known. Recent epidemiological studies 
show that even exposure to low doses of ionizing radiation increases the risk 
of cancer development. The study on a 300,000-cohort of nuclear industry 
workers demonstrated increased risks of leukaemia and solid tumour 
development after exposure to cumulative doses below 100 mSv [349, 350]. 
Even more concerns are raised by reports showing increased risks of 
leukaemia and brain tumours in paediatric patients following doses of 30-50 
mGy from CT scans [351, 352]. The accumulated scientific data led to a 
drastic shift in public perception of radiation technologies: from the use of 
shoe-fitting fluoroscopes until about 1950s [353] to the recognition of the need 
for regulation, justification and reduction of the doses resulting even from 
medical diagnostic procedures [354, 355].  
In case exposure to ionizing radiation is justified or unavoidable the 
knowledge of the exposure dose becomes important in order to take all the 
necessary measures to prevent or timely diagnose and treat the potential 
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health consequences. Radiation biomarkers of exposure investigated in the 
present study play a crucial role in this regard. 
Biological response to ionizing radiation is a very complex process. However, 
it can also be regarded as something very simple – radiation damages DNA, 
and all the following events are the result of this. In fact, almost all the 
radiation biomarkers of exposure developed so far are in one way or another 
based on this simplistic assumption, but given the real complexity of DNA 
damage response, the list of potential end points to be used as biomarkers is 
enormous [192, 193]. For example, the idea behind the well-known dicentric 
assay is very simple: the higher the exposure dose – the higher the number of 
DNA breaks – the higher the number of dicentrics. It is probably the simplicity 
of the approach that makes this assay so robust 
However, the development of new techniques opened new horizons for 
radiation biomarkers development. Gene expression measurements used as 
the main technique in the present study are one of the examples. If regarded 
from a simplified point of view, the gene expression changes observed in 
normal cells, such as PBMCs used in our study, are the direct result of DNA 
damage caused by ionizing radiation. Again, the higher the exposure dose – 
the higher the number of DNA breaks – the higher the amplitude of gene 
expression changes. However, more sophisticated methodologies bring about 
the need for more sophisticated analysis and assay validation.  
Validity of in vitro models 
In the present study we used human PBMCs or peripheral blood as in vitro 
model for radiation response. Isolated PBMCs were used in transcriptome-
wide microarray studies as this allowed to avoid the necessity to perform an 
additional globin reduction step. Isolated PBMCs also showed better viability 
in our set up (data not shown), which was particularly important for heavy ion 
irradiations performed at GSI. For the qPCR arrays part of the study we used 
peripheral blood as this would be more applicable to emergency situations 
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and it is likely to better reflect the in vivo response. Although in vitro models 
are not fully representative of the more complex in vivo situation, in vitro 
experiments represent an essential step preceding the in vivo validation of the 
results. In vitro experiments offer several practical advantages, for instance, 
they are usually cheaper, less complex and time-consuming and make it 
possible to strictly define the experimental conditions. For obvious reasons it 
is also very hard if not impossible to obtain human blood samples exposed in 
vivo to specific doses. However, it is possible to validate the results obtained 
in in vitro experiments using the samples of patients undergoing radiotherapy 
or medical diagnostic procedures involving exposure to radiation.  
Transcriptional studies in radiation biomarkers research 
Several genome-wide studies have been conducted so far to assess the in 
vivo transcriptional response to ionizing radiation using blood samples from 
radiotherapy patients undergoing either total body irradiation [229] or local 
intensity modulated radiotherapy [230]. These investigations showed that in 
vivo irradiation mainly affected genes involved in pathways related to the 
immune system and inflammatory responses, but also p53-mediated 
pathways such as the cell cycle and DNA damage and repair, which were 
also found in ex vivo irradiated blood and PBMCs. This corresponded to the 
finding of induction of p53-dependent genes in patients undergoing either CT 
scans (up to 4.3 cGy) or administration of (F-18)-fluoro-2-deoxy-D-glucose 
(0.6 cGy) [231]. Overall, an increased expression of the examined genes was 
measured in all the samples, however, differences in response in vivo and in 
vitro were found especially for doses below 5 cGy [231]. Other studies have 
identified in vitro gene signatures which could accurately predict in vivo 
radiation exposure status [158, 232, 233]. In a recent RENEB inter-laboratory 
comparison exercise gene-expression calibration curves obtained from in vitro 
irradiated blood samples could be used to distinguish blood samples of 
prostate cancer patients exposed to 0.009–0.017 Gy (first fraction only, partial 
body exposure) [55]. 
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In all, these studies have shown that the in vitro transcriptional radiation 
response is a good model for the in vivo situation. Another possibility for 
biodosimetry studies is the use of animal models as it was demonstrated that 
radiation-responsive genes in mice exposed to physiologically relevant 
radiation doses show a similar response to homologous genes from ex vivo 
human studies [232, 280, 282], although gene expression profiles developed 
via analysis of murine blood radiation response alone were found to be 
inaccurate in predicting human radiation exposures [158]. 
Alternative transcription and splicing of radiation-responsive genes 
One of the most important findings made in the first step of the present study 
is the identification of the many radiation-responsive genes regarded as 
potential radiation biomarkers as alternatively transcribed and/or spliced in 
PBMCs in response to radiation. One of the examples of alternatively spliced 
genes found in our study is the FDXR gene, which is probably the most well-
validated gene in the biodosimetry field [55, 155, 227]. FDXR is a 
mitochondrial flavoprotein, which is involved in several p53-mediated 
processes and ROS-associated apoptosis [222, 356]. FDXR is one of the 
most radiation-responsive genes, showing up to 46-fold up-regulation 24 h 
after 4 Gy irradiation in human blood [155], making it especially suitable for 
discrimination between high- and low-dose exposures. However, different 
studies applying qRT-PCR show significantly different expression levels of 
this gene, for example, ≈16-fold up-regulation shown in [159] and ≈40-fold up-
regulation shown in [155] 24 h following exposure to 2 Gy of X-rays. This 
discrepancy might be explained by radiation-induced expression of transcript 
variants, shown in our study, and interrogation of more or less responsive 
exons in different studies. The choice of optimal primer location has therefore 
the potential of increasing the sensitivity of the assay, which is particularly 
important for low- or very low-dose exposures. This observation has direct 
implications for practical gene expression-based biodosimetry which will most 
probably rely on primer or probe-based methods. Identification of the exact 
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sequence identity of radiation-induced splice variants, for example, using 
next-generation sequencing and further functional studies would contribute to 
understanding of the molecular mechanisms of radiation response. Although it 
might not be immediately useful in view of biomarkers of exposure, it might 
point to potential biomarkers of individual response. 
Alternative transcription and splicing are universal mechanisms essential for 
many cellular processes, as confirmed by the determinative role of disrupted 
splicing in human disease [357]. The biological relevance of splicing is also 
emphasized by its presence in species throughout the phylogenetic tree, 
although its prevalence and characteristics vary considerably [176]. It is 
difficult to distinguish functionally significant alternative splicing events based 
on transcriptional studies, as not every observed transcript necessarily 
encodes a functional product. In addition, transcription and splicing are error-
prone processes and erroneous transcripts that might occur are eliminated by 
pathways such as nonsense mediated decay [358].  
Nevertheless, the results obtained in the present study, can be considered 
reliable and should serve as the basis for further functional studies as similar 
observations were made in murine brain cells [190] and fibroblasts and 
lymphoblastoid cells [188] exposed to ionizing radiation. Our data suggest 
that alternative transcription initiation from alternative promoters was the most 
common event, although the activation of other alternative splicing 
mechanisms (e.g. exon skipping, alternative splice sites and alternative 
polyadenylation) was observed as well. Our findings are also supported by 
the fact that alternative splicing is considered to be a key player in DDR as 
suggested by e.g. the large number of apoptotic genes that are alternatively 
spliced, with the generated isoforms often playing antagonistic roles [179]. 
Radiation exposure activates the expression of neighboring genes 
Furthermore, we observed that a substantial fraction of the radiation-
responsive genes are located in close physical proximity on the genome 
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(often as neighbors with bidirectional promoters). This observation is 
important for identification of new radiation-responsive genes. One such 
example is the long non-coding PAPPA-AS1 gene which is transcribed from 
the opposite strand of the PAPPA gene, presumably from a shared 
bidirectional promoter with ASTN2. To the best of our knowledge, this is the 
first time that this gene has been identified as a potential radiation biomarker. 
The observed co-regulation may be related to radiation-induced DNA damage 
and might be required for a more coordinated response to it, since the 
frequency of bidirectional promoters is enriched in DNA repair genes 
compared to other gene classes [283]. In addition, it was suggested that 
transcriptional activation has a ripple effect (i.e. intensive transcription at one 
locus frequently “spills over” into its physical neighboring loci), which may be 
advantageous for coordinated expression [359]. This might explain the 
seemingly unexplainable activation by radiation of some genes which do not 
have (yet) a defined role in DDR. It is important to mention, though, that even 
if the activation of some of the identified radiation-responsive genes is in the 
end not biologically relevant, eventually this does not affect their suitability as 
biomarkers of radiation exposure.  
Gene and exon signatures are equaly suitable for prediction of low to 
moderate radiation doses  
We also observed that radiation-induced differences in expression were more 
pronounced at the exon level compared to genes, suggesting that exon 
signatures may show increased sensitivity to doses below 0.1 Gy. In our set 
up, gene and exon signatures from PBMCs were equally suitable for 100% 
accurate classification of the samples either sham-irradiated, irradiated with a 
low dose (0.1 Gy) or a high dose (1 Gy) of X-rays.  
Gene expression measurements applicable to emergency situations: 
tackling the issue of confounding factors and high dynamicity of gene 
expression by using gene signatures 
Chapter 6. General discussion and perspectives 
160 
 
Microarray studies represent an essential step for identification of radiation-
responsive genes and exons, however, their usefulness for large-scale 
exposure scenarios is very limited due to the complexity of the analysis, high 
costs and comparatively long time needed to obtain the results [55]. qRT-PCR 
represents an attractive alternative to microarrays. This technique is widely 
used, and allows automation and miniaturization of scale making it an 
attractive method for biodosimetry applications. For instance, it can be 
multiplexed (i.e. multiple targets are amplified in a single tube). Multiplex qRT-
PCR minimizes the amount of required starting material and saves time by 
increasing throughput and decreasing sample handling. This technique was 
successfully used in a study by Kabacik et al. [154].  
In the present study we explored another method, the qRT-PCR arrays. 
Based on our previous microarray results we selected a panel of 25 gene 
biomarkers, of which the most sensitive exons were interrogated, whenever 
applicable. Gene expression changes are a highly dynamic process and the 
exact kinetics depend strongly on every specific gene [155], therefore 
knowing the point in time at which sample is taken following the radiation 
exposure is highly important for correct dose estimation. In an emergency 
situation such information might not be precise or might not be available at all. 
To address this issue, we opted for testing the potential of our gene signature 
not only in predicting the exposure dose, but also the time point following 
irradiation, which, to the best of our knowledge, has never been tested before. 
Time point prediction would not be possible if using only one gene as its 
expression would be affected by both dose and time. Therefore, this can only 
be done based on a signature of genes. We also suggest that using a 
signature of genes has a stronger potential in overcoming issues related to 
individual differences in response caused by such possible confounding 
factors, as age, gender, smoking status and health status (e.g., inflammation). 
Experiments performed by Tucker et al. in mice and by Budworth et al. in ex 
vivo irradiated human blood samples showed that although the expression of 
Chapter 6. General discussion and perspectives 
161 
 
some biodosimetry-relevant genes (e.g. CDKN1A, FDXR, BBC3) is affected 
by the bacterial endotoxin lipopolysaccharide, used to mimic inflammatory 
stress, the gene expression analysis may still be useful for dose prediction 
[159, 302]. Paul and Amundson also achieved very accurate classification of 
the samples according to the exposure dose independent of the smoking 
status or gender of the subjects [271].  
Accurate prediction of both dose and time point achieved using qPCR 
arrays technology 
The classification method used in our study allowed to classify the samples 
according to the time elapsed since exposure with high precision (errors ≤ 4 
h). Dose prediction was very accurate as well, even though pre-exposure 
controls were not available for blind samples. It is important to note, however, 
that the gene expression kinetics might be different following in vivo exposure, 
as a result adaptation of the methodology for in vivo exposure situation might 
be required. In the present study we used blood cells as comparatively easily 
accessible biological samples and suggested blood preservation and RNA 
extraction methodology suitable for field conditions, but one of the further 
improvements of the method would be the exploration of non-invasive 
sampling, allowing samples to be collected by the potentially exposed 
individuals unassisted, e.g. the use of hair follicles. This would require further 
confirmation of the validity of gene expression signature identified as 
activated in blood cells in hair follicle cells.   
The importance of dose rate for further studies 
Another factor, which might have an effect on radiation-induced gene 
expression, is the dose rate. Depending on the exposure situation following a 
radiological accident, protracted low-dose rate exposures, resulting from e.g., 
fallout or ground shine, might constitute much of the total dose. As low dose 
rate exposures can significantly decrease the extent of injury compared to an 
acute dose [124], assessing the rate of exposure might also be important for 
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adequate triage of the casualties. In our study in all the experiments high 
dose rates of 0.14 or 0.26 Gy/min were used. From the obtained results, 
differences in dose rates seemed to have no significant effect on gene 
expression changes at least for the tested doses, however, there might be a 
difference if higher doses are used. Although this issue was not addressed in 
the present study, it is tempting to test whether our biodosimetric panel of 
genes used for dose and time point prediction would also allow discrimination 
between acute and chronic exposures. Several studies addressing this issue 
were performed by the group of Sally Amundson in mice [360] and ex vivo 
irradiated human blood [361]. Overall, these studies showed that a large 
number of the same genes responded to low dose rate and acute exposures 
with typical p53-related gene responses also observed at lower dose rates, 
however, for some genes the magnitude of response was lower after low 
dose rate exposures [360, 361]. In both studies classification models were 
used to discriminate between different dose rates which resulted in very 
efficient classification both in case of in vivo irradiated mice (97% accuracy) 
[360] and ex vivo exposed human blood (100% accuracy) [361]. These very 
promising results suggest that it may be possible to develop a gene 
expression-based signature that can not only detect protracted exposures, but 
also discriminate them from acute exposures. This is particularly important as 
while cytogenetic methods were shown to effectively reconstruct individual 
total doses from chronic occupational or environmental exposures [362, 363], 
cytogenetic approaches cannot distinguish these from acute radiation 
exposures.  
Coordinated actions in case of emergency – the key to efficient 
management of radiation casualties 
Another important point in efficient management of radiation casualties is the 
well-developed and operated network of laboratories providing biodosimetry 
services, as no single laboratory would be capable of handling thousands of 
samples in a short period of time. RENEB - Realizing the European Network 
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of Biodosimetry - is a good example of such initiative. It started as a project 
aiming at “creating a sustainable network in biodosimetry that involves a large 
number of experienced laboratories throughout European Union which will 
significantly improve dose assessment capacity”. In the course of the project, 
several biodosimetry interlaboratory comparison exercises were organized in 
order to assess and harmonize the biodosimetry methods used by different 
laboratories. Currently the name of the initiative was changed from the 
“Realizing the European Network of Biodosimetry” to “Running the European 
Network of Biological Dosimetry and Physical Retrospective Dosimetry”, 
reflecting the broadening of the initial scope and the efforts in maintaining and 
strengthening the built network.  
The importance of comparison of low- and high-LET radiation effects for 
biomarker studies 
Other possible situations apart from nuclear power plant accidents which 
might result in radiation mass casualties are attempts towards the malevolent 
use of radiation. These include the use of a radiological dispersal devices (i.e. 
“dirty bombs”), which would result in potential contamination of a large 
number of people or placement of strong radiation sources (i.e. radiological 
exposure devices), which would potentially result in exposure of a large 
number of people to high doses of radiation [364]. In the event of use of one 
of the above-mentioned devices, the radiation exposure would consist of an 
unknown combination of photons, neutrons, α-particles and heavier ions, 
which would contribute to the total dose [365]. Therefore, it is of paramount 
importance to have “universal” biomarkers able to estimate the exposure dose 
to both low- and high-LET radiation. The vast majority of genes identified as 
radiation-responsive in our study are transcriptionally regulated by the p53 
protein and common for the radiation types used in the present study (X-rays, 
carbon ions and iron ions), increasing their potential as biomarkers of 
exposure. At the same time, as biological effects of low- and high-LET 
radiation differ, finding biomarkers capable of discriminating exposures to 
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different radiation types, is also of high interest. In this regard it might be 
possible to further explore the temporal differences in gene up-regulation 
following the exposure to X-rays and heavy ions observed in our study. A 
recent study comparing the gene expression response of human peripheral 
blood exposed in vitro to neutrons and X-rays suggests that gene expression 
may serve as a means to differentiate between total dose and the neutron 
component [312].  
While the biomarkers of exposure certainly benefit from the simplicity of the 
approach the biomarkers which can be potentially used for radiosensitivity or 
individual response assessment would certainly benefit from more nuanced 
research into the details of transcriptional response to radiation. In addition, 
exposure to different types of radiation can also trigger different pathways, 
contributing to the complexity of the response. To date, there have been only 
a limited number of studies comparing gene expression profiles in mouse or 
human blood cells following exposure to low- and high-LET radiation. A 
microarray study on isolated PBMCs exposed to α-particles identified 29 
responsive genes associated with signaling pathways centered around p53 
and GADD45A [235]. Although all genes modulated in cells exposed to α-
particles were also differentially expressed 24 h after X-ray exposure, the 
degrees of induction were different [235]. A recent study by Broustas and co-
authors on blood samples obtained from mice irradiated with X-rays and 
neutrons reported a total of 34 genes being differentially expressed (25 genes 
were uniformly downregulated, the remaining 9 genes were downregulated at 
day 1 post-irradiation and upregulated at day 7) in response to all exposures 
[313]. Gene ontology analysis revealed that cell cycle-related genes were 
significantly down-regulated at day 1 and significantly up-regulated at day 7. 
Most of the genes which were downregulated starting at day 1 and showed 
persistent reduction of expression at day 7 in both neutron and X-ray 
exposures were related to immune response, and B and T cell physiology 
[313].  
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Particularity of PBMCs as in vitro model for transcriptional studies in 
radiation biology 
It should be noted that PBMCs include several cell sub-populations, the 
majority of which are in G0 phase of the cell cycle, therefore any 
extrapolations of the obtained results to other cellular systems should be 
made with care. The fact that PBMCs are quiescent is particularly important 
for the genes involved in cell cycle regulation, but also for those involved in 
the DNA damage repair, as these cells can only use non-homologous end-
joining (NHEJ) to repair the DSBs because homologous recombination (HR) 
requires the presence of intact sister chromatid and resolves DSBs during the 
S and G2 phases of the cell cycle [327]. Differences in DNA damage 
response in G0 cells seem to be strictly cell type-specific and depend on the 
physiological context. For example, DSBs occurring in G0-arrested MCF10A 
epithelial cells were not repaired, although G0-arrested cells showed similar 
expression levels of DDR factors when compared to proliferating cells, with 
the exception of RAD51 involved in HR [328], while in our study we observed 
efficient DNA DSBs repair. Another study showed that terminally differentiated 
astrocytes show strongly attenuated expression of most of DDR genes in 
response to irradiation compared to proliferating progenitors [329]. 
Nevertheless, astrocytes retained the expression of NHEJ genes and are 
DNA repair proficient [329].  
Earlier study from our group also showed that different lymphocyte sub-
populations differ in their gene expression response to ionizing radiation 
[366], suggesting that using a more radioresponsive cell population might 
increase the sensitivity of the method. Another study using apoptosis 
induction as the endpoint showed that a minor CD8(+) subset of natural killer 
cells could be used as a radiosensitive lymphocyte population the 
disappearance of which correlated with the received dose (doses ranging 
from 3 to 20 Gy) [367]. However, in our opinion, using all PBMCs or whole 
blood rather than a specific blood cell population requiring sophisticated cell 
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sorting is more applicable to emergency situations. This is also supported by 
the fact that dose reconstruction in PBMCs required fewer genes and 
appeared more efficient compared to isolated CD4(+) lymphocytes [368].  
 
Combining gene expression and RBE: a complex issue 
In general, comparing the effects of radiations with different LET 
characteristics often comes to the differences in their RBE. However, while 
RBE does depend on the LET of the radiation used, precise RBE predictions 
cannot simply be made on the basis of LET information and require detailed 
knowledge of the beam composition, of fluency, charge, and velocity of the 
particles [9]. In addition, RBE also depends on the biological endpoint and 
biological system being studied [11]. For instance, carbon ions are more 
efficient than photons in cell killing [369, 370] and induction of apoptosis in 
normal cells which coincided with a differential effect on p53 phosphorylation 
[370]. However, the same group showed in two cell lines that induction of 
profibrotic PAI-1 is the same after high- and low-LET irradiation [370].  
Defining RBE for gene expression changes is a difficult and questionable 
task. First of all, gene expression cannot be regarded as a true endpoint, such 
as cell survival or chromosomal aberrations induction, as it is a dynamic 
process. In theory, one could define the dose needed to induce the same 
level of up- or down-regulation of a gene at a certain time point after exposure 
and thus calculate the RBE, but it is very probably that if another time point is 
chosen the RBE value would be different. Obviously, RBE values would also 
be very different if different genes are investigated. In addition, PBMCs 
include multiple cell types with varying radiosensitivity [371, 372] and, 
therefore, defining a single RBE value for this in vitro model is not feasible. 
Therefore in our transcriptome-wide study we decided to use equal rather 
than equitoxic doses of all radiation types. 
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X-rays and heavy ions induce up-regulation of similar p53-dependent 
genes, albeit with different amplitude and dynamics  
 
In our study we compared the transcriptional profiles of freshly isolated 
peripheral blood mononuclear cells of healthy donors after the cells were 
exposed to 1 Gy of X-rays, iron ions and carbon ions. Overall, the identity of 
the affected genes at 8 h post-exposure was very similar between all the 
radiation types, with most of the genes being regulated by p53 and involved in 
DNA repair, apoptosis and cell cycle regulation. In our opinion, this 
observation suggests that no matter what radiation type it is, in essence it 
causes DNA damage which triggers the activation of the above-mentioned 
processes. However, qRT-PCR validation of gene expression changes at 24 
h showed differences in kinetics of expression of several genes in response to 
exposure to high- and low-LET radiation. This observation is most probably 
the result of the more complex DNA damage caused by heavy ions which is 
more difficult to repair compared to X-rays, as confirmed by slower DNA 
repair kinetics shown in our study. This discrepancy in expression kinetics of 
different genes might also illustrate the RBE issue described above. Although 
we also found several genes “unique” to a specific radiation type, it is likely 
that many of them would also respond to the other radiation types in a 
different experimental set-up (i.e. time-dose combination).  
Heavy ions induce more significant enrichment of epithelial-
mesenchymal transition and immune response-related gene sets as 
compared to X-rays 
 
We also performed the enrichment analysis of different pathways induced by 
different radiation types. The most obvious discrepancy was observed for the 
gene sets involved in the immune response. Among these, NF-kB plays a 
central role in regulation of the expression of pro-inflammatory cytokines and 
chemokines such as TNF-α, IL-1, IL-2, IL-6 and MCP-1 [333]. Several studies 
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show that a lower dose of heavy ions is needed to activate NF-kB compared 
to low-LET radiation [335] [336]. Because NF-kB is involved in regulation of 
apoptosis, angiogenesis, proliferation and adhesion, its activation and 
interplay with p53-regulated pathways may play a critical role in cellular 
response to radiation, and especially heavy charged particles [139]. 
Interestingly, a study on 3D oral mucosa model showed that equivalent doses 
of both X-rays and carbon ions induced activation of NF-kB, although with 
different kinetics [373]. Same study showed 2- to 3-fold higher levels of pro-
inflammatory cytokine IL-6 and chemokine IL-8 after irradiation with X‑rays 
and carbon ions in 3D mucosa model co-cultures including PBMCs compared 
to mucosa models without PBMCs [373]. This observation is highly relevant 
for our study and might have implications for both radiotherapy patients and 
astronauts on long-term Space missions, not only in view of possible 
mucositis initiation but also overall increase of carcinogenic potential related 
to NF-kB activation [337]. It is clear that different radiation types have the 
potential to induce different immune alterations [334]. However, there are two 
sides of the coin. Carbon ions were also shown to induce anti-tumor immunity 
in a murine model [339]. Another study examining five human cancer cell 
lines showed that comparable levels of high mobility group box 1, which plays 
an important role in activating anti-tumor immunity were detected after 
irradiation with iso-survival doses of X-rays and carbon ions, meaning that a 
lower dose of carbon ions was needed to achieve the same effect [340]. 
These results suggest that carbon ion therapy might activate the immune 
system to a greater extent than conventional radiotherapy, even when 
equivalent doses are used. 
Another important gene set identified as significantly enriched by GSEA after 
exposure to all radiation qualities was related to EMT. Importantly, the 
enrichment of this gene set was more significant after exposure to carbon and 
iron ions. This gene set was also particularly enriched in up-regulated genes 
after exposure to iron ions. Although this process which contributes 
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pathologically to fibrosis, cancer progression and metastasis is not 
characteristic to the blood cells as such, these cells produce cytokines and 
growth factors which might trigger EMT [374]. Another explanation for this 
observation might be the partial overlap of the genes present in the EMT gene 
set with those from e.g. inflammation-related gene sets or p53-pathway gene 
set. In fact, EMT is tightly connected to inflammation, which has been recently 
identified as a key inducer of EMT during cancer progression [375]. Activation 
of EMT-related genes in response to different radiation types is highly 
important and needs further investigation and experimental confirmation as 
EMT has been proposed to be one of the critical mechanisms for the 
acquisition of malignant phenotypes by epithelial cells [376]. Several studies 
also suggest that EMT can be induced by radiation and is involved in 
radioresistance [377-380]. 
Exposure to heavy ions, and in particular to carbon ions, promotes 
alternative transcription and splicing 
As described for the X-ray exposures above, in the present study we also 
observed induction of alternative transcription and splicing by high-LET 
radiation, and the observed effect was more pronounced after exposure to 
heavy ions, especially carbon ions. The exons most extensively regulated in 
response to X-ray exposure were not the most regulated after heavy ions 
exposure, suggesting specificity in response. Although it is not possible to 
draw any definite conclusions on the biological relevance of this observation 
from the microarray data, it is tempting to further study the role of alternatively 
transcribed/spliced genes in the response to different radiation types. In a 
very recent study exposure to UV was shown to trigger a shift from protein-
coding mRNA of the ASCC3 gene, which was alternatively spliced in 
response to heavy ions exposure in our set up, to a shorter non-coding 
isoform incorporating alternative last exon, of which the RNA, rather than the 
encoded protein, is critical for the eventual recovery of transcription [343]. The 
non-coding ASCC3 isoform, in fact, counteracts the function of the protein-
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coding isoform and has an opposite effect on transcription recovery after UV-
induced DNA damage [343].  
Gene expression as a promising biomarker of radiosensitivity 
In view of the continuing search for biomarkers of sensitivity to (high-LET) 
radiation, in the present study we also investigated the potential of a signature 
of genes responsive to iron ions exposure to serve as an indicator of varied 
DNA repair capacity. However, it is important to stress that at this stage we 
performed a small-scale pilot study involving apparently healthy subjects, 
without any known abnormal variations in radiosensitivity. As a result, the 
differences in DNA repair efficiency of the four studied donors were not 
significantly different. However, the subject who showed the lowest rate of 
DNA DSBs repair, also showed a distinct gene expression profile observed 
for some genes as highest levels of up-regulation compared to control and for 
the others as higher overall expression in all samples. Interestingly, a recent 
study comparing transcriptional response of radiosensitive and radioresistant 
immortalized B-lymphocytes also showed a greater and prolonged response 
in radiosensitive cells with genes involved in DNA damage response and 
apoptosis still up-regulated 24 h post-exposure to 2 Gy of γ-rays [348].  
The ATM/CHEK2/p53 pathway plays a crucial role in cell cycle regulation 
(e.g. through the transcription of CDKN1A), DNA repair (e.g. through the 
transcription of DDB2) and apoptosis (e.g. through the transcription of PUMA) 
following radiation exposure and was suggested as a promising biomarker of 
susceptibility and late effects [193]. For example, Atm/Chek2/p53 pathway 
activity assessed by the response of Puma gene showed a good correlation 
with cancer induction in mice with different Trp53 gene copy number [381]. 
The data obtained in mice was further validated in human mitogen stimulated 
T-lymphocyte cultures from healthy donors, ATM mutation carriers and Li 
Fraumeni Syndrome patients following irradiation [381]. The ATM mutation 
carriers showed very weak up-regulation of PUMA, while Li Fraumeni 
Syndrome patients showed an intermediate response compared to healthy 
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individuals. These data confirm that monitoring radiation-induced changes in 
key p53 regulated genes can serve as a proxy of the overall DDR pathway 
activity, pointing to variation in susceptibility. 
Taking into account the higher potential of high-LET particles in inducing 
biological effects, it might be advisable to protect the individuals with aberrant 
gene expression response from long-term exposure to Space radiation and 
make extrapolations from low-LET radiation exposures data for radiation 
protection purposes with caution.  
As a general conclusion of our study it can be stated that low- and high-LET 
radiation induces similar processes in normal blood cells but heavy ions have 
a higher potential of their activation and the effect is more persistent. Our 
results imply that further more detailed investigations of transcriptional 
response could bring new insight into differential normal tissue responses to 
high- and low-LET radiation and might have implications for the development 
of hadron therapy treatment and radiation protection. 
To summarize, we would like to highlight the following main results and 
perspectives of this study: 
1. We identified gene and exon signatures suitable for precise 
classification of the in vitro irradiated samples based on the exposure 
dose. Genes and exons showed very similar dose prediction capacity 
for doses higher than 0.1 Gy. The next step would be the validation of 
the identified signatures in vivo, e.g. in radiotherapy patients, and the 
exploration of potential of exon signatures in predicting very low 
(below 0.1 Gy) dose exposures, which might also be done in 
individuals undergoing diagnostic CT scans. 
2. We demonstrated that exposure of human PBMCs to ionizing 
radiation induces alternative transcription and splicing. This 
observation has direct implications for any biodosimetry method 
relying on primer or probe-based assays. Functional studies on 
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radiation-induced splice variants would contribute to our 
understanding of the molecular mechanisms of radiation response 
and might point to potential biomarkers of individual response. 
3. We designed and tested a qRT-PCR array suitable for prediction of 
both dose (from 25 to 2000 mGy) and time (from 8 to 48 h). However, 
the validation of the method in vivo is of paramount importance. In 
addition, the potential of the present biodosimetric panel for 
assessment and discrimination of acute and chronic exposures could 
be investigated. The potential improvement of the methods would 
also be the exploration of non-invasive sampling (for example, 
collection of hair follicles). Another important point is the 
strengthening the network of biodosimetry laboratories and 
standardization and harmonization of the methods and protocols 
used. Further attention should be paid to validation of the new 
promising techniques, such as gene expression measurements used 
in our study. 
4. Transcriptional response to high- and low-LET radiation was similar in 
view of identity of activated genes at least at 8 h post-exposure. 
However, heavy ions showed higher potential of activation of 
immunity-related gene sets and more persistent activation of p53-
regulated genes compared to X-rays. More resolved mechanistic 
studies focusing on specific pathways would further contribute to the 
development of hadron therapy treatment and radiation protection of 
astronauts. 
5. We showed the potential of gene signatures, although in a very small-
scale pilot study, in assessing slight differences in DNA repair 
capacity following the exposure to iron ions of apparently healthy 
individuals. Further validation of the obtained results in larger cohorts 
of subjects, and, possibly, radiotherapy patients with abnormal 
radiosensitivity, would significantly improve our knowledge on gene 
expression biomarkers of individual radiosensitivity.   
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